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SUMMARY
Attempts were made to clone the yeast adenosine-5’- 
monophosphate deaminase (AMP deaminase) gene from- 
S .cerevisiae using a number of strategies. Initially, it was 
hoped that overproduction of AMP deaminase could be detected 
in yeast, by selecting for resistance to the AMP deaminase 
inhibitor, deoxycoformycin (dCF). This involved the 
construction of ade, hotl yeast strains in which the AMP 
deaminase reaction is the major source of inosine-5f- 
monophosphate (IMP). Although yeast AMP deaminase is 
sensitive to dCF in vitro no effect was observed in vivo 
(possibly due to lack of uptake of the drug).
Alternative screening methods based on adaptations of 
histoenzymatic stains and colorimetric assays for AMP 
deaminase were then studied for their suitability for 
selection of the AMP deaminase gene. These were unsuccessful 
due to the production of unsuitably high background signals 
and the stains’ relative insensitivity to yeast AMP deaminase 
activity.
AMP deaminase was then purified from S .cerevisiae using, a new 
purification method based on standard FPLC techniques to 
allow the production of N-terminal amino acid sequence data. 
These data were used to design, an oligonucleotide probe to 
screen a yeast genomic library. The N-terminal sequence of 
this purified protein proved to be "identical" to yeast heat 
shock protein 90 (hsp90), raising the question; are hsp90 and 
AMP deaminase the same protein?
Initial experiments were inconclusive since they revealed 
that AMP deaminase activity is maintained, but not markedly 
elevated during heat shock in yeast.
Since the yeast HSP90 gene was not available for this study 
(Farrelly and Finkelstein, 1984), the decision was made to 
construct a yeast integrating vector (Yip) to allow 
insertional inactivation of the HSP9/0 chromosomal locus. A 
Yip vector containing a hsp90:URA3 gene was constructed and 
was used to transform a suitable yeast strain. When this 
strain was compared under heat shock conditions with the host
1
strain and a strain carrying the entire HSP90 gene on a 
multicopy plasmid, no significant difference was observed in 
AMP deaminase activities. This strongly suggests that hsp90 
and AMP deaminase are not the same protein and hence that 
hsp90 had copurified with AMP deaminase during all stages of 
the purification. Presumably, it was this contaminating 
protein that yielded the N-terminal amino acid sequence data.
2
CHAPTER 1 
INTRODUCTION
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1.1 THE ROLE OF AMP DEAMINASE IN THE PURINE NUCLEOTIDE CYCLE
AMP deaminase (AMP aminohydrolase E.C.3.5.4.6.) is one of the 
enzymes that comprise the purine nucleotide cycle in 
eukaryotes along with adenylosuccinate synthetase and 
adenylosuccinate lyase as shown in Figure 1.1. The overall 
reaction catalysed in the cycle is shown below:
aspartate + H2O ----> fumarate + NH3
The functional significance of this cycling is obscure but it 
seems clear that the production of ammonia is of importance 
as discussed later (Lowenstein and Tornheim, 1971;
Lowenstein, 1972).
In E .coli no adenine deaminase or AMP deaminase activities 
have been detected, only adenosine deaminase has been found 
(Leung and Schramm, 1980). Therefore in prokaryotes AMP 
catabolism occurs via dephosphorylation to adenosine by AMP 
nucleosidase. Eukaryotic cells also contain a 
dephosphorylating enzyme capable of using AMP as a substrate, 
called 5 1-nucleotidase. This is a non-specific nucleotide- 
degrading enzyme which removes the phosphate group from 
mononucleotides. However, there is good evidence that in 
many eukaryotic systems the major purine degradation products 
are inosine and hypoxanthine rather than adenosine (Kather, 
1988). Van den Berghe et al. (1980) reported that in 
isolated rat hepatocytes 5'-nucleotidase is inactive on AMP 
unless the nucleotide rises to unphysiological 
concentrations. This also appears to occur in human 
erythrocytes where AMP deaminase is the preferred route of 
AMP degradation (Paglia et al. . 1986). Zoref-Shani et__aJL_ 
(1987), showed that a similar situation exists in primary rat 
muscle cultures. More recently the same group showed that 
while under normal circumstances rat cardiomyocytes produce 
and efflux inosine, hypoxanthine, xanthine and uric acid from 
the IMP produced by the AMP deaminase reaction, there is a 
greatly increased rate of AMP dephosphorylation by 5 1 
nucleotidase during periods of rapid ATP degradation (i.e. 
the simultaneous inhibition of glycolysis and electron 
transport) (Zoref-Shani et al.. 1988). Therefore it seems 
that the AMP deaminase reaction is the major route of AMP
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catabolism under normal physiological conditions, while 5 1 
nucleotidase acts at high AMP concentrations.
1.2 DISTRIBUTION OF AMP DEAMINASE
In a review by Zielke and Suelter (1971) it was reported that 
there is a virtual lack of adenine deaminase in animal 
tissues, although all eukaryotes contain both adenosine and 
AMP deaminases. As far as cellular localisation was 
concerned it was stated that in mammalian skeletal and heart 
muscle, AMP deaminase activity was found both in the 
cytoplasm and mitochondria, whereas in fish kidneys and gills 
the activity was located solely in the cytoplasm.
It is now clear that AMP deaminase activity is found at 
different levels in different tissues. In vertebrate sys'tems 
it is found at the highest levels in skeletal muscle 
(Makarewicz and Stankiewicz, 1974; Koretz and Frieden, 1980). 
Fishbein (1985) has stated that skeletal muscle shows 10 to 
50-fold higher AMP deaminase activity than any other tissue. 
The activity has been shown to be higher in type 2 fibres 
than type 1 (Higuchi et al.. 1987). Human muscle however 
shows lower AMP deaminase activities compared with rat 
(Makarewicz and Stankiewicz, 1974).
High AMP deaminase activities are also found in erythrocytes 
(Askari and Rao, 1968) and in lymphoblasts, where higher 
activities are found in B rather than T lymphoblasts (Dornand 
et al.. 1985).
There has been much less work done in invertebrate systems 
where AMP deaminase activities are generally very low, but 
again, highest in anaerobic muscle (Lazou, 1989). Far higher 
levels are found in the snail Helix lucorum's foot muscle 
than elsewhere in the molluscs and crustaceans surveyed. 
However, the general pattern of low AMP deaminase activity in 
invertebrates has led to the suggestion that there may be 
differences in the pattern of adenylate regulation in 
invertebrates relative to the better studied vertebrate 
systems (Lazou, 1989).
5
It the case of yeast, it was assumed for a long time that AMP 
deaminase was absent. It has now been established that the 
enzyme does exist in S .cerevisiae and it has been purified 
from that organism (Yoshino et al.. 1979b). The yeast enzyme 
has been shown to be similar to other AMP deaminases as 
regards its regulatory properties. It was shown that AMP 
deaminase from yeast is specific, showing no activity with 
ATP, ADP, adenosine or adenine. It shows only 7% of its 
maximal activity with deoxyAMP as its substrate instead of 
AMP (Yoshino et al.. 1979b).
1.3 DEVELOPMENTAL EXPRESSION OF AMP DEAMINASE
It is now clear that there are various isoforms of AMP 
deaminase in different vertebrate tissues (as indicated 
earlier, less is known about the invertebrate and lower 
eukaryote enzyme(s)). Ogasawara et al. (1972) identified 4 
different isoenzymes from rat brain tissue which varied with 
respect to their molecular weights and kinetic properties.
Ten years later it was shown that there are also four 
isozymes in human tissues (Ogasawara et al.. 1982). These 
were designated El and E2 (the major erythrocyte forms),, M 
form (major skeletal muscle form) and L (which is the major 
isozyme in liver and brain). In surveying other tissues it 
was shown that the heart, kidney and spleen contain a mixture 
of El, E2 and L isoforms (Ogasawara et al.. 1982). Again 
these different forms vary in molecular weights and at least 
in the case of El, M and L, they are immunologically 
different (Ito et al.. 1988). El and E2 are however very 
similar immunologically and kinetically (Ogasawara et al..., 
1982).
There is now good evidence that there is sequential 
expression of different isoforms of AMP deaminase during the 
development of the skeletal muscle of mammals.
Chromatography on phosphocellulose revealed the presence of 
two well separable forms of AMP deaminase in skeletal muscle 
extracts of 11 and 16 week old human foetuses (Kaletha et 
al.f 1987a; Kaletha and Novak, 1988). One form was identical 
to that found in adult muscle, and the second form (which is 
found in vestigial amounts in adult skeletal muscle) shows
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different kinetic properties.
This situation has been studied more extensively in the rat. 
It has been shown that in drug induced myogenesis of myocytes 
in vitro there is an increase in AMP deaminase activity which 
parallels the appearance and accumulation of myosin (Sabina 
et al.r 1984a). Similarily during the differentiation of 
myoblasts to myotubes there is a 10 to 100-fold increase in 
AMP deaminase activity. It is now clear that in the 
developing hind limbs of the rat, three different isoforms 
can be detected (Marquetant et al.. 1987). Firstly, an 
embryonic form is seen 7 to 14 days through gestation. This 
isoform is not unique to skeletal muscle or to the embryo, 
but can be seen in many non-muscle tissues of the adult rat. 
There is also a perinatal form which is restricted to 
skeletal muscle and which is produced from 4 to 6 days before 
birth and is continued to be expressed for 2 to 3 weeks 
postnatally. The third or adult isoform appears at birth and 
reaches adult levels three weeks after birth (Marquetant et 
al.. 1987). It was not clear whether these three isoforms 
represented the products of separate genes or the products of 
differential splicing of the same primary transcript.
Recently, Sabina et al. (1987) have succeeded in cloning a 
cDNA corresponding to the rat adult muscle AMP deaminase 
isoform mRNA and using this they have looked at the 
expression of AMP deaminase in the development of the muscles 
of the hind limb and during myocyte differentiation in vitro. 
Their conclusions are that in embryonic muscle and 
undifferentiated myoblasts a 3.4kb transcript encodes a 78kD 
peptide which cross-reacts with antisera raised against an 
isoform from adult kidneys. In perinatal muscle and myocytes 
at an intermediate stage of differentiation, a 2.5kb mRNA 
encoding a 77.5kD polypeptide is produced which cross reacts 
with antisera to the major adult heart muscle isozyme. And 
at birth, another 2.5kb transcript is produced representing 
the adult muscle isoform (Sabina et al.. 1989). This group 
have now concluded that the two 2 .5kb transcripts may be the 
products of the same gene, through differential splicing of a 
single primary transcript, but that the 3.4kb mRNA represents 
a functionally distinct gene.
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A similar situation has been studied in the skeletal muscle 
of chickens, where there appears to be only two isoforms of 
AMP deaminase, an embryonic form (similar to the isozyme 
found in adult chicken brain) and an adult form (Sammons and 
Chilson, 1977 and 1978; Kaletha, 1983).
Spychala et al. (1985) have also studied the expression of 
AMP deaminase in the chicken liver. Unlike the development 
of rat skeletal muscle (Marquetant et al.. 1987), and other 
chicken tissues, (for example; brain tissue where there is an 
increase in AMP deaminase activity throughout development 
(Spychala et al.. 1985)), in the chicken liver there is no 
such continual increase. There are two distinct isoforms, 
type I and type II. Type I reaches 80% of the adult level 
within the first ten days of development. This may indicate 
that it plays a crucial function in the liver, possibly 
connected with the massive production of uric acid (Spychala 
et al., 1985). Koretz and Frieden (1980) showed that AMP 
deaminase binds strongly to subfragment 2 of. myosin in vitro, 
and to the ends of the A bands of myofibrils in vivo. Cooper 
and Trinick (1984) showed that the interaction between AMP 
deaminase and myofibrils is due to the presence of specific 
binding sites for the enzyme (6 binding sites/thick 
filament). A similar situation seems to exist in 
invertebrate muscle where in general AMP deaminase activities 
are much lower. Raffin and Thebault (1987) have purified the 
tail muscle AMP deaminase from prawn. The enzyme was closely 
associated with contaminating contractile proteins, 
especially actin. There is also evidence of specific binding 
sites for AMP deaminase on the surface of hepatocytes (2.6 x 
10^/hepatocyte) which contribute to the rapid clearing of 
intravenously injected AMP deaminase from the circulation of 
chickens (Husic and Suelter, 1984).
Higuchi et al. have shown that in addition to its association 
with myosin, high AMP deaminase activity is found in rimmed 
vacuoles in muscles cells in certain myopathic conditions 
(Higuchi et al.f 1986 and 1987). They suggest that AMP 
deaminase may be bound to membrane domponents as well as 
myosin in muscle cells.
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TABLE 1.1 EFFECTORS OF AMP DEAMINASE
POSITIVE NEGATIVE
ATP1'2
dATP1
fatty acids9
polyamines8 '21
11 15 spermine-1"1-'
monovalent cations10'22
alkali metals10
alkaline earth metals10'20
polyphosphoinositols19
GTP1'4
inorganic phosphate-1-'0'-1-0 
fatty acids9 '11'12 
fatty acyl Co-As®
O
polyamines0
2,3-diphosphoglycerate23 
1 Rpolyphosphates-1-0
1 ntransition metals ,J-
7
tetraiodofluorescein
c
blue dextran0
1 7anthraquinone compounds-1-1 
napthosulfonate
1 ficompounds
1 Murakami (1979)
2 Cunningham and Lowenstein
(1965)
3 Spychala and Marszalek
(1987a)
4 Ashby et al. (1982)
5 Yoshino et al. (1974)
6 Yoshino et al. (1976)
7 Yoshino and Kawamura (1978a)
8 Yoshino and Murakami (1978b)
9 Yoshino et al. (1979a)
10 Yoshino and Murakami (1980)
11 Yoshino and Murakami (1981a)
12 Yoshino and Murakami (1981b)
13 Yoshino and Murakami (1981c)
14 Yoshino and Murakami (1981d)
15 Yoshino and Murakami (1982a)
16 Yoshino et al. (1984)
17 Yoshino and Kawamura (1986b)
18 Yoshino and Murakami (1988)
19 Spychala (1987b)
20 Almarez and Garcia-Sancho
(1989)
21 Yoshino and Murakami (1987)
22 Raffin (1984)
23 Askari and Rao (1968)
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1.4 REGULATION OF AMP DEAMINASE
The enzyme has been purified from a number of systems 
including rat liver (Smith and Kizer, 1969); rat skeletal 
muscle (Coffee and Kofke, 1975); S .cerevisiae (Yoshino et 
al.f 1979b) and snail foot muscle (Stankiewicz, 1986). The 
purification of the yeast enzyme is discussed fully in 
Chapter 5.
Each of these enzymes has been found to be large, in the 
region of 240 and 360 kDaltons. And in each case AMP 
deaminase is tetrameric with subunits of identical size. The 
methods of purification have varied, although some have 
relied on the enzyme's affinity for ATP in either affinity 
adsorption or affinity elution chromatography. The 
purification of AMP deaminase from these sources has allowed 
detailed study of the regulation of the enzyme.
The regulation of AMP deaminase is highly complex.. There are 
a host of cellular metabolites and synthetic compounds which 
allosterically activate or inhibit the enzyme. In some 
cases, the same effector will inhibit the enzyme from one 
tissue and activate it from another. These effectors are 
summarised in Table 1.1.
Most AMP deaminase isoenzymes are strongly activated by ATP, 
including the enzyme found in the brain (Cunningham and 
Lowenstein, 1965, Setlow et al.. 1966). liver (Smith and 
Kizer, 1969), platelets (Ashby and Holmsen, 1983), small 
intestine (Spychala et al.. 1986), kidney, lungs, pancreas, 
spleen and testes (Setlow et al.. 1966). AMP deaminase from 
S.cerevisiae is also activated by ATP (Murakami, 1979).
There are however, some forms of the enzyme which are 
insensitive to the effects of ATP including the heart muscle 
isoform (Skadanowski and Zydowa, 1988).
There is now evidence that MgATP^" is the true physiological 
activator, since most isozymes which are activated by ATP are 
maximally activated in the presence/of MgATP (Ashby and 
Holmsen, 1983; Spychala et al.. 1986). The presence of ATP 
has also been shown to largely prevent heat-inactivation of 
AMP deaminase from mammalian brains (Cunningham and
9
Lowenstein, 1965).
In general AMP deaminase from almost all sources is strongly 
inhibited by inorganic phosphate (Van den Berghe et al., 
1977; Murakami, 1979; Ashby et al.. 1982; Spychala et al.,
1986). In contrast to ATP, another purine triphosphate 
nucleotide, GTP is a general and potent inhibitor of AMP 
deaminase from most sources (Setlow et al.. 1966; Van den 
Berghe et al.. 1977; Ashby et al.. 1982). For some isoforms 
however, the effect of GTP is somewhat complex. The 
mammalian liver isoenzyme is activated by GTP when AMP is 
present at low concentrations, but inhibited by GTP at high 
substrate concentrations (Smith and Kizer, 1969).
It has been proposed that the regulation of AMP deaminase in 
any particular tissue, may be regulated at least in part by 
the endogenous concentrations of AMP, ATP and GTP (Smith and 
Kizer, 1969). This hypothesis may be an oversimplification 
because AMP deaminase activities respond to a wide range of 
allosteric effectors (Table 1.1).
Saturated fatty acids are inhibitors of purified yeast AMP 
deaminase (if there are more than ten carbon atoms in the 
hydrocarbon chain), but show little inhibition of the enzyme 
in the presence of ATP. Unsaturated fatty acids are more 
powerful inhibitors, whose inhibition is not significantly 
overcome by ATP (Yoshino and Murakami, 1981b). Similarly, 
spermine can release AMP deaminase in permeabilised yeast 
cells from fatty, acid inhibition, whereas alkali metal ions 
cannot (Yoshino and Murakami, 1981a). Therefore, there 
appears to be a hierarchy in the regulation by effectors of 
this highly allosteric enzyme, which must contribute to the 
fine-control of its activity in the cell. Forms of the 
enzyme from different sources or tissues show different 
levels of inhibition or activation with respect to these 
effector molecules. For instance, brain AMP deaminase is 
more sensitive to inhibition by fatty acyl CoAs than the 
isozyme found in liver (Yoshino et al.. 1976).
V
A great deal of information has been produced about the 
regulation of the yeast AMP deaminase either in its purified 
form or in situ in permeabilised cells. The results of such
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work suggests that there are two types of cation binding 
sites on the enzyme. One class of binding site includes 
activating sites for alkali metals, polyamines, and free 
alkaline earth metals and the inhibition sites for transition 
metals. The other sites are the activating sites for ATP- 
metal complexes (Yoshino and Murakami, 1980).
Kinetic studies show that in the case of the yeast enzyme, 
there are two interaction sites for AMP and inorganic 
phosphate per molecule, and have led to the proposal that the 
enzyme (which is a tetramer) consists of two "protomer" units 
each of which consists of two polypeptide chains with 
identical molecular weights (Yoshino and Murakami, 1980).
There is strong evidence that at least in some systems, 
activation of AMP deaminase occurs, at least in part, by non- 
allosteric methods. Buniatian and Haroutunian (1971) showed 
that the addition of hexokinase (purified either from yeast 
or brain tissue) to mitochondrial fractions of rat brain 
causes a considerable increase in the formation of ammonia, 
due to the activation of AMP deaminase. Another isozyme of 
hexokinase isolated from the brain which was shown to be very 
similar to the skeletal muscle form showed no activating 
power (Haroutunian and Buniatian, 1974). Hexokinase is found 
in brain mitochondria where there is no glycolysis, and the 
function of this protein in this location is unknown 
(Buniatian and Haroutunian (1971). It is not yet clear how 
this form of regulation occurs since it appears that an 
active hexokinase is not required, since subunits of the 
yeast hexokinase (produced by urea treatment) also activate 
AMP deaminase.
Another interesting form of activation of AMP deaminase has 
come to light in two quite different tissues. In 1985, 
Ranieri-Raggi et al. demonstrated that limited proteolysis of 
rabbit skeletal muscle AMP deaminase with trypsin results in 
the conversion of the enzyme to a form which is no "’longer 
inhibited by ATP and exhibits hyperbolic kinetics even at low 
potassium concentrations and in the/absence of ADP. The 
interaction with troponin T from white skeletal muscle or 
with the phosphorylated 42 amino acid N-terminal peptide of 
troponin T restores to the trypsin-treated AMP deaminase the
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sensitivity to adenine.nucleotides and increases the KA for 
potassium activation of the enzyme from 1 to 12mM. Treatment 
of the N-terminal peptide of troponin T with alkaline 
phosphatase abolishes the modulating properties of the 
peptide suggesting that phosphorylation and dephosphorylation 
processes may be involved in the regulation of the enzyme.
Raffin (1986a) showed that trout gill AMP deaminase can be 
activated by an endogenous proteinase, in a manner similar to 
the alteration of the rabbit muscle enzyme described above. 
These alterations of the regulation of the enzyme include 
shifting the optimal activating concentration of sodium and 
potassium ions from 10 to 75mM resulting in a large increase 
of enzyme activity near the physiological concentrations of 
these ions. The modified enzyme is also much less sensitive 
to modifications in pH and inhibition by inorganic phosphate. 
In total the level of activation by this limited proteolysis 
was estimated to be approximately 40-fold in in vivo 
conditions (Raffin, 1986a). This may be a widespread form of 
regulation of this enzyme since Raffin also observed that in 
crude extracts of frog muscle, rabbit muscle and trout gill, 
the AMP deaminase activity increased with storage, suggesting 
that the activation may normally be mediated by an endogenous 
proteinase which can be mimicked by trypsin (Raffin, 1986a). 
He also showed that AMP deaminase purified from trout gills 
is insensitive to this proteolytic activation, suggesting 
that some modification has already occurred. Under 
environmental peturbations (starvation, pollution with 
pesticides, transfer to sea water, and reverse transfer to 
fresh water), the gills produce a greater proportion of 
modified enzyme (Raffin, 1986b). This proportion can vary 
from 8 to 100% of total depending on the nature of the stress 
and the length of time the fish is exposed to it. As a 
consequence of this modification during stress, increases in 
AMP deaminase activity of between 2 and 12-fold were 
observed. Raffin proposed that proteolysis occurs in the 
gill tissues to activate AMP deaminase under conditions of an 
increased energy demand (Raffin, 1986b). Raffin also 
suggests that AMP deaminase may be iriodified in this way in a 
wide range of systems under conditions of stress. Metabolic 
or cellular stress is often accompanied by and increase in 
the cellular inorganic phosphate concentration which will in
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general inhibit the enzyme. Therefore by producing a 
modified form of the enzyme with a reduced sensitivity to 
inorganic phosphate a high specific activity may be 
maintained when it is most required (Raffin, 1986b and 
1986c).
With reference to AMP deaminase from yeast, one group in 
particular have studied the regulation of this enzyme in 
depth. Yoshino and Murakami have been studying AMP 
deaminases since the early seventies and have carried out a 
detailed biochemical study of the yeast enzyme over the last 
ten years. They initially used purified AMP deaminase 
(Murakami, 1979; Yoshino and Murakami, 1979b) to study its 
regulation and then went on to study the regulation of the 
enzyme in situ in permeabilised yeast cells (Murakami et al,.,. 
1980).
The enzyme is similar in most respects to those found in 
other systems. It is activated by ATP, cLATP, alkali metal 
ions, alkaline earth metals and polyamines (Murakami, 1979; 
Yoshino and Murakami, 1980). It is inhibited by GTP, 
inorganic phosphate, transition metals (Murakami, 1979; 
Yoshino and Murakami, 1980). In these respects it seems most 
similar to the mammalian liver isozyme (Murakami, 1979). The 
patterns of regulation are similar in situ and with the 
purified enzyme, with some minor modulations (Murakami,
1980).
There has been a great deal of interest in the effects of 
adenosine deaminase inhibitors including coformycin (CF), 
deoxycoformycin (dCF) and erythro-9-(2-hydroxy-3-nonyl) 
adenine (EHNA) on AMP deaminase. This body of work on the 
effect of adenosine deaminase inhibitors has been produced, 
in part, because of the interest in adenosine deaminase as a 
suitable enzyme to be targetted for certain cancer 
treatments. CF and dCF especially are currently being tested 
for their effectiveness in the treatment of certain lymphoid 
malignancies (Bagnara and Hershfield, 1982). The drugs act 
by inhibiting adenosine deaminase resulting in an 
accumulation of adenosine, 2 1deoxyadenosine and other 
metabolites which are toxic to the cell. Henderson et al_._ 
(1977) showed that high concentrations of EHNA and dCF
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inhibit all pathways of purine ribonucleotide synthesis and 
also inhibit purified AMP deaminase from Ehrlich ascite 
tumour cells. Similarly, Agarwal and Parks (1977) showed 
that CF and dCF are potent inhibitors of rabbit muscle AMP 
deaminase. They appear to be behaving as transition state 
analogues (Frieden et al.. 1980). Frieden et al. (1979) 
showed that the favoured inhibitor is likely to be the 5 1 - 
phosphate form of these drugs, which mimic more closely the 
structure of AMP.
A group headed by Debatisse, have used the analogue 
coformycin to select for Chinese hamster fibroblast lines 
with increased AMP deaminase activity due to amplification of 
the AMP deaminase gene (Debatisse et al.. 1984). This is 
discussed fully in Chapter 3.
More recent work has been done to test the effectiveness of 
these analogues in conjunction with 2-halo-2 1,3'- 
dideoxyadenosine derivatives against the HIV-I virus. These 
halo-derivatives have in vitro activity against the HIV-I 
virus, but can be catabolised by human T cells even when the 
cell's adenosine deaminase is inhibited by CF (Haertle et 
al.. 1988). The suggestion is that they are being deaminated 
by AMP deaminase which is not inhibited by the concentrations 
of CF being used (concentrations lower than those that 
produce cyto-toxicity in uninfected cells). The conclusion 
is that dideoxyadenosine derivatives are of limited value in 
preventing the spread of HIV-I infection, because of the high 
AMP deaminase activity found in lymphocytes (Carson et al.., 
1988).
Buchwald et al. (1981) have produced a murine T-cell lymphoma 
line which has altered AMP deaminase activity by selection in 
medium containing arabinosyl 2,6-diaminopurine. Selected 
cell lines were characterised and showed increased 
sensitivity to adenine and adenosine, in the presence of the 
adenosine deaminase inhibitor, EHNA. Adenine and adenosine 
cause inhibition of de novo purine biosynthesis and when used 
in conjunction with adenosine deamiiiase/AMP deaminase 
inhibitors they result in cytotoxicity caused by IMP and 
guanylate nucleotide starvation (Debatisse et al.. 1981).
This sensitivity was reduced by the addition of hypoxanthine,
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guanosine or deoxyguanosine. The cell line also shows 
decreased sensitivity to thymidine, deoxyadenosine (plus 
EHNA), arabinosyl guanine and arabinosyl adenine (plus EHNA). 
They concluded that this phenotype was due to two separate 
mutations. This first was concluded to be an alteration of 
ribonucleotide reductase activity. The second was an AMP 
deaminase with altered kinetic properties which accounts for 
the increased sensitivity to growth inhibitors adenine or 
adenosine, and decreased flux of nucleotides from AMP to IMP. 
This altered AMP deaminase also showed increased sensitivity 
to inhibition by inorganic phosphate. Characterisation of 
such variants with altered AMP deaminase activity may give an 
insight into the true role of AMP deaminase in the cell.
1.5 THE ROLE OF AMP DEAMINASE IN HUMAN DISEASE
Two histoenzymatic stains have been developed to detect and 
localise AMP deaminase activity in skeletal muscle sections 
(which are discussed fully in Chapter 4) (Nakatsu, 1975; 
Fishbein, 1977a). However, the development of the more 
recent stain (Fishbein, 1977a) has led to in the discovery of 
a new disease of skeletal muscle, myoadenylate deaminase 
deficiency (MADD) (Fishbein, 1978). In applying the 
histoenzymatic stain to muscle biopsies it was found that 6 
out of 300 biopsies surveyed had little or no AMP deaminase 
activity. This finding was confirmed by biochemically 
assaying for AMP deaminase (Fishbein et al., 1978). The 
biopsies were histologically normal, but ischemic forearm 
exercise followed by determination of plasma ammonia and 
lactate levels showed that MADD patients do not produce the 
expected increase in plasma ammonia relative to lactate 
(Fishbein et al.. 1978). Patients with this deficiency 
suffer from mild to moderate cramping or fatique following 
exercise (Dimauro et al.. 1980). The AMP deaminase 
activities from erythrocytes, leukocytes and cultured 
fibroblasts are all normal (Dimauro et al.. 1980; Fishbein et 
al.f 1981) which led to the suggestion of there being 
different genes involved in the different tissue-specific AMP 
deaminases. Intriguingly, primary muscle cultures from 
these patients also had normal AMP deaminase activities 
suggesting the persistant expression of a fetal isoenzyme
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(Dimauro et al.r 1980).
Fishbein et al. (1981) went on to show that some lymphoblast 
lines show an AMP deaminase which is more sensitive to CF, 
dCF and EHNA than their adenosine deaminases, again 
suggesting that immature lymphoblasts, too, may have a 
qualitatively distinct isozyme.
It now seems clear that MADD is an autosomal recessive 
disease (Sinkeler et al.. 1988) which, it has been estimated, 
occurs at a frequency of 1-2% in the population. It is 
therefore the most common enzyme deficiency of skeletal 
muscle (Fishbein et al.. 1985). It is clear that MADD 
disrupts purine metabolism which accounts for the muscle 
dysfunction observed (Sabina et al.. 1984b; Valen et al..
1987). However, individuals with MADD were shown to be 
equally capable of maintaining a high adenylate energy charge 
value, as controls. This is probably due to the normal 
regulation between ATP consumption and regeneration (Sinkeler 
et al.f 1987). However ATP, ADP and total adenylates (not 
AMP) are significantly elevated in MADD muscle cells 
(Sinkeler et al.. 1987). The age of onset of the symptoms of 
the disease is variable as is the severity of the 
musculoskeletal symptoms. However the disease does appear to 
be progressive (Daily et al.. 1985).
The discovery of this deficiency has attracted a great deal 
of interest, for a number of reasons. It has long been known 
that AMP deaminase activity can be reduced in different forms 
of muscular dystrophy (Pennington, 1961; Kar and Pearson,
1973; Young et al.. 1984; Nagao et al.. 1986). It is now 
clear that this deficiency of AMP deaminase is either 
coincidental or a secondary effect of the disease (Kar and 
Pearson, 1973). However, MADD has continued to be implicated 
in a wide range of neuromuscular disorders including primary 
hypokalaemic periodic paralysis (Engel et al.. 1964), myalgic 
encephalomyelitis (Staines, 1985), McCardles disease 
(Sinkeler et al.r 1986; Heller et al.. 1987), Carnitine 
palmitoyl transferase deficiency (Reuschenbach and Zierz,
1988) and malignant hyperthermia susceptibility (Fishbein et 
al.. 1985).
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There is some evidence that MADD may be associated with 
malignant hyperthermia susceptibility, which is a 
susceptibility to anaesthesia induced fever, muscle rigidity 
and paralysis. This was believed to be inherited as a 
dominant trait with incomplete penetrance and variable 
expressivity (Fishbein et al.. 1985). There is now evidence 
that this susceptibility requires a primary dominant gene 
defect and possibly a second recessive trait. It is 
suggested that this latter gene may encode AMP deaminase 
(Fishbein et al.. 1985).
It seems likely that the implied association of AMP deaminase 
deficiency with most of the neuromuscular disorders listed 
above is coincidental because of the frequency of this gene 
disorder. Alternatively, it may be that some of these 
disorders result in a secondary deficiency in AMP deaminase 
(Fishbein et al.. 1985). One suggestion is that such 
patients are heterozygous for AMP deaminase (which will be a 
common occurrence since MADD occurs in 1-2% of the 
population).
More recently a deficiency of AMP deaminase has been reported 
in erythrocytes, once again inherited as an autosomal 
recessive trait (Ogasawara et al.. 1984). There appears to 
be no hematological disorder and the individuals with this 
deficiency are healthy. The deficiency is only seen in 
erythrocytes. Mononuclear cells and platelets have normal 
levels and the deficiency is only in one isozyme, one of the 
erythrocyte forms. Like the skeletal muscle disease, this 
deficiency is also seen at a high frequency, in the areas of 
Japan surveyed. It was estimated that approximately one in 
thirty individuals are heterozygotes. One similarity to 
MADD is that ATP in the deficient cells was approximately 50% 
higher than in control erythrocytes (Ogasawara et al.., 1987) 
again emphasising the important role AMP deaminase plays in 
the regulation of cellular adenylates.
1.6 THE ROLE OF AMP DEAMINASE IN THEf MAINTENANCE OF THE 
ADENYLATE ENERGY CHARGE
As previously stated, AMP deaminase is an important component
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of the purine nucleotide cycle. However, the enzyme has been 
implicated in other important roles within the cell. In 
particular, it plays a part in the stabilisation of the 
adenylate energy charge. The adenine nucleotides 
stoichiometrically couple all the metabolic processes of a 
cell. The amount of metabolically available energy and 
thereby the cell's viability and growth capability that is 
momentarily stored in the adenylate system is known as the 
adenylate energy charge. The adenylate energy charge is 
measured by the following equation:
[(ATP) + 1/2(ADP)]
[(ATP) + (ADP) + (AMP)]
The energy charge must be maintained at a high value to 
maintain viability and growth. Values vary from organism to 
organism. In E .coli for instance the energy charge must be 
greater than 0.5 to prevent cell death, and must be 
maintained at or above 0.8 to allow growth (Chapman et al.., 
1971). Chapman and Atkinson (1973) showed that in liver 
cells, where the energy charge is normally 0.7 to 0.8 the 
rate of deamination of AMP increases sharply as the adenylate 
energy charge falls. Clearly the AMP deaminase reaction 
increases the energy charge by removal of AMP from the 
adenylate pool. However, the same group showed that this 
depletion of adenylates by the AMP deaminase reaction 
continues only until the adenylate pool drops to below a 
physiological range (Chapman and Atkinson, 1973), at which 
point AMP deaminase activity drops sharply. This may be a 
self-limiting response to prevent excessive depletion of the 
pool. This response has also been confirmed in muscle 
extracts (Tornheim and Lowenstein, 1974).
The pattern of stabilisation of the adenylate energy charge 
appears to be more complex in the yeast S .cerevisiae. When 
grown aerobically on ethanol or glucose and allowed to pass 
into stationary phase, yeast cells manage to maintain a 
normal energy charge value of 0 .8-0 .9 even'during prolonged 
starvation in media depleted of nutrients. This is in 
contrast to yeast grown either anaerobically on glycogen or 
in the early stages of aerobic growth on glucose which when 
transferred to medium lacking an energy source, the energy
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charge rapidly drops (Ball and Atkinson, 1975). The results 
suggest that functional mitochondria and/or the enzymes of 
the glyoxylate pathway are required for maintenance of a 
normal energy charge during starvation. Yeast are also 
unusual in that unlike E .coli they can maintain viability at 
energy charge values as low as 0.1 (Ball and Atkinson, 1975).
There is increasing evidence that cells respond more to the 
adenylate energy charge than the actual amount of cellular 
ATP. For instance, in platelets cell function is maintained 
even when two-thirds of metabolic ATP is lost, but becomes 
aberrant if the adenylate energy charge falls by only as much 
as 5% (Holmsen and Robkin, 1977). Again, the removal of AMP 
to stabilise the energy charge occurs primarily by the AMP 
deaminase reaction, although 5 1-nucleotidase can respond to 
drops in the adenylate energy charge but only, as in the case 
of cultured lymphoblasts, when the AMP deaminase reaction 
alone has been unsuccessful and the energy charge has dropped 
below 0.6 (Matsumoto et al.. 1979). Clearly, maintenance of 
a high adenylate energy charge is vital to normal cell 
function in many systems.
Recently, Ilzasa and Miyamoto (1987) have shown that the 
pattern of excretion from human lymphoblasts alters with the 
energy charge. When the energy charge is high, most of the 
excreted purines are intermediates of the de novo purine 
synthetic pathway, whereas when the energy charge drops, IMP 
produced by the AMP deaminase reaction, and its by-products 
are the major source of excreted purines.
It has been known for some time that the AMP deaminase 
reaction is the major source of NH3 in blood (Conway and 
Cooke, 1938 and 1939). The AMP deaminase has also been shown 
to produce most of the ammonia which accumulates in working 
muscle (Lowenstein and Tornheim, 1971). In fact, it has been 
shown that in frog skeletal muscle, the amount of ammonia 
produced is proportional to the amount of work done by the 
muscle, although AMP deaminase is not directly involved in 
muscle contraction. (Lowenstein and Tornheim, 1971). There 
is now evidence that in the production of ammonia, the AMP 
deaminase reaction, in addition to its direct affect on the 
adenylate energy charge by the removal of AMP, may also
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stimulates the regeneration of cellular ATP, thus indirectly 
enhancing stabilisation of the energy charge (Yoshino and 
Murakami, 1982b).
As already stated, AMP deaminase is activated when the energy 
charge falls and hence increases the production of ammonia.
In so doing the AMP deaminase reaction has been proposed to 
stimulate at least two glycolytic enzymes. Ammonia is an 
allosteric activator of phosphofructokinase and pyruvate 
kinase. ATP inhibits these two enzymes (Weber et al.. 1967), 
and hence when the energy charge is low, ATP concentrations 
are low and ammonia concentrations increase, allowing 
activation of these two enzymes. It has been proposed that 
this stimulation may result in an increase in glycolytic flux 
(Yoshino and Murakami, 1982c and 1983). Phosphofructokinase 
and pyruvate kinase along with hexokinase are often stated to 
be rate-limiting steps in glycolysis (Hess, 1971), i.e. have 
high control coefficients with respect to glycolytic flux 
(Kacser, 1983). However, there is some debate as to whether 
this is the case in yeast. One group has shown that 
overproduction of either phosphofructokinase or pyruvate 
kinase has little effect on glycolytic flux (Schaff et a l , 
1989). It now seems clear that these two enzymes have high 
control coefficients in many tissues although the situation 
in yeast awaits clarification (Bosca and Corredor, 1984;
Fell, 1984). It may be that when the energy charge within 
cells is low (thus enhancing AMP deaminase activity), the 
production of allosteric activators of glycolytic enzymes 
leads to the enhanced regeneration of ATP suggested by 
Yoshino and Murakami (1982d).
This response to changes in the adenylate energy charge has 
been studied in great detail in yeast. Yoshino and Murakami 
(1983) showed, using permeabilised yeast cells, that both AMP 
deaminase and phosphofructokinase activities were activated 
by reductions in the adenylate energy charge. The optimal 
energy charge value for the response of phosphofructokinase 
being between 0.3 and 0.5. They also showed that the addition 
of N H ^  ions further stimulated phosphofructokinase activity. 
Spermine activation of AMP deaminase resulted in activation 
of phosphofructokinase, by the increase in ammonium ion 
concentration, (spermine has no direct affect on
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phosphofructokinase). Similar effects were also noted for 
pyruvate kinase (Yoshino and Murakami, 1985a). The same 
group later showed that during aerobic growth where cellular 
citrate concentrations are high the AMP deaminase reaction 
can participate in the stabilisation of the energy charge 
only by the depletion of total adenylates and not by 
glycolytic stimulation (citrate is an inhibitor of 
phosphofructokinase) (Yoshino and Murakami, 1985c). Tornheim 
(1979) postulated that the purine nucleotide cycle and the 
glycolytic pathway oscillate to maintain a high ATP:AMP 
ratio. It was shown in skeletal muscle extracts that the 
control of phosphofructokinase activity by adenine 
nucleotides alone leads to the establishment of a steady 
state, but where appropriate, oscillations in the purine 
nucleotide cycle through the AMP deaminase reaction will also 
produce oscillations in the rate of glycolysis (Tornheim, 
1979).
In platelets AMP deaminase is activated in response to 
changes brought about by thrombin stimulation, which leads to 
the loss of 30% of platelet metabolic adenine nucleotides 
(Ashby and Holmsen, 1983) and the suggestion has been made 
that, under these conditions, AMP deaminase may, instead of 
stimulating ATP production by NH3 activation of glycolysis, 
simply cause displacement of the adenylate kinase reaction 
(2ADP = ATP + AMP) in favour of ATP production. E .coli AMP 
nucleosidase behaves in a qualitatively similar manner as 
platelet AMP deaminase with regard to its interactions with 
AMP, MgATP^ and inorganic phosphate and precisely the same 
mechanism has been proposed for the regulation of the 
bacterial enzyme (Ashby and Holmsen, 1983).
As previously stated, in muscle the ammonia produced by the 
AMP deaminase reaction is proportional to the work done by 
the muscle. Clearly work carried out by muscle depletes the 
energy stores of the muscle. Mommsen and Hockachka (1988) 
showed that during exhaustive exercise trout muscle ATP is 
depleted by more than 90%, resulting in a stoichiometric 
increase in IMP and ammonium ions. /During exercise, of the 
three enzymes of the purine nucleotide cycle only AMP 
deaminase is active. Conversely',' during slow recovery after 
exercise AMP deaminase is effectively inactive, while the
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other two enzymes of the cycle, adenylosuccinate synthetase 
and adenylosuccinate lyase replenish the adenylate pool. 
Mommsen and Hockachka (1988) therefore propose that under 
certain conditions, the two halves of the purine nucleotide 
cycle, AMP deaminase and adenylosuccinate 
synthetase/adenylosuccinate lyase are functionally and 
temporally separated. They also proposed that AMP deaminase 
functions during exercise to supply allosteric effectors to 
aid recovery from whatever stress is applied. The situation 
in rat hepatocytes is somewhat different. In normally fed 
rats, ATP depletion can be induced in anoxic conditions, but 
the depletion is slow due to the presence of glycogen stores, 
allowing the generation of ATP by anaerobic glycolysis, 
whereas in hepatocytes from rats starved for 24 hours, the 
ATP almost completely disappears in the first five minutes of 
anoxic conditions, being replaced partly by the accumulation 
of AMP (Vincent et al.. 1982). This can be explained by the 
fact that ATP (a major activator of AMP deaminase) disappears 
and is replaced by inorganic phosphate (a major inhibitor of 
AMP deaminase) and therefore AMP deaminase activity drops. 
Therefore, the AMP deaminase reaction can be shut down to 
prevent depletion of the adenylate pool under certain 
conditions.
Another central role in the metabolism of the cell has been 
suggested for the AMP deaminase reaction. It has been 
demonstrated that in rabbit reticulocyte lysates, AMP 
inhibits protein synthesis by inhibiting polypeptide chain 
elongation. This inhibition can be lifted by removing the 
AMP via the addition of AMP deaminase to the lysate (Mosca et 
al.. 1983). Therefore, it has been proposed that under 
certain conditions the AMP deaminase reaction may play a role 
in controlling the rate of protein synthesis. In yeast the 
AMP deaminase reaction has also been implicated in the 
stimulation of threonine dehydratase activity by its 
production of ammonia, (Yoshino and Murakami, l'981d) and in 
the stimulation of fructose-1 ,6-bisphosphatase activity by 
the removal of AMP (Yoshino and Murakami, 1985b).
22
1.7 THE AIMS OF THIS STUDY
AMP deaminase has been shown to have a central role in many 
key reactions within the cell. At the outset of this 
project, although work was going on to elucidate the 
biochemical regulation of the enzyme itself, very little was 
known about the expression of the enzyme at the genetic 
level. There were no reported mutations of AMP deaminase in 
any system. Although in yeast, mutants for the other two 
members of the purine nucleotide cycle, adenylosuccinate 
synthetase and adenylosuccinate lyase had been isolated and 
named ade!2 and ade!3 respectively, little was known of the 
AMP deaminase gene (Dorfmann, 1968; Jones and Fink, 1982). 
Neither had the gene for AMP deaminase been cloned from any 
system. It was of interest to study the regulation of this 
enzyme as it related to metabolism in the cell. Clearly the 
enzyme is highly allosteric and thereby a proportion of the 
enzyme's activity would be controlled at that level. But it 
was of interest to study whether this enzyme is also 
regulated at the level of gene expression, and if so, just 
how that regulation was brought about. It was felt that a 
first step in achieving these objectives was to clone the 
gene from yeast. S .cerevisiae seemed an ideal system in 
which to study the expression of this enzyme because of the 
ease of growing the organism in a defined growth medium, 
studying the expression with respect to stages of growth and 
nutrient availability, and in the generation of specific 
mutations using well established "reverse genetics" 
techniques.
AMP deaminase was also of commercial interest. RNA is a 
biproduct of many biotechnological processes and as such it 
is of limited value. However, some of the degradative 
products of RNA are presently being used as flavour enhancers 
in the preparation of proprietary foods. In particular, two 
mononucleotides GMP and IMP can be used in this way and since 
IMP is one of the products of the AMP deaminase reaction this 
project has been partly funded by I.C.I.'s biological 
products division. /
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1.8 NOTES ON THE ORGANISATION OF THE THESIS
Not all the background information regarding this project has 
been covered in this chapter. Further information is 
included in the introductions to specific chapters.
Therefore, further information regarding the use of adenosine 
analogues as inhibitors of AMP deaminase, and the use of one 
of these inhibitors to produce a variant mammalian cell line 
is discussed in Section 3.1. Similarly, the use of 
histoenzymatic stains for AMP deaminase are discussed in 
Chapter 4. At the beginning of Chapter 5 is an account of 
the previously described method for the purification of AMP 
deaminase from yeast. And finally, a brief review of the 
heat shock response especially with regard to hsp90 and AMP 
deaminase is given in Section 6.1.
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 MATERIALS
Chemicals and enzymes used in this study and the sources from 
which they were obtained are listed below
Material
General laboratory chemicals
Media
Biochemicals
Antibiotics
Agarose
Radiochemicals
Nitrocellulose membrane
Nylon membrane
Amino acids
DNA-modifying enzymes
Lysozyme
Novozyme
Glucoronidase
Zymolyase
GIDH
X-ray film 
Gene Clean kits 
Glass beads
phenol/acetone reagent 
hypochlorite
Source
Sigma, Formachem,
BDHchemicals
Koch-Light, Pharmacia, Biorad
laboratories, May and Baker,
BCL, Aldrich, Serva
Difco, Oxoid
Sigma, BCL
Sigma
Sigma, BRL 
NEN
Schleicher and Schuell
Amersham
Sigma
BRL,
Sigma
Novo Industries 
Sigma
Miles Laboratories
BCL
Kodak
Stratetech Scientific
BDH
Fisons
ICI
2.2 E.coli STRAINS
The E .coli strains used in this work are shown below with 
their genotypes.
Strain Genotype Source
C1400 supE. supF. hsd5. met", ^ecA. K. Murray
DS902 recA14, thr. leu, his; pro. David Sherratt 
str
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CB51 ara, thi. A  lac pro), rpsL. 
dam-3 . str
Christopher Boyd
2.3 S.cerevisiae STRAINS
The S .cerevisiae strains used and produced in this work are 
shown below with the appropriate genotypes and sources
Strain
DBY746
Phenotype Source
alpha. his3. ura3-52. David Botstein
leu2-3. Ieu2-112.
trpl-289
DBY747
DBY868
a , his3. ura3-52. 
leu2-3. Ieu2-112, 
trpl-289
alpha. ade2-l. 
his4-619
David Botstein
David Botstein
W1-2D a, hptl.27 Woods et al. . 198,3
W1-2D rhoX a, rho , hptl.27 By mutation of W1-2D
(Chapter3)
JMMDIP-1 a/alpha By mating of DBY 747 
and W1-2D (Chapter 3)
JMM1-1D alpha. his4-619. 
ade2-l. hptl.27
By sporulation of 
JMMDIP-1 (Chapter3)
JMM1-2C a, ade2-l. hptl.27 By sporulation of 
JMMDIP-1 (Chapter 3)
JMM1-5C alpha. ade2-l. hptl.27 By sporulation of
JMMDIP-1(Chapter 3)
JMMDIP-2 a/alpha, his4 By mating of X4003-5B 
and JMM1-1D
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JMM2-4C
JMM2-9D
JMMDIP-3
JMM3-2A
JMM3-7B
JMM3-8C
JMM3-9D
X2928-31>
X2928-3D
X4003-5B
X4003-22
a, ade2-l. hptl-27. By sporulation of
ura, his4. met2 f JMMDIP-2 (Chapter 3)
leu2
a, ade2 f hptl.27. By sporulation of
ura3. his4. met2, JMMDIP-2 (Chapter 3)
leu2
a/alpha By mating of X4003-5B
JMM1-5C (Chapter 3)
a, adel, hptl.27. By sporulation of
ura3. Ieu2. trp5 JMMDIP-3 (Chapter 3)
alpha f adel. ade2. By sporulation of
hptl.27. ura3. met2. JMMDIP-3 (Chapter 3)
trp5
a, adel. ade2. By sporulation of
hptl.27. ura3. met2. JMMDIP-3 (Chapter 3)
leu2 . trp5
alpha. adel. ade2. By sporulation of
hptl. 27 r ura3 JMMDIP-3 (Chapter, 3)
1A a, adel. gall. trpl.
ura3. his2 . leul. 
met!4
1C alpha. adel. gall.
trpl. ura3. his2 . 
leul. met!4
a, leu2 . adel. his4, 
met2 . ura3. trp5.
gall
a, leu2 . adel. his4. By transfomi-ng X4003- 
met2. trp5. gall. 5B with integrating
hsp90— / vector pHSPUR22
(Chapter 6)
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X4003-3.4 a, leu2 . adelf his4, 
met2 . trp5, gall.
By transforming X4003- 
5B with multi-copy 
plasmid p378-3.4 
bearing the complete 
hsp90 gene (Chapter 6)
2.4 PLASMIDS
The plasmids used in this study, other than those whose 
construction, are described in this thesis are listed below.
Plasmid Description 
pUC8 Cloning vector derived from 
pBR322
Source
Pouwels et al.. 1988
pSPUR2 l.lkb HindIII URA3-containing 
fragment from Yep24 cloned 
into pSP64
Alistair Brown
YEp24 E .coli-Yeast shuttle vector.
Carries 2.2kb Eco RI fragment 
from 2um and l.lkb URA3 - 
containing Hind III fragment
Carlson and 
Botstein, 1982
pBSAMPD Blue script plasmid containing Sabina et al., 1987 
2.5kb EcoRI fragment comprising 
rat muscle AMP deaminase cDNA
2.5 E.coli CULTURE MEDIA AND GROWTH CONDITIONS
Media 
L Broth: lOg tryptone, 5g yeast extract, 5g NaCl, lg 
glucose, 20mg thymine, made up to 1. litre in 
distilled water and adjusted to pH7.0 with NaOH
L Agar: As above but without glucose and the addition of
Bacto-agar to 2% /
All growth media were sterilised by autoclaving at 120°C for 
15 minuteso Buffer solutions and nutrient additions, where
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appropriate were autoclaved at 108°C for 10 minutes.
Antibiotics
In both liquid and plate selection, ampicillin was added to 
the medium at a final concentration of lOOjig/ml. The drug 
was stored for several months at -20°C, as a stock solution 
of lOOmg/ml in sterile, distilled H20.
Growth Conditions
Liquid cultures for transformation or plasmid DNA 
preparations were routinely grown in L broth at 37°C with 
vigorous shaking. Stationary phase overnight cultures were 
grown from small inocula in 2.5ml L broth with vigorous 
shaking,
Growth on plates was on L agar with antibiotics added as 
required. Plates contained 25ml agar solution and were 
incubated for approximately 16 hours at 37°C.
Strains were stored in the following way. The strain was 
grown in L broth at 37°C with vigorous shaking. 1.5ml of 
this culture was then added to 300jul of glycerol and after 
mixing the strain was stored at -70°C indefinitely. In. order 
to use these stored strains, they were streaked on to L agar 
plates and incubated at 37°C overnight. These plates could 
then be stored at 4°C for some time.
2.6 S.cerevisiae CULTURE MEDIA AND GROWTH CONDITIONS
Minimal/Selective media (GYNB) 2% glucose, 0.65% yeast
nitrogen base (amino acid 
free)
Media
Complete media (YPG) 2% glucose, 2% Bactopeptone, 
1% yeast extract
YPG agar As above with the addition of 
Bacto-agar to 2%
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GYNB agar
Presporulation media
Sporulation media
Transformation Top agar
Transformation Bottom agar
As above with the addition of 
Bacto-agar to 2%
0.8% Bacto yeast extract,
0.3% Bacto peptone, 10% 
glucose, 2% Bacto agar
1% Potassium acetate, 0.1% 
Bacto peptone, 0.05% glucose, 
2% Bacto agar
2% glucose, 0.65% yeast 
nitrogen base (amino acid 
free), 2% Bacto agar, 1.2M 
Sorbitol
2% glucose, 0.65% yeast 
nitrogen base (amino acid 
free), 3% Bacto agar, 1.2M 
Sorbitol
All growth media were sterilised by autoclaving at 120°C for 
15 minutes. Buffer solutions and nutrient additions, where 
appropriate were autoclaved at 108°C for 10 minutes.
Nutrient additions
Amino acids and adenine were added to minimal media, where 
required for growth of auxotrophic mutants, to a final 
concentration of 5^ug/ml unless otherwise stated. Stock 
solutions of these additions, at a concentration of lOmg/ml 
in distilled H20 were sterilised by filtration or autoclaving 
and stored at 4°C for up to several months.
Growth conditions
Strains were streaked onto YPG or GYNB agar with appropriate 
additions and grown for 3 days at 30°C. Plates could be 
stored for several weeks at 4°C.
Liquid cultures in either YPG or GYtfB were normally 
innoculated with small volumes of a 2 day stationary culture 
and grown at 30°C with vigorous shaking, overnight or until 
the appropriate phase of growth was attained. Growth was
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monitored by absorbance at 600nm. Before use cultures were 
checked for bacterial contamination by light microscopy.
For storage purposes, 300^al of sterile glycerol was added to
1. 5ml of a midlog culture grown in GYNB with the appropriate 
additions. This mixture was then stored at -70°C 
indefinitely.
2.7 BUFFERS AND SOLUTIONS
Buffer solutions, where appropriate were autoclaved at 108°C 
for 10 minutes.
Electrophoresis
10 x TBE Buffer, pH8 .3 109g Tris, 55g boric acid, 9.3g
Na2EDTA.2H20 made up to 1 litre in
distilled H20, the pH is 8.3
10 x TAE Buffer, pH8 .2 48. 4g Tris, 16.4g Na acetate, 3 . 6g
Na2EDTA.2H20, made up to 1 litre in 
distilled water, pH adjusted to 8.2 
with acetic acid
10% Ficoll, 0.5% SDS, 0.06% 
Bromophenol blue, 0.06 xylene 
cyanol
121.lg Tris, 51.35g Boric acid, 
3.72g EDTA made up to 1 litre in 
distilled water, the pH is 8.3
SDS/PAGE Loading Buffer 80mM Tris, pH6 .8 , 10% glycerol,
0.0024% bromophenol blue, 2% SDS, 
lOOmM DTT
5 x SDS/PAGE running 72.05g glycine, 15.15g TiMs (base),
buffer 5g SDS, made up to 1 litre with
distilled/water
Agarose Gel Loading 
Buffer
10 x Sequencing TBE
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10 x MOPS Buffer 0.2M 3-[N-Morpholino]-propane- 
sulphonic acid, 0.05M Na acetate, 
0.01M Na2EDTA
MMV solution
Northern gel loading 
buffer
500pl formamide, 162jul of 37% 
formaldehyde, 100/ul 10 x Mops 
buffer, made up to lOOOjul with 
distilled H20
50% glycerol, 0.4% bromophenol 
blue, 0.4% xylene cyanol, ImM EDTA
Protein Phastael staining solutions
Coomassie Blue stain 0.02% Phastgel Blue R (-tablet-form)
dissolved in 30% methanol, 10% 
acetic acid
Destain 30% methanol, 10% acetic acid
Preserving solution 10% acetic acid, 5% glycerol
Wash 1 50% ethanol, 10% acetic acid
Wash 2 
Sensitiser 
Silver nitrate 
Developer
10% ethanol, 5% acetic acid
8.3% glutaraldehyde
0.25% silver nitrate
0.04% formaldehyde in 2.5% sodium 
carbonate (prepared fresh each day)
Stop bath 5% acetic acid
DNA and RNA Preparation and Purification
Birnboim Doly I (BD-I) 50mM glucose, 25mM Tris-HCl ph 8.0,
lOmM EDTA/ add lysozyme to lmg/ml 
immediately before use
Birnboim Doly II (BD-II) 0.2M NaOH, 1% SDS; used fresh
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Birnboim Doly III 
(BD-III)
5M KAc, pH 4.8; mix equal volumes 
of 3M CH3COOK and 2M CH3COOH, pH 
should be 4.8
STET buffer 8% sucrose, 2% Triton X-100, 20mM 
EDTA, 50mM Tris, pH 8 .0
Phenol N All phenol used in the purification 
of DNA was buffered against 0.1M 
Tris-HCl, pH 8.0
Phenol/chloroform For most purposes a 1:1 mix of 
phenol (equilibrated as above) and 
chloroform
TEN solution lOmM Tris,HCl, pH 7.6, ImM EDTA, 
lOmM NaCl
SB solution 0.2M Tris-HCl, pH 7.5, 1M sorbitol, 
0.1M EDTA, 0.1M 2-mercaptoethanol
RNA extraction buffer 0.1M LiCl, 0.1M Tris, pH 7.5, 0.01M 
DTT (added fresh)
DNA Manipulations 
Restriction Buffers Restrictions were normally carried 
out using the appropriate BRL 
R e a c t ™  buffer which were supplied 
with the enzyme used
10 x Ligation Buffer 250mM Tris, pH 7.5, lOOmM MgC^, 
lOOmM DTT, 4mM ATP.
10 x Klenow Buffer lOOmM Tris, pH 7.4, lOOmM MgC^, 
0 .66% gelatin
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DNA Hybridisation 
Denhardt's Solution
20 x SSC 
20 x SSPE
2g BSA (Pentax fraction V), 2g 
Ficoll (MW 400000), 2g polyvinyl 
pyrrolidone (MW 360000) in 100ml 
distilled H20
3M NaCl, 0.3M Na3 citrate, pH7.0
3.6M NaCl, 200mM NaH2P04 , 20mM 
Na2EDTA, pH7.4
Denaturation Buffer 1.5M NaCl, 0.5M NaOH
Neutralising Buffer 1.5M NaCl, 0.5M Tris.HCl, pH 7.2
Radiolabelling of DNA 
10 x Kinase Buffer 0.5M Tris-HCl, pH 7.6, lOOmM MgCl2 , 
50mM DTT, ImM spermidine, ImM EDTA
Random Prime mix
Random prime solution A
200jul solution A, 500jul solution B 
and 300jul solution C (as below)
lml solution 0 with 18jul 14.4M B- 
mercaptoethanol and 5jul each of 
triphosphate nucleotides; dA, dG 
and dT (stock solutions of lOOjuM)
Random prime solution 0 1.25M Tris, pH8.0, 0.125M MgCl2
Random prime solution B 2M Hepes, pH6.6
Random prime solution C 50 O.D. units of hexanucleotides
(p(dN)g from Pharmacia in 556plwater
Transformation of E.coli and S.cerevisiae
SE solution 1M sorbitol, 25mM EDTA, pH8 .0
SEN solution 1. 2M sorbitol, lOmM EDTA, lOOmM Na
citrate, pH 5.8
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SC solution 1.2M sorbitol, lOmM CaCl2
CT solution 
SY solution
Protein Analyses 
Bradford Reagent
Extraction Buffer 
Oxoglutarate buffer
NADH/NaHCO3 solution 
acetate buffer
lOmM CaCl2 , lOmM Tris, pH 7.5
2 volumes of 1 .8M sorbitol, 1 
volume of 3 x YPG
lOOmg Coomassie Brilliant Blue G- 
250 dissolved in 95% ethanol, to 
which lOOmls 85% (w/v) phosphoric 
acid, is added, this was made up to 
1 litre with distilled H20 and was 
then filtered through Whatman 
filter paper into scrupulously 
clean glassware. This solution was 
stored in the dark for up to 6 
months
yeast proteins were normally 
extracted into 50mM potassium 
phosphate buffer, pH 7.5, ImM PMSF
9.3g TEA.HCl, 95mg Na2ADP, 670mg 2- 
oxoglutarate, pH to 8 .0 with 5M 
NaOH and make up to lOOmls with 
distilled water
30mg Na2 NADH, 60mg NaHCC^ in 6ml 
distilled water
13.61g sodium acetate trihydrate, 
7mls conc. HC1 made up to 1 litre 
with distilled water
Reagent 1 sodium phenoxide/acetone solution
(supplied by Fisons)
Reagent 2
Reagent 3
2.8 IN VIVO TECHNIQUES (E.coli)
Transformation of E.coli
A single colony of the appropriate recipient E . coli strain 
was innoculated into L broth from a fresh L agar plate which 
had been incubated overnight. The culture was then incubated 
at 37°C with vigorous shaking to a density of approximately 
108 cells/ml. The cells were chilled rapidly in an ice-water 
bath and harvested by centrifugation at 3K for 5 minutes at 
4°C and resuspended in 1/5 culture volume of ice cold 50mM 
CaCl2 * The cells were then incubated on ice for 30 minutes 
and then centrifuged at 1100 x g for 5 minutes at 4°C. The 
cells were then very gently resuspended in 1/100 culture 
volume of ice cold 50mM CaC^. This was then incubated on 
ice for 15 minutes. 50 - 200 ul aliquots were routinely used 
for each transformation. Plasmid DNA was added and gently 
mixed, and left on ice for at least 30 minutes. The cells 
were then heat shocked at 42°C for 2 minutes and returned to 
ice for at least a further 15 minutes. The cells were 
diluted to 1ml with L broth and incubated at 37°C for 30 
minutes to allow ampicillin resistance to be expressed. The 
cells were then plated out on L agar + ampicillin. Unused 
cells were stored at -70°C in 20% glycerol.
2.9 IN VIVO TECHNIQUES (S .cerevisiae)
Transformation of S.cerevisiae
Transformation of S .cerevisiae was carried out by the method 
of Beggs (1978). A 100ml culture of the appropriate yeast 
strain grown in YPG to mid or late-logarithmic growth was 
used for each transformation. The cells were harvested by 
centrifugation at 1000 x g for 5 minutes at room temperature.
0.5% hypochlorite; 50ml stock 
hypochlorite solution (5% free Cl- , 
as supplied) made up to 500ml with 
acetate buffer
0 .01% sodium nitroprusside 
dissolved in acetate buffer
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The cells were resuspended in 50ml SE solution containing 
50mM DTT (added immediately before use and filter sterilised) 
and incubated at 30°C for 20 minutes with gentle shaking.
The cells were reharvested by centrifugation at 100 x g for 5 
minutes at room tefnperature. The cells were resuspended in 
50ml SEN solution (containing 2-3% (v/v) B-glucoronidase 
added immediately before use and filter sterilised) and 
incubated at 30°C with gentle shaking until spheroplast 
formation had reached approximately 90% (as monitored by 
light microscopy). The spheroplasts were harvested by 
centrifugation at 1000 x g for 3 minutes at room temperature 
and washed gently twice with 1.2M sorbitol. They were then 
gently resuspended in lOO^ul SC solution to generate a thick 
suspension. DNA was added to 50ul of the spheroplasts in 
sterile eppendorf tubes and incubated at room temperature for 
15 minutes. 500pl of 20% PEG in CT solution (made fresh and 
filter sterilised) was added and left for 45 seconds prior to 
centrifugation in a microfuge for 1 second. The PEG was 
immediately removed and the spheroplasts resuspended in lOO^il 
SY solution. They were then incubated at 30°C for 30 
minutes. The speroplasts were diluted as required with 1.2M 
sorbitol and aliquots were added to lOmls Top agar containing 
the appropriate supplements for growth of transformants 
(equilibrated at 48°C and immediately spread over Bottom agar 
containing the appropriate supplements. The plates were 
incubated at 30°C until the appearance of colonies (normally 
3-7 days). Putative transformants were then streaked onto 
selective plates to confirm the predicted genotypes.
Standard mating of S.cerevisiae strains
This technique was used to produce strains with appropriate 
combinations of auxotrophic markers as described in this 
thesis (Chapter 3).
The parental strains were streaked onto YPG agar to produce 
single colonies. The 2 strains were then mixed on a fresh 
YPG agar plate with a sterile toothpick. This plate was 
incubated at 30°C overnight. At the end of this time mating 
had occurred and diploids had been produced. The cells were 
then streaked onto plates which will only support growth of 
the diploids. These plates were then incubated for 3-4 days. 
A single colony was then patched onto presporulation media,
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grown overnight at 30°C/ after which these cells were patched 
onto sporulation media, and then incubated at room 
temperature for 2-5 days. During this time sporulation was 
occasionally monitored by light microscopy, and once 
efficient ascus production was observed, the cells were 
subjected to tetrad dissection and analysis.
Tetrad dissection and analysis
Tetrad dissection and analysis was carried out by the method
of Sherman et al. (1986^ with the exception that 13-
glucuronidase was used instead of glusulase.
2.10 IN VITRO TECHNIQUES: NUCLEIC ACIDS
Birnboim Poly Plasmid DNA Preparations (Birnboim and Dolv,
19791
A 100-200ml L broth + Amp culture of the appropriate strain 
was harvested by centrifugation at 3800 x g for 10 minutes. 
The cell pellet was then resuspended in 2ml BD-I until an 
even cell suspension was achieved. To this 1ml of BD-I with 
lysozyme freshly added at 6mg/ml was added and thoroughly 
mixed. This was incubated at room temperature for 
approximately 5 minutes. To this 8mls of BD-II (freshly 
made) was added and mixed by inversion, followed by the 
addition of ice-cold BD-III which was again mixed by gentle 
inversion. This mixture was then incubated on ice for at 
least 5 minutes. Cell debris was then removed by 
centrifugation at 35000 x g for 20-30 minutes. The majority 
of the chromosomal DNA appears to be removed at this stage. 
The supernatant was removed to a fresh tube by straining 
through a sterile tissue and was precipitated by the addition 
of an equal volume of isopropanol for 15 minutes at room 
temperature. The precipitate was harvested by centrifugation 
at 35000 x g for 15 minutes at 20°C. The pellet was then 
washed with ice-cold 70% ethanol and drained.
i
The plasmid DNA was further purified on a CsCl/ethidium 
bromide gradient. The DNA was resuspended in lOmls TE and 
500ul ethidium bromide (lOmg/ml) and CsCl was added to a 
final density of 1.58g/ml. The gradients were then
39
centrifuged in a Beckman Ti70 rotor at 170000 x g at 20°C 
overnight. After this treatment, 2 bands were visible, the 
upper composed of chromosomal and relaxed plasmid DNA and the 
lower of supercoiled plasmid DNA which was removed using a
i
lml syringe. The 'ethidium bromide was removed by repeated 
butanol extraction (with water saturated butanol) and the 
salts were removed by dialysis in 2 litres of TE (one change 
of buffer). The DNA was then ready to use.
STET DNA Preparations
This rapid method-of plasmid preparation by the method of 
Holmes and Quigley (1981) and was used for the analysis of 
putative constructs where several plasmids were to be 
screened.
1.5ml of an overnight L broth + ampicillin culture containing 
the plasmid of interest was harvested by centrifugation in a 
1.5ml eppendorf tube and resuspended in 35jul of STET buffer. 
25jul of STET buffer containing lysozyme at a concentration of 
lOmg/ml (freshly made up) was added and the tube vortexed 
briefly. This mixture was boiled for 50 seconds and 
centrifuged in a microfuge for 15 minutes at room 
temperature. The pellet was discarded using a sterile 
toothpick. 40jul of 3M Na acetate and 400jul of isopropanol 
were added and mixed. This was incubated at room temperature 
for 15 minutes and then the nucleic acid was harvested by 
microcentrifugation for 10 minutes. The pellet was washed 
with 70% ethanol and dried briefly under vacuum. The pellet 
was then resuspended in 50jul sterile water. This DNA was 
suitable for restriction digestion and other in vitro 
manipulations.
Plasmid purification for sequencing
It was found that standard CsCl gradient purified plasmid was 
not always of sufficient quality to allow efficient dideoxy 
sequencing. When this was found to be the case the DNA was 
further purified in a adaptation of the method of 
Hattari and Sakaki, 1986.
lml of normally purified DNA was first treated with RNAase A 
(preboiled for lOminutes) at a final concentration of 20pg/ml 
for 30 minutes at 37°C. The solution was then extracted once
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with phenol/chloroform and once with chloroform. To the 
aqueous phase was added 0.6 volumes of 20% PEG, 2.5M NaCl 
(ice-cold). The DNA was precipitated on ice for at least 1 
hour and then harvested by microcentrifugation for 10 
minutes. The pellet was washed twice with ice-cold 70% 
ethanol and vacuum dried. The DNA was then resuspended in 
sterile, distilled water and its concentration estimated by 
agarose\gel electrophoresis. The DNA was then suitable for 
plasmid DNA sequencing analysis.
Precipitation of DNA with Ethanol 
Ethanol precipitation was routinely used for the 
concentration or harvesting of DNA where appropriate. The 
DNA solution was made 0. 3M Na acetate and 2 volumes of 
ethanol was added. After mixing the DNA was precipitated by 
incubation at -20°C for 30 minutes or more. The DNA was then 
pelleted by centrifugation either in a microfuge, or at 27000 
x g in a standard centrifuge for 15 minutes. The pellet was 
then washed in cold 70% ethanol and dried briefly under 
vacuum.
Restriction enzyme digestion of DNA 
Restriction digests were performed with the DNA at a 
concentration no higher than l/ig/20jul. For small scale 
analyses the volume of the digest would normally be 2Ojul.
The digest would be composed of 1 x the appropriate R e a c t ™  
buffer, the appropriate amount of DNA and at least 1 unit of 
enzyme/jag of DNA. The volume was made up with sterile, 
distilled water. For larger scale restrictions the volumes 
were scaled up accordingly. The reactions were allowed to 
proceed for 1 - 2  hours at the appropriate temperature. 
Reactions were stopped by the addition of gel loading buffer 
or by rapid heating to 70°C for 5 minutes followed by cooling 
on ice.
Ligation of DNA
The restriction fragments to be ligated were mixed such that 
the insert was in at least 3-fold excess over the vector (and 
at least 10-fold excess in the case of blunt-end ligations) 
and made up to 2Qul by the addition of 2jul 10 x ligase buffer 
and sterile water. T4 DNA ligase was added at 0.5units/jug 
DNA for sticky end ligations and 2units/pg DNA in blunt end
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ligations. The mix was incubated at 16°C overnight. Sticky 
end ligations could alternatively be incubated at room 
temperature for 3 hours. Aliquots of the ligation mix were 
diluted at least 5-fold with water prior to transformation of 
competent E .coli dells.
Cal‘f Intestinal Phosphatase (CIP) treatment 
To increase the cloning efficiency, CIP was used to remove 
the 5 'terminal phosphate groups from the linearised vector to 
reduce recircularisation of the vector. This treatment is 
necessary if there is no direct selection method for plasmids 
containing inserts. CIP treatment was normally carried out 
in 1 x React™ 2 buffer immediately following restriction 
digestion. CIP was added at a concentration of l-2units/ug 
DNA. Incubation was at 37°C for 20-30 minutes. The enzyme 
was heat-denatured and the vector gel purified prior to use 
to ensure removal of contaminating CIP.
Filling in 3* recessed ends with Klenow 
This was carried out where a blunt-ended fragment was 
required to be produced from a fragment with 3' recessed 
ends. 0.1-lwg of DNA with 3' recessed ends were added to a 
20}il mix made up of 2jul 10 x Klenow buffer, and containing 
all four dNTPs at a final concentration of 50uM each. 1 unit 
of Klenow fragment was added and reaction carried out for 15 
minutes at 23°C.
Gsl purification of DNA fragments: Gene Clean 
The kit for this method was obtained from Stratatech 
Scientific. This method was routinely used where the 
fragment to be purified was less than 3kb in size. Fragments 
larger than this were normally purified by electroelution. 
Restriction digests were run on TAE agarose gels until the 
band to be purified is well resolved. The band of interest 
was then cut out and trimmed with a fresh scalpel blade, 
placed in an eppendorf tube, and dissolved in and 3 volumes 
of Nal solution (as supplied) at 60°C. Glass milk suspension 
(as supplied) was then added (5jil solutions containing less 
than 5pg DNA and an additional l^ il for each additional l^ ig 
DNA). This was mixed thoroughly by pipetting and incubated 
on ice for 10 minutes. The glass beads were then pelleted in 
a microfuge for 5 seconds and the supernatant removed. The
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glass beads were then washed three times with 500^il ice-cold 
NEW (as supplied) keeping the mixture ice-cold at all times. 
The glass beads were then pelleted and all the NEW removed. 
They were then resuspended in 50jul water and heated to 65°C 
for 5-10 minutes. ' The tube was then microfuged for 30 
seconds and the supernatant removed to a fresh tube. DNA 
purified in this way was used directly in ligations and 
labelling procedures.
Gel purification of DNA fragments: Electroelution 
This method was used routinely to purify fragments greater 
than 3kb in size. The DNA band was cut and trimmed as 
described above. The gel fragment was placed at one edge in 
a wide piece of dialysis tubing, the bag was then filled with 
TE until the gel fragment was covered and then the bag was 
sealed. The bag was then placed in a normal horizontal gel 
electrophoresis tank and 1 x TAE was added to just cover the 
bag. The edge of the bag with the gel fragment was placed 
farthest from the positive terminal in the tank. The bag was 
then subjected to a current of 10-20 mAmps for up to 1 hour 
depending on the size of the fragment. During this time the 
DNA would run out of the gel fragment and into the buffer 
along the other edge of the bag. This could be monitored 
with a hand held UV lamp since the fragment will remain 
complexed with ethidium bromide. Once the fragment has been 
successfully electroeluted the terminals were reversed and a 
low current run in the opposite direction for approximately 1 
minute. The TE in the bag was then removed and the DNA 
precipitated with ethanol in the standard manner. This DNA 
could be used directly in ligations and labelling procedures.
Isolation of high molecular weight DNA from S.cerevisiae 
The method used was an adaptation of the method of 
Lautenberger and Chen (1987). This adaptation was 
communicated by Stewart Finlayson and produces l-2mg of 
DNA/litre culture of a size greater than 40kb.
A 1 litre stationary culture (more than 2 x 10® cell/m)1 in 
YPG was harvested by centrifugation at 15000 x g for 10 
minutes at 4°C. The cell pellet was resuspended in 10ml TEN, 
centrifuged at 15000 x g for 10 minutes and the resulting 
pellet weighed. The pellet was then resuspended in SB buffer
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at a concentration of 0.25g cells/ml. 5mg Zymolyase 20000 
(or 1.5mg Zymolyase 60000) was mixed in and the cell 
suspension incubated kt 30°C with occasional gentle mixing 
for approximately 1 hour or until more than 80% of the cells 
are spheroplasted ks determined by light microscopy. After 
this stage it is of the utmost importance that the mixing 
stejps be by very gentle inversion and pipetting be carried 
out with wide-bore cut tip pipettes. The spheroplasts were 
harvested by centrifugation at 2500 x g for 5 minutes and 
then gently resuspended in 20ml SB. To this was added 40ml ! 
TEN, 5ml 10% SDS and 5mg RNAase A. This mixture was 
incubated at 37°C for 2 hours. After this 2mg Proteinase K 
was added and mixed by inversion. The mixture was incubated 
at 37°C for a further 2 hours, then heated to 65°C for 30 
minutes and then cooled rapidly to room temperature. To this 
was added an equal volume of phenol/chloroform and mixing was 
continued for 15 minutes by gentle inversion. The phases 
were separated by centrifugation at 15000 x g for 10 minutes, 
after which the aqueous phase was removed and similarly 
extracted with an equal volume of chloroform. The aqueous 
phase was removed to a fresh tube and to it was added 1/25 
volume of 5M NaCl and 2 volumes of ethanol (chilled to - 
20°C). This was then mixed by gentle inversion until the DNA 
was clumped together. The DNA was spooled out to a fresh 
tube and the excess ethanol removed by aspiration. The DNA 
was resuspended in 50ml TEN. THis step was carried out at 
37°C to allow the DNA to completely dissolve. Img of RNAase 
A was added and the solution was incubated at 37°C for 1 
hour. The DNA was then subjected to one phenol/chloroform 
and one chloroform extraction reprecipitated as described 
above. The DNA was spooled out again and resuspended in 
approximately lOmls TE. Once dissolved the DNA solution was 
dialysed against TE at 4°C overnight. This DNA was suitable 
for restriction analysis.
Isolation of RNA from S.cerevisiae
RNA was isolated according to the procedure of Lindquist 
(1981). Cultures in mid-logarithmic growth were harvested by 
centrifugation at 960 x g for 5 minutes at 4°C. The pellet 
was rapidly resuspended in 5ml lysis buffer and the resulting 
cell suspension was transferred to tubes containing 14g glass 
beads (40 mesh), lmllo%SDS, 10ml phenol/chloroform. This
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mixture was vortexed continuously for 5 minutes and the 
centrifuged at 12000 x g for 5 minutes at 4°C. The aqueous 
phase was removed and'added to 10ml phenol/chloroform and 
then vortexed for 1 minute and centrifuged at 12000g for 5 
minutes at 4°C. The aqueous phase was made to 0.3M Na 
acetate, and 2.5 volumes of ethanol were added. This was 
incubated at -20°C for at least 1 hour. The RNA was then 
harvested by centrifugation atiS&pw for 15 minutes and 
resuspended in 2ml water. The RNA was further purified by 
centrifuging through a CsCl cushion according to the method 
of Chirgwin et al. (1979).
2.11 IN VITRO TECHNIQUES: PROTEINS
Extraction of native soluble proteins from S.cerevisiae 
10 mis or more of a yeast culture was harvested by 
centrifugation at 3500 x g for 5 minutes. The pellet was 
washed 1-2 times with water and resuspended in at least lml 
of extraction buffer (the choice of extraction buffer is 
detailed where appropriate in the text of this thesis) to 
give an even cell suspension. To this glass beads (40 mesh) 
were added to the meniscus. This mixture was then chilled on 
ice and then vortexed for 30 seconds, 3-4 times with 1 
minutes on ice between each 30 second vortex. To this an 
appropriate volume of extraction buffer was added and 
vortexed briefly. The supernatant was removed to a fresh 
tube. Cell debris was removed by centrifugation at 12000 x g 
for 10 minutes.
Bradford assay for protein concentration
Bradford assays for protein concentration were carried out by 
the method of Bradford (1978). For any batch of measurements 
a set of BSA standard assays were carried out to allow the 
production of a calibration curve.
AMP deaminase reaction mixes
The AMP deaminase activity was determined by carrying out a 
reaction for a known period of time followed by determination 
of the ammonia produced by either the GIDH assay or the 
phenol-hypochlorite assay, as detailed below.
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The standard reaction mix was as follows, unless otherwise 
stated:
20mM cacodylic acid, pH7.1, lOOmM KCl, lOmM NaCl, 
lOmM AMP, ImM ATP, lOmM MgCl2 , 0.02% BSA
In addition, for every sample assayed for AMP deaminase 
activty'*a substrate blank was carried out to allow the 
endogenous NH3 in protein extracts and solutions to be taken 
into account. The reactions were stopped either by the 
addition of 10% TCA in the case of the GIDH assay (see below) 
or the sodium phenoxide/acetone reagent in the case of the 
phenol/hypochlorite assay.
•Glutamate dehydrogenase (GIDH) ammonia assay 
Initially it was decided to assay the ammonia produced from 
the AMP deaminase reaction by the sensitive enzymatic assay 
system decribed by Bergmeyer and Beutler (1982). This relies 
upon the use of NH3 by glutamate dehydrogenase (GIDH) in the 
reduction of NADH to NAD with its concomitant decrease in 
absorbance at 339nm. The principle of this assay is shown 
below.
GIDH
2-oxoglutarate + NADH + NH4   ---> L-glutamate + NAD+ + H20
This assay was used for the determination of NH3 produced by. 
the AMP deaminase reaction as detailed above. Into a 4ml 
cuvette the following were pipetted successively:
lml oxoglutarate buffer
1 . 5 - 2 . 0ml water to bring volume up to 3.2ml 
0.1ml NADH/NaHC03 solution
0.1 - 0 .6ml sample of deproteinised reaction mix
The absorbance at 339nm was measured and noted and 0.02ml of 
the GIDH solution was added and stirred. Reactions were then 
incubated at room temperature for 20-30 minutes, by which 
time the reaction was complete and the absorbance at 339nm 
was again noted. The amount of NH3 in the determination is 
then calculated thus
A A ^ n m  x s . m  = molarity of a 0.1ml sample in a 3.2ml mix.
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Samples containing proteins required to be deproteinised 
prior to the assay. This was carried out by adding one half 
volume of ice-cold 10% TCA to the sample or reaction mix to 
be assayed. The sample was then incubated on ice for 5-10
minutes and then microfuged for 5 minutes to remove any
particulate material. The supernatant was removed and 
neutralised by the addition of one half volume of 2M KHCO3 . 
When C0£ production had ceased the mixture was subjected to 
normal NH3 determination in the GIDH assay.
This method was used in all analyses detailed in Chapter 3 
and the sensitivity and accuracy of this assay is further 
discussed in appendix I . Subsequent analyses used the 
phenol-hypochlorite ammonia assay.
Phenol/hypochlorite ammonia assay
This method is an adaptation of Guisti's method (1974) as 
communicated by John Fitton. No deproteinisation step is 
required in this determination since the sodium 
phenoxide/acetone reagent brings about immediate denaturation 
of all proteins in the reaction mix.
Normally a 0.1ml sample was added to lml of sodium 
phenoxide/acetone and mixed. To this was added successively 
1.5ml 0.5% hypochlorite and 1.5ml 0.01% sodium nitroprusside. 
The mixture was incubated at room temperature for 30 minutes 
(by which time colour production is complete) and the 
absorbance at 595nm was measured. Colour production was 
found to be stable for up to 24 hours. With each patch of 
determinations a set of NH^Cl standards were also assayed to 
allow the production of a calibration curve. The method was 
adapted to increase its sensitivity. Again, in each case a 
suitable set of standard determinations were carried out.
The adaptation was simply to reduce the volumes of the 
reagents used. Thus a 0.1 or 0.2ml sample was added to 
0.33ml sodium phenoxide/acetone reagents followed by the 
addition of 0.5ml each of the hypochlorite and nitroprusside 
solutions. This allowed spectrophotometric measurements to 
be made in standard lml cuvettes.
Precipitation of proteins with ammonium sulphate or acetone 
The following method was adopted for the analytical 
precipitation of proteins with ammonium sulphate or acetone.
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At all stages of the analysis the extract was kept at between 
0 and 4°C. A known volume of crude protein extract was 
cooled to 4°C and placed in a glass beaker on a magnetic 
stirrer. To this was added, slowly with stirring the 
appropriate volume' of acetone or amount of solid ammonium 
sulphate (see Figure 2.12.1). This mixture was then stirred 
continuously and slowly for 15 - 30 minutes. At the end of 
this time the precipitated protein was harvested by 
centrifugation at 10K for 10 minutes, and the supernatants 
subjected to further precipitations as required (and detailed 
in Chapter 5). The precipitate was then resuspended in the 
smallest convenient volume of extraction buffer, and in the 
case of ammonium sulphate precipitations dialysed against 2 
litres of extraction buffer at 4°C, with one change of 
buffer. These precipitated fractions were then subjected to 
AMP deaminase and protein analysis.
Liquid chromatography using an FPLC system
All chromatography with the exception of Cibacron blue
TMsepharose analyses was carried out on a Pharmacia FPLC 
system. All methods were carried out according to each 
specific column's data sheet (supplied with column) and are 
detailed in Chapter 5. Extract and semi-purified material 
was filtered through 0 .22pm filters before application to the 
column. In the case of Phenyl Superose and Mono Q columns 
the sample was always applied in the start buffer (the buffer 
with which the column had been pre-equilibrated). Once the 
sample was applied the column was washed with this start 
buffer until no appreciable protein elution was observed on a 
trace of absorbance at 280nm. After this linear gradients 
were applied to the column as detailed in Chapter 5.
Fractions were collected in small test tubes and removed to 
ice as soon after elution as possible. Fractions were then 
assayed for AMP deaminase activity and aliquots of the 
fractions of interest were retained for protein concentration 
and SDS gel electrophoretic analyses. The fractions used for 
further analysis were pooled as indicated in Chapter 5.
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2.12 GEL ELECTROPHORESIS
Standard agarose gel electrophoresis of DNA 
Agarose gels of 0.6 - 1.5% (normally 0.8 or 1.0%) were used 
in this work for the separation of DNA molecules on the basis 
of length (MW). DNA was visualised by ultraviolet 
fluorescence after staining with EtBr. The EtBr was either 
added to the agarose at a final concentration of 0 .2ug/ml, or 
after running, the gel was soaked in 1 x running buffer plus 
0.6pg/ml EtBr. Gels were photographed with 260nm UV trans­
illumination using a Polaroid camera loaded with 4x5 Land 
Film (no.57). The camera was fitted with a Kodak Wratten 
Filter N o .6 (red).
Formaldehyde gel electrophoresis of RNA: Northern analysis 
These gels were used for the electrophoresis of RNA under 
denaturing condition, such as in the case of Northern blot 
analysis. The were run under RNase-free conditions according 
to the modified-procedures of Maniatis et al. (1982). 1.5g
of RNase-free agarose was melted in 73mls of RNase-free water 
and cooled to 60°C. 10ml of 10 x MOPS buffer and 16.2ml 
37%(v/v) formaldehyde were added, mixed well and poured.
Well formers (made RNase-free) were inserted into the molten 
agarose and removed after the agarose was set. The RNA 
sample for analysis was mixed with 8 volumes of MMF and the 
mixture was incubated for 15 minutes at 65°C to denature the 
RNA. The denatured RNA samples were mixed with formaldehyde 
gel loading buffer, loaded on to the gel and run at 100V with 
1 x MOPS as running buffer with constant circulation of the 
buffer from anode to cathode to maintain a constant pH. This 
gel was then suitable for Northern blot analysis.
Standard SDS polyacrylamide gel electrophoresis of proteins ■ 
Standard 7 or 9% SDS polyacrylamide gel electrophoresis was 
used both in some analyses during purification (Chapter 5) 
and for the confirmation of heat shock (Chapter 6) and was 
carried out by the standard method of Laemmli (1970). In the 
case of heat shock gels, after electophoresis the gels were 
dried down and autoradiographed.
Phastael SDS polyacrylamide gel electrophoresis of proteins 
Most electrophoretic analyses during purification were
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TABLE 2.1Z.1 COOMASSIE BLUE STAINING USING THE PHASTSYSTEM
Reagent Temperature Time(minutes)
Stain 50°C . 8
Destain 50°C 5
Destain
uooin 8
Destain .
Oooin 8
Preserving solution 50°C 5
TABLE 2.1Z.2 SILVER STAINING USING THE PHASTSYSTEM
Reagent Temperature Time(minutes)
Wash 1 50°C 2
Wash 2 50°C 2
Wash 2 50°C 4
Sensitiser 50°C 6
Wash 2 50°C 3
Wash 2 50°C 5
Water 50°C 2
Water 50°C 2
Silver nitrate 40°C 13
Water 30°C 0.5
Water 30°C 0.5
Developer 30°C 0.5
Developer 30°C 4
Stop bath 50°C 2
Preserving solution 50°C 3
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carried out using the Pharmacia Phastsystem™. This system 
uses small pre-cast gels and solid buffer strips and the 
electrophoretic conditions are controlled automatically. 
Standardly used in this study were 10-15% gradient gels and 
SDS buffer strips/ lml samples in SDS loading buffer were 
loaded and the electrophoretic conditions used were as 
follows. The sample was applied for IVh (250V/10mA)/ 
followed by electrophoresis for 60Vh (250V/10mA). Separation 
takes approximately 30 minutes and in carried out at 15°C. 
After this the gel was either Coomassie-blue or silver 
stained, again these processes were automated by the 
Phastsystem. The details of staining are shown in Tables 
2 .12.1 and 2 .1Z.2 .
Sequencing gels
8% denaturing polyacrylamide wedge gels were used for all 
sequence analysis and were made from the following stocks.
40% acrylamide (acrylamide:bisacrylamide, 19:1), urea and 10 
x sequencing TBE buffer. The gel was prepared thus (for an 
8% gel). 42g of urea, 20ml 40% acrylamide stock and 10ml 10 
x TBE were made up to lO.Omls (once the urea had completely 
dissolved) and filtered through a 0.45jum membrane filter 
prior to the addition of-0 .8ml 10% ammonium persulphate and 
40ul TEMED. The gel was poured into pre-cleaned and sealed 
plates and allowed to polymerise for at least 2 hours. A 
shark's tooth comb was used for the application of samples. 
The gel was pre-electrophoresised for 30 - 60 minutes at a 
constant power 60W. Prior to loading the samples were heated 
at 100°C for 5 minutes and cooled on ice. After loading the 
gels were electrophoresised for 2-3 hours. The gel was then 
soaked in 10% acetic acid, 10% methanol, prior to drying onto 
filter paper (Whatman 3MM) and autoradiography.
2.13 DNA AND RNA HYBRIDISATION TECHNIQUES 
Southern Blots
DNA was transferred from agarose gels to nitrocellulose or 
nylon membrane using the procedure of Southern (1975), and 
those modifications proposed by the manufacturers of the 
membranes. In the case of genomic digests the DNA was 
partially depurinated by soaking the gel in 0.25M HC1 for 15-
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20 minutes. In all cases the gel was soaked in denaturing 
solution for 30 minutes with gentle agitation, after which 
the solution was replaced with neutralising solution and 
agitated for a further 30-60 minutes. A glass plate spanning 
two reservoirs of "20 x SSC was covered with 2 or 3 sheets of 
filter paper (Whatman 3MM), the filter paper being submerged 
in the 20 x SSC at both sides. The gel was placed on the 
paper/glass support and a pre-cut sheet of membrane was 
placed over the gel excluding any bubbles. Several sheets of 
filter paper were placed on top of the membrane, which was 
then covered with a stack of paper towels and a glass plate. 
This sandwich was weighted down and transfer was allowed to 
continue for 12-16 hours. The membrane was then removed and 
fixed either by baking at 80°C for 1-2 hours, in the case of 
nitrocellulose membrane and by UV fixing on a 
transilluminator for 2-3 minutes in the case of nylon 
membranes.
Colony Hybridisations
For the screening of the YEp24 library (described in Chapter 
6), standard colony hybridisation techniques were employed. 
Nitrocellulose membrane was cut to the appropriate size and 
laid gently onto the surface of an agar plate bearing E .coli 
colonies stabbed in an array. Using a sterile needle marks 
were made through the membrane into the agar to allow 
orientation of the filters with the plate. The membrane was 
removed after 1 minute and placed colony side up on 
chloramphenicol (250^ig/ml) plates. The plates were then 
incubated at 37°C for 8 hours to allow amplification of the 
plasmid. The filters were then removed and placed, colony 
side up, on a pad of filter paper soaked in 10% SDS for 4 
minutes. This acts as a prewash to remove debris. The 
filters were then placed on a pad of filter paper soaked in 
denaturing solution for 10 minutes or until the colony 
appeared smeary. This lyses the bacteria and denatures the 
DNA. The filter is then placed on a pad soaked in
neutralising solution for 10 minutes and finally on a pad of
2 x SSC for 5 minutes. The filters were then baked at 80°C 
for 1 hour. Because of the amount of cell debris the filters 
were washed in 2 x SSC. The cell debris was gently brushed
off with the gloved hand prior to prehybridisation.
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Northern Blots
RNA was transferred from formaldehyde agarose gels to nylon 
membrane to facilitate Northern blot analysis. The technique 
used was -the same as that for Southern blot analysis with the 
exception that the' gel does not need to be treated with
denaturing and neutralising solution because the RNA has been
denatured by the formaldehyde gel.
Hybridisation Conditions
Filters with nucleic acid fixed as described in the sections 
above were sealed in plastic bags. To the bag was added 
enough prehybridisation solution to allow adequate coverage 
of the filter. All air was excluded and the bag was sealed.
Filters were generally prehybridised at 37°C and the
concentration of formamide in the prehybridisation solution 
was altered to vary the stringency. Standardly 20% formamide 
was used (unless otherwise stated) and the normal 
prehybridisation solution consists of the following (for 
20mls)
5mls 20 x SSC
lml 0.4M Na P04/ pH7.0
lml 100 x Denhardt's solution
0.8ml 0.25M EDTA, pH8 .0
lml 10% SDS
make up total volume to 20ml with distilled water
Filters were prehybridised for 2-24 hours prior to the 
addition of the probe. The probe was then added to the bag 
and hybridisation continued at 37°C for at least 3-4 hours 
(in the case of oligonucleotide probes, hybridisation was 
continued for 12-24 hours). Filters were then washed. 
Oligonucleotide probes were standardly washed off in 6 x 
SSPE, 0.1% SDS at room temperature and then 42°C or as 
required. Filters hybridised with random primed probes were 
generally washed in 2 x SSPE, 0.1% SDS at room temperature 
and 42°C as required. After washing the filters were again 
sealed in plastic bags and autoradiographed.
Radioactive probe production: end labelling oligonucleotides 
Mixes containing 100-200ng of oligonucleotide DNA, 1 x kinase 
buffer, 50yuCi [^P]-dATP, and 1 unit of T4 kinase were
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incubated at 37°C for 30 minutes. The probe was then 
purified on a Sephadex G-50 column. A portion of the 
purified probe was counted in a scintillation counter and the 
specific activity in cpm/pg DNA was calculated. On average 
oligonucleotide pr^obes had a specific activity of between 
10®-109 cpm^iug. Probe was then added to prehybridised 
filters at approximately 106 cpm/ml of prehybridisation 
solution.
Radioactive probe production: random priming (Feinbera and
Voaelstein.. 1983) 
Between 10 and lOOng of a DNA fragment was incubated at 100°C 
for 3 minutes. It was then cooled at 37°C for 10-15 minutes. 
To the DNA was added the following; lOjil random prime mix, 
50^iCi [^P]-dCTP, 2jil (DNase free) BSA, and water to make up 
the volume to 54pl. 1 unit of Klenow fragment was then added
and this mix was incubated overnight at room temperature or 
for 1 hour at 37°C. The probe was then purified on a 
Sephadex G-50 column and the specific activity of the probe 
was calculated as for oligonucleotide probes. Again the 
specific activity was routinely between 108-10  ^ cpm/jag.
Prior to the addition of the probe to the hybridisation 
solution the probe was boiled for 10 minutes.
2.14 PLASMID DNA SEQUENCING
Plasmid DNA sequencing was carried out using the Pharmacia T7 
polymerase sequencing kit. The method was based upon the 
dideoxynucleotide sequencing method of Sanger et al. (1977) 
and was carried out as detailed in instructions supplied with 
the kit. Gel electrophoresis conditions and method of 
plasmid purification have been detailed previously.
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CHAPTER 3
ATTEMPTED CLONING OF THE AMP DEAMINASE GENE BY RESISTANCE TO
DEOXYCOFORMYCIN
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3.1 INTRODUCTION
The initial aim of this project was to isolate and clone the 
AMP deaminase gene from Saccharomyces cerevisiae. 
Theoretically a number of strategies could be used to achieve 
this aim.
At the outset of this project there were no AMP deaminase 
genes cloned from any organism. Therefore, it was not 
possible to consider a strategy whereby sequences are 
selected by homologous hybridisation techniques. Had there 
been a readily available source of anti-AMP deaminase 
antibodies, or a source of the purified protein (to allow the 
manufacture of such antibodies) it might have been possible 
to isolate clones of the yeast AMP deaminase cDNA from a 
library in a suitable E .coli expression vector such as lambda 
gtll. This however was not the case. The only alternative 
was therefore to use a selection strategy which makes use of 
the expression of the active enzyme. Unfortunately, there 
had been no identified mutants in the gene for AMP deaminase 
in a suitable system to allow selection by complementation. 
There was also no obvious method by which a S .cerevisiae 
strain defective in AMP deaminase could be produced other 
than by random mutagenesis and assaying all resulting mutants 
biochemically until a strain lacking AMP deaminase activity 
was found. Initially it was anticipated that this was 
unlikely to succeed since AMP deaminase might be an essential 
enzyme given its prominant role in the regulation of the 
adenylate energy charge (see Chapter 1).
The only alternative was to find some strategy to detect and 
select for elevated intracellular levels of AMP deaminase in 
yeast. There are certain classical strategies to allow 
selection of a cloned gene in this way. All such strategies 
require a library which must be representative of all 
sequences in the organism’s genome. The library must be made 
in.a suitable vector depending on the requirements of the 
screening strategy and whether the DNA fragments borne on the 
vector are to be genomic fragments or cDNAs. To this end it 
was judged advisable to use a genomic library cloned into a 
multicopy episomal vector, which should allow elevated levels 
of the product of most genes borne on that vector when
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transformed into S.cerevisiae. It was also advisable to 
choose a vector which can also be transformed and stably 
maintained in E .coli. This facilitates easy amplification, 
purification and manipulation of the vector. Therefore, the 
ideal choice was argenomic library based upon an episomal 
S .cerevisiae-E .coli shuttle vector. The genomic DNA 
fragments must be of a great enough size to allow a large 
proportion of them to contain entire coding sequences and 
flanking regulatory sequences which make up a specific gene. 
At the outset of this project a suitable genomic library was 
available from David Botstein. This is a size selected 
(average insert size is reported as lOkb) S .cerevisiae 
genomic library cloned into the YEp24 shuttle vector which 
is maintained at multiple copies in the yeast cell (Carlson 
and Botstein, 1982)
Using the choice of this multicopy, episomal library, a 
method was required to allow selection of overproduction of 
AMP deaminase in clones containing the S .cerevisiae AMP 
deaminase structural gene. This might have been achieved by 
simply assaying transformants for an increased AMP deaminase 
specific activity, but this was adjudged laborious. It would 
have required the growth of transformants to a similar cell 
density, followed by protein extraction and finally assaying 
the specific activity of AMP deaminase in individual 
transformants. It was calculated that several thousand 
transformants would have to be screened to allow a high 
probability of finding any one gene using the genomic library 
described above. The formula used for the calculation of 
this number is shown below:
N = ln( l-P'V 
ln(l-f)
where N = the number of clones which must be screened,
P = the probability of finding a particular sequence
f = the fractional proportion of the genome in a single
a n
recombinant which is in this case 1 x 104/1.4 x 10 
since the average insert size of this library is 
lOkb and the haploid yeast genome is 1.4 x 10
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FIGURE 3.1.1 THE STRUCTURES OF COFORMYCIN AND
DEOXYCOFORMYCIN
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The answer to this calculation is 6450 recombinants which 
must be screened to give a 99% probability of finding any 
particular sequence and therefore this strategy was rejected.
An alternative strategy was to use the classical method of 
looking for increased resistance to a drug which inhibits the 
enzyme in question and thus select for increased enzyme 
synthesis. Coformycin and deoxycoformycin are two adenosine 
analogues currently being used effectively in the treatment 
of some lymphoid malignancies (Bagnara and Hershfield, 1982). 
The structure of these two compounds is shown in Figure
3.1.1. This toxicity to tumour cells is due to the drug’s 
ability to inhibit adenosine deaminase, resulting in an 
accumulation of adenosine, 2 'deoxyadenosine and other 
metabolites toxic to the cells. Coformycin (CF) and 
deoxycoformycin (dCF) are also powerful non-competitive 
inhibitors of AMP deaminase in all mammalian cell lines so 
far studied (Henderson et al. . 1977; Agarwal and Parks,
1977),
CF and dCF have been studied fairly extensively in in vitro 
studies with purified rabbit muscle AMP deaminase. Under the 
conditions used (Agarwal and Parks, 1977) AMP deaminase was 
inhibited 45% and 66% by 1.3]uM and 2.8juM of dCF respectively 
whereas, CF inhibited the enzyme 67% and 99.5% with 55nM and 
1.3pM respectively. In other words, CF is the more powerful 
inhibitor and the level of inhibition was much greater when 
the enzyme was preincubated with the inhibitor prior, to 
addition of the substrate to initiate the assay. This 
preincubation effect was less marked in the case of dCF.
Freiden et al. (1979) chemically synthesised deoxycofomycin 
5'-phosphate which proved to be a much more potent inhibitor 
of AMP deaminase than deoxycoformycin. This is to be 
expected since dCF is an analogue of deoxyadenosine while 
deoxycoformycin 5 '-phosphate is more similar to deoxy- 
adenylate (dAMP) which, though not the natural substrate for 
AMP deaminase can be used as a substrate, though at a lesser 
rate (Yoshino et al.. 1979b). There is good evidence that 
deoxycoformycin 5 ’-phosphate binds to the active site of the 
enzyme of which there appears to be four per molecule (i.e. 
one per subunit; AMP deaminase is a tetramer) (Freiden et
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FIGURE 3.1.2 PRINCIPLE OF COFORMYCIN TOXICITY
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al., 1979). They also showed that inhibition is time 
dependent which may reflect that deoxycoformycin 5 1-phosphate 
induces conformational' changes in the enzyme. The inhibitor 
binds extremely tightly, only being released from the enzyme- 
inhibitor complex after protein denaturing treatments. The 
inhibitor is then still active and is able to inhibit freshly 
added enzyme (Freiden et al.. 1979).
These inhibitors have also been used in studies involving 
intact cells as well as in in vitro studies. Debatisse et 
al. (1982)- found that although AMP deaminase was not strongly
inhibited by 0. 5jug/ml CF in cell free extracts of Chinese
/
hamster fibroblasts, AMP deaminase activity is reduced to 15 
- 20% of its normal specific activity in intact cells 
cultured in medium containing the same concentration of 
CF for 48 hours. They also showed that this concentration of 
CF is toxic to Chinese hamster fibroblasts when they are 
cultured in medium containing adenine. This toxicity is 
thought to be due to starvation of IMP and resulting guanylic 
derivatives. Evidence for this is that the concentration of 
adenine required for this toxic effect is the same as the 
concentration required to inhibit and block de novo 
biosynthesis of IMP (Debatisse and Buttin, 1977). The above 
cells can be rescued from these conditions by the addition of 
hypoxanthine as long as they contain hypoxanthine-guanine 
phosphoribosyl-transferase activity. They hypothesised that 
this toxicity requires both the inhibition of de novo 
biosynthesis of IMP and the inhibition of adenosine deaminase 
and AMP deaminase by CF as shown in Figure 3.1.2. (Debatisse 
et al.. 1981) .
This treatment resulted in the isolation of CF-resistant 
lines which fall into two categories: stable and unstable 
(Debatisse et al.. 1982). The stable lines showed altered de 
novo IMP biosynthesis, that is they are no longer inhibited 
in the production of IMP by the presence of adenine. The 
second, unstable class showed a 6 to 10-fold increase in 
their AMP deaminase specific activity. They went on to study 
this second class of variants and found that their AMP 
deaminase was biochemically unaltered with regard to its Km, 
its cofactor requirements or its chromatographic properties.
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By stepwise selection using increasing concentrations of 
CF, Debatisse et al. (1982) isolated variants with up to 150- 
fold increased AMP deaminase activity. From SDS 
polyacrylamide electrophoresis it was clear that thist
increased AMP deaitfinase activity correlated with an 
accumulation of the protein. Several other, unidentified 
poTypeptides also accumulated (Debatisse et al.. 1982 and 
1984) which led to the hypothesis that gene amplification was 
responsible for this overexpression of AMP deaminase. By 
isolating RNA from amplified variants they succeeded both in 
showing in vitro translation of four of the accumulating 
polypeptides, though not of AMP deaminase itself. They also 
isolated the cDNAs of the same four polypeptides but again, 
not of AMP deaminase (Debatisse et al.. 1984). They 
suggested that this failure to clone AMP deaminase cDNA by 
this method may be due to a failure to isolate its mRNA, 
possibly because of some inherent instability in this system, 
or that there is something about this isolated mRNA which 
makes it a poor substrate for reverse transcription in their 
hands.
The four isolated cDNA clones were used as probes to show 
that there are differential degrees of amplification in each 
cell line, and that although the four open reading frames 
corresponding to these four polypeptides are linked, the end 
points of the amplification units vary in their positions in 
different amplified isolates (Debatisse et al.. 1986). They 
have recently managed to clone the open reading frame assumed 
to code for AMP deaminase by chromosome walking using these 
cloned cDNAs as starting points (Debatise et al.. 1988).
Our strategy was to select a plasmid containing the AMP 
deaminase structural gene by its increased resistance to dCF. 
In mammalian systems these drugs are only effective in the 
presence of adenine which inhibits de novo IMP synthesis.
The toxic effects observed result from the cell being blocked 
in its production of IMP from both the de novo biosynthetic 
route and the AMP deaminase reaction, and thereby being 
unable to produce guanine containing nucleotides.
Our plan was to mimic this effect by producing strains whose 
only route of production of IMP was via the deamination of
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FIGURE 3.1.3 THE BIOSYNTHESIS OF PURINE NUCLEOTIDES
(Genetic blocks are indicated below)
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AMP by the AMP deaminase reaction. The central position of 
IMP in purine metabolism is shown in the Figure 3.1.3. It 
was assumed that this' strain would have a basal sensitivity 
to dCF which could be overcome by the presence of higher 
levels of AMP deaminase brought about by the presence of 
multiple copies of a plasmid bearing the AMP deaminase gene. 
In 'this manner clones containing this gene would hopefully be 
selected. To mimic the inhibitory effect of adenine on de 
novo synthesis of IMP in mammalian systems the decision was 
made that our constructed yeast strain would be mutated in 
one of the steps of de novo IMP biosynthesis, for instance 
adel or ade2. Another obvious route to IMP is from 
hypoxanthine via the hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT) activity encoded by the 
HPT1 gene (Woods et al.. 1983). Fortuitously this enzyme has 
a second activity in the phosphorylation of guanine to GMP.
A strain defective in this enzyme therefore cannot produce 
GMP via this route and must rely on metabolism of IMP. This 
would also further our ultimate aim in producing a dCF- 
sensitive strain.
Other factors in the design of our sensitive strain were also 
taken into consideration. It was thought possible that the 
enzymes adenylosuccinate synthetase (adel2) and 
adenylosuccinate lyase (adel3) may, under certain conditions, 
catalyse the reverse reactions. There is evidence however, 
that in yeast these reverse reactions do not occur (Jones and 
Fink, 1982) and initially it was considered that the strain 
constructed would not have to contain one of these mutations.
Another possible problem is that one of the intermediary bi­
products of the histidine biosynthetic pathway is an 
intermediate in the IMP biosynthetic pathway. This 
intermediate is phospho-ribosylamino-imadazole-carboxamide 
(AICAR). Hence the introduction of a mutation making the 
strain defective in the early stages of histidine 
biosynthesis may have proved necessary.
It is necessary finally that the strain has a suitable 
auxotrophic mutation to allow selection of cells receiving 
plasmids bearing a suitable auxotrophic marker gene. Yeast 
vectors routinely carry marker genes such as LEU2, HIS3 and
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URA3 . The marker in the chosen YEp24 library is URA3. The 
constructed strain should therefore carry a mutation in the 
URA3 gene.
Thus a suitable ancl new yeast strain was to be constructed 
that theoretically relies largely on AMP deaminase for the 
production of IMP and thereby guanylate nucleotides. It was 
hoped that this strain would have an increased sensitivity to 
the AMP deaminase inhibitor dCF, and therefore that clones 
resulting from transforming such a strain with the chosen 
genomic library would show relatively high resistance to this 
drug because they had increased levels of AMP deaminase due 
to the presence of multiple copies of the AMP deaminase gene.
3.2. PRODUCING A DEOXYCOFORMYCIN SENSITIVE STRAIN
A list of the strains used and produced in this project can 
be found in chapter 2 .
3.2.1. Confirming the hptl" phenotype of W1-2D
A strain W1-2D carrying a mutation in the hypoxanthine- 
guanine phosphoribosyl transferase gene, hptl was kindly 
donated by Robin Woods (Woods et al.. 1983). This strain was 
to be used in the production of our dCF sensitive strain. 
According to Woods et al. (1983), strain W1-2D was isolated 
by selecting for resistance to the base analogue 8- 
azaguanine, at a concentration of 200pg/ml. 8-azaguanuine is 
toxic by virtue of it being incorporated into nucleic acids 
via the hypoxanthine-guanine phosphoribosyl transferase 
(HGPRT) reaction. Hence W1-2D should be resistant to azaG 
because it lacks HGPRT activity.
Attempts to confirm the hptl- genotype by its resistance to 
this analogue over other strains have been wholly 
unsuccessful. W1-2D shows resistance up to 40(^ig/ml 
azaguanine, but DBY868 which was presumed to be HPT1+ shows a 
similar if not greater level of resistance to the analogue. 
The basis of DBY868’s resistance has not been characterised, 
and use of the analogue as a selective agent in the yeast
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matings was abandoned.
A hptl" mutant by definition is unable to utilise 
hypoxanthine to produce IMP. Therefore an ade2" . hptl" 
strain according to Woods et al. cannot grow on hypoxanthine 
(hpx) in the absense of adenine (ade) (Woods et al.. 1983). 
The ability of an ade2" strain, DBY868, to grow on 
hypoxanthine containing medium in the absense of adenine was 
confirmed, but since the inability of an ade2~ . hptl" mutant 
to grow on this same medium could not be confirmed prior to 
mating it was assumed to be the case, and subsequently used 
successfully in the selection of mating progeny, (see section 
3.2.3).
3.2.2 Production of a rho" W1-2D variant strain
The strain W1-2D carried no chromosomal markers apart from 
hptl". It was therefore necessary to have some way to 
select for diploids made by crossing W1-2D with DBY868 (the 
strain used to donate the ade2" marker) since the strain Wl- 
2D can grow on minimal medium (GYNB).
It was decided that the simplest way to make a variant of Wl- 
2D was to make it rho" . that is, defective in its 
mitochondrial-based respiration. Rho" mutants cannot 
therefore grow on non-fermentable carbon sources such as 
glycerol. Rho" mutants in yeast are also known as petites. 
since they produce small colonies in comparison to wildtype 
strains on the appropriate media (Monnolou et al.. 1966; 
Nagley and Linnane, 1970). To check that both DBY868 and Wl- 
2D are capable of growth on glycerol, they were both plated 
on glycerolYNB and GYNB with the necessary supplements and 
incubated at 30°C. Most yeast strains will grow well on 
glucose and will produce reasonably sized colonies after 2-3 
days. However, both DBY868 and W1-2D grew much more slowly 
on glycerol containing medium and colonies attained a 
reasonable size only after approximately seven days.
Rho" mutants were isolated by mutagenesis using ethidium 
bromide, and was carried out in the following manner. (Brian 
Cox, personal communication. A single W1-2D colony was
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picked into 1ml of sterile water in an eppendorf tube. This 
was serially diluted on to YPG plates, in duplicate, to give
a density of approximately 100 colonies per plate. A single
ethidium bromide crystal is placed in the centre of one of 
the duplicate plates and then the plates are incubated, non­
inverted for 3 days. At the end of this time, a clear zone 
of 'inhibition of growth was seen on the plate due to 
diffusion of the ethidium bromide from the crystal, and 
immediately outside this was a zone where only small colonies 
grew. Finally, colony size increased towards the outside of 
the plate. Several of the small colonies were stabbed in 
duplicate onto glycerolYNB and GYNB and allowed to grow at 
30°C for ten days. At the end of this time everything had 
grown on GYNB, and only some on glycerolYNB. Eight of those 
strains incapable of growth on glycerol were picked and
streaked on to YPG. Of these, six gave clearly small
colonies and the two remaining gave rise to a mixture of 
small and larger colonies. These latter two were discarded 
and the remaining six (named W1-2D rho” A,B,C,D,F and G) were 
retained for future use.
3.2.3 The production of an ade2~ . hptl” mutant strain
DBY868 and W1-2D rho~C were mated and sporulated using 
standard methods (see Chapter 2). In addition, control 
crosses of DBY868 with X1056-1C, and of W1-2D rho~C with 
DBY747 were carried out to confirm the mating types of DBY868 
and W1-2D rho“C. Diploids were selected by streaking on to 
glycerol YNB, which only supports the growth of these 
diploids. The diploids were then presporulated and 
sporulated in the standard manner. The resulting asci were 
dissected and the resulting tetrads were grown and their 
phenotypes analysed. The phenotypes of ten such tetrads and 
the analysis of this cross are shown in appendix 1 .
Differential growth on minimal medium +hpx, -ade (ie 
containing hypoxanthine but excluding adenine) was observed 
for ade2“ , hptl+ and ade2” , hptl” strains. Ade2” , hptl” 
strains were not completely inhibited in their growth on this 
medium but their rate of growth was considerably less than 
ade2” , hptl+ strains. It was this much slower growth rate on
63
minimal medium +hpx -ade which allowed assignment of the 
ade2 . hptl genotype.
From the ten tetrads analysed, only 3 spores had the required 
genotype of ade2- /  hptl" . These are spores ID, 2C and 5C.
The mating types of these 3 haploids were analysed thus.
ID, 2C AND 5C were each mixed with X2928-3D-1A and X2928-3D- 
1C in the standard method for yeast matings. Diploids of 
these reciprocal matings were selected on GYNB. In the case 
of ID and 5C, diploids were only yielded in crosses with 
X2928-3D-1A, and hence ID and 5C are therefore mating type 
alpha. In contrast, 2C yielded diploids with X2928-3D-1C, 
and is therefore mating type a.
Therefore the 3 constructed strains have the following 
genotypes.
JMM1-1D alpha r ade2- . hptl- , hisA- 
JMM1-2C a, ade2~ . hptl- 
JMM1-5C alpha. ade2- , hptl-
3.2.4. Making the ade2- . hptl- strain into a suitable 
transformation strain
Before using these strains as hosts for a transformation with 
a genomic library, a suitable auxotrophic mutation must be 
introduced to allow for selection and stable maintenance of 
the vector. In this instance, the decision was made to use 
ura3 as the selectable marker since this was the marker gene 
carried by the YEp24 library discussed in the introduction. 
Therefore an ade2- , hptl- strain was also made ura3- . This 
was done by classical yeast genetic mating. The decision was 
made to use the strain X4003-5B as a source of the mutated 
ura3 allele. This strain was also chosen because of its 
phenotype of giving high transformation efficiencies. It was 
hoped that some of the resulting haploids of this mating 
would also exhibit this phenotype.
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Therefore the following two matings were set up in the 
standard manner
Cross 2: JMM1-1D x X4003-5B
Cross 3: JMM1-5C x X4003-5B
The diploids of these crosses were selected by streaking onto 
GYNB with histidine and GYNB,; . respectively.
This allows selection of diploids only. The diploids thus 
produced were induced to sporulate in the standard way. The 
resulting asci were dissected and the phenotypes of the 
spores and partial genetic analysis of these crosses are 
presented in appendix 2". As expected, all progeny of cross 2 
are his"" (with the exception of spore 2-3B) . The two alleles 
of his4 in the two parent strains, X4003-5B and DBY868 are 
not the same. Therefore, this his4+ spore may have resulted 
from a rare recombination event between the two closely 
linked mutations or it may have been mis-assigned. Analysis
with respect to the hptl mutation was only analysed in
strains which proved to be ade~ . ura3~ . as listed below
Cross 2 1A; 2C; 4C; 6A; 8B; 9D; 11C; 14B; 15C; 16C; 17C;
18C
Cross 3 2A; 6D; 8C; 9D
It was necessary to characterise these strains for their full 
ade genotype. By the nature of the crosses carried out they 
could fall into three categories, either adel” , ade2“ or the 
double mutant adel~"/ade2~ . This characterisation was carried 
out by mating each strain in the standard way in the crosses 
described below to produce diploids. The resulting diploids 
were then streaked out on media which would either support 
growth of the diploid in the absence or presence of adenine. 
Those crosses which produced diploids which were able to grow 
on medium in the absence of adenine did so because 
complementation of two separate mutations had occurred 
allowing further classification of the haploid strains. 
X2928-3D-1A and X2928-3D-1C are isogenic strains, differing 
only in mating type, carrying the adel” mutation and 
therefore able to complement ade2~ mutants in the diploid but
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FIGURE 3.3.1 INHIBITION OF AMP DEAMINASE BY DEOXYCOFORMYCIN 
IN CELL FREE EXTRACTS
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The percentage of maximal activity is given in figures on top 
of each bar in the histogram.
These results were obtained using identical cell free extract 
from yeast strain X4003-5B in standard lOOul reactions (see 
Chapter 2), incubated at 37°C for 10 minutes.
All determinations of AMP deaminase activity were carried out 
triplicate and the results represent the average of these 
data.
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not the other two categories. The haploids were therefore 
initially crossed with strains X2928-3D-1A and X2928-3D-1C. 
These crosses could distinguish between ade2~ mutants and 
adel" or adel~/ade2~ mutants Those mutants which were not 
complemented in the X2928-3D-1A/1C crosses were then crossed 
with either JMM1-1D or -2c which as previously stated are. isogenic 
except at the mating locus and carry the ade2" mutation.
These crosses could distinguish between adel" mutants and 
ade2~ or adel~/ade2~ mutants. Those strains which did not 
complement for ade requirement in either of the test crosses 
were therefore adel"/ade2~ double mutants. These test 
crosses also allowed classification of mating type for each 
strain of interest. A total of six strains were retained 
for future use and the full genotypes of these strains are 
shown below.
Cross 2: JMM2-4C - a, ade2~ . hptl" . his4", ura3“ , met2~ .
Ieu2~
JMM2-9D - a , ade2~ . hptl" f his4" . ura3~ . .Im23 
met2" , leu2~ , trp5~
Cross 3: JMM3-2A - a, adel" .ade2~ . hptl" . ura3~ . Ieu2" . trp5" 
JMM3-7B - alpha. adel" . hptl" . ura3" . met2" . trp5" 
JMM3-8D - aloha. adel". ade2~. hptl". his4". ura3~.
met2~ , leu2~
JMM3-9D - alpha. ade2~ f hptl" . ura3"
3.3. IN VITRO EXPERIMENTS WITH DEOXYCOFORMYCIN
Because of the value of CF and dCF as therapeutic chemicals, 
and because they are only produced in a few laboratories 
throughout the world they are not widely available. We were 
fortunate, however to be given lOOmg of dCF. This was the 
generous gift of Martin L. Black, Warner Lambert.
The first priority was to show that in our hands yeast AMP 
deaminase is inhibited by dCF. To this end, AMP deaminase 
reactions were set up using yeast cell free extracts 
containing a variety of concentrations of deoxycoformycin.
The results of this experiment are shown in figure 3.3.1.
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FIGURE 3.3.2 THE EFFECT OF PREINCUBATION OF CELL FREE 
EXTRACT WITH DEOXYCQFORMYCIN PRIOR TO 
DETERMINING AMP DEAMINASE ACTIVITY
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The percentage of maximal activity is given in figures on top 
of each bar in the histogram.
Reaction mixes were set up with identical X4003-5B cell free 
extract and were incubated at 37°C in the presence (or 
absence, where indicated) of 100^ig/ml deoxycoformycin prior 
to the addition of lOmM AMP to start a standard AMP deaminase 
assay (see Chapter 2). The reactions mixes were in a total 
volume of lOOul containing lOul extract and the AMP deaminase 
assay was carried out for a total of ten minutes.
All determinations of AMP deaminase activity were carried out 
triplicate and the results represent the average of these 
data.
Note: All reaction mixes were incubated at 37°C for a total 
of 60 minutes prior to the addition of substrate 
All reactions were carried out in triplicate
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Note: All the AMP deaminase determinations described in this
chapter were carried out using the glutamate dehydrogenase 
ammonia assay method (Bergmeyer and Buetler, 1982) (as 
detailed in Chapter 2). All the activities are the average 
of three identical' reactions and a single, parallel substrate 
blank reaction. Errors (not shown) are in the range of not 
greater than +/- 4%.
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From these results it is clear that yeast AMP deaminase is 
inhibited by concentrations of lOOjug/ml dCF although the 
inhibition is not complete even at 500yug/ml under these 
conditions. Since deoxycoformycin is an adenosine analogue, 
it has been postulated that it is a more effective inhibitor 
when it is phosphorylated to form deoxycoformycin 5 1- 
phosphate (Freiden et al.. 1979). There is also strong 
evidence that at least in the case of CF, pre-incubation of 
AMP deaminase with the inhibitor prior to the assay increases 
the inhibitory power of the drug. To test if this was also 
the case for dCF with respect to yeast AMP deaminase, 
reaction mixes were incubated in the presence or absence of 
lOOjug/ml dCF, at 37°C for a variety of times, prior to the 
start of the reaction, by the addition of AMP. The results 
of this experiment are presented in figure 3.3.2.
It is clear that the level of inhibition increases markedly 
with pre-incubation time of the enzyme with the inhibitor, 
showing almost complete inhibition after 60 minutes. It is 
also clear from these results that the AMP deaminase is 
differentially inhibited from one cell-free extract to 
another, ie the extract used in the experiment described in 
figure 3.3.1 is inhibited 47% by the addition of lOOug/ml dCF 
with no pre-incubation whereas the extract used in the 
production of the results in figure 3.3.2 is inhibited only 
21% under the same conditions. The differential sensitivity 
of these two extracts may be explained in a number of ways.
For example, minor differences in the extraction process may 
yield differential recovery of the enzyme(s) responsible for 
the phosphorylation of dCF which is thought to be required 
for maximum inhibition of the enzyme.
Therefore, although there may be some experimental 
variability in the level of inhibition by dCF, there is
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TABLE 3.4.1 THE EFFECT OF DEOXYCOFORMYCIN ON RECOVERING 
PROTOPLASTS
THE NUMBER OF COLONY FORMING UNITS/ML X 10^ 
Recovery Time Concentrations of dCF
(mins) Qug/ml)
0 1 10 100 1000
0 328 238 232 286 279
30 330 314 291 387 478
60 291 393 226 259 279
120 205 193 87 162 149
The number of colony forming units produced following the 
adapted transformation technique (detailed in section 3.4) in 
the presence (and absence) of various concentrations of 
deoxycoformycin in the recovery media.
Protoplasts were made in the in the manner of normal 
transformation with DNA (Beggs, 1978) with the exception that 
after PEG treatment, identical aliquots of cells were allowed 
to recover in YPG media containing various concentrations of 
deoxycoformycin (as indicated). The protoplasts were then 
plated onto standard transformation media with the 
appropriate supplements and incubated at 30°C. The number of 
colony forming units produced in each case was then scored.
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obviously an observable level of inhibition of the yeast AMP 
deaminase by dCF.
/
3.4 IN VIVO STUDrES WITH DEOXYCOFORMYCIN
Thd"next priority was to show that dCF could inhibit AMP 
deaminase in vivo in yeast cells and would thereby be toxic 
to the cells under prescribed conditions. This was a 
prerequisite for our cloning strategy.
The intent was to find a concentration of dCF which is toxic 
to normal, untransformed cells of our specially constructed 
strain, whose sensitivity would theoretically be reduced by 
the presence of multiple copies of the complete AMP deaminase 
gene. Initial investigations of the toxicity of dCF on 
laboratory strains of S .cerevisiae were carried 
out prior to the production of our constructed strains. The 
following strains were patched ond later plated in dilution 
series on GYNB with necessary additions and 0, 50 and 
lOOug/ml dCF. No appreciable difference was seen either in 
the rate of growth or the number of surviving colonies 
produced in the presence or absence of dCF. These 
experiments were later carried out with the ade2", hptl” 
strains, JMM1-1D, JMM1-2C AND JMM1-5C described in section
3.2.3. These strains too, showed no detectable sensitivity.
It has been shown that yeast AMP deaminase is sensitive to 
inhibition by dCF in vitro. It was hypothesised that if the 
dCF was entering the cells one would expect to see some 
effect, at least on the rate of growth of the ade2", hptl" 
strains in comparison to other laboratory strains.
Therefore, it was argued that either the concentrations of 
dCF we were using were too low to have a toxic effect, or 
that the cells were either metabolising the drug or failing 
to take it up.
The experiments were also carried out on glycerol containing 
medium since it has been suggested that glycerol may increase 
the uptake of certain molecules by yeast cells (Alistair 
Brown, personal communication). This too, had no appreciable 
effect on the growth of cells in the presence of dCF.
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The decision was made to see whether cells undergoing normal 
yeast transformation treatments would show sensitivity to 
dCF. One technique frequently used for the transformation 
of S .cerevisiae involves protoplasting cells in 
an osmotically stabilized buffer, ie partially removing their 
cell walls by enzymatic treatment. The cells are then 
treated with polyethylene glycol (PEG) to bring about cell 
fusion which allows uptake of DNA. It was hoped that during 
this treatment cells would also be able to take up dCF. To 
this end a number of experiments were carried out.
Protoplasts were produced from strain JMM1-2C in the standard 
manner (see chapter 2). After PEG treatment the protoplasts 
were allowed to recover normally in lOOpl YPG at 30 C for 30 
minutes. The protoplasts were then plated in overlays 
containing 0, 1, 10 and lOOjug/ml dCF. No difference could be 
seen in the resulting number of colonies(data not shown).1
In the next experiment, identical aliquots of protoplasts 
were recovered in YPG containing 0, 1, 10, 100 and lOOOjug/ml 
dCF following PEG treatment. Aliquots from each tube were 
then plated at various times and at various dilutions in agar 
overlays without dCF. The results are shown in table 3.4.1. 
There appears to be no significant difference between those 
cells recovered in the presence or absence of dCF. It does 
show however that a 30 minute recovery period is the most 
efficient for the regeneration of protoplasts under these 
conditions, and that longer recovery results in a loss of 
viability. In subsequent experiments these results were 
borne out, and viability is effectively wiped out after 8 
hours (results not shown).
Although dCF was shown to be a potent inhibitor of yeast AMP 
deaminase in vitror all attempts to make dCF toxic to yeast 
cells failed. Since the use of larger concentrations of dCF 
could not be contemplated due to the unavailability of this 
drug, our strategy to select for the AMP deaminase gene using 
this drug was abandoned.
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3.5 DISCUSSION
As previously stated the initial aim in this study was to 
design a suitable screening system to clone the AMP deaminase 
gene. '
The initial strategy was to demonstrate sensitivity of yeast 
AMP deaminase to an AMP deaminase inhibitor, dCF which would 
then be overcome by the presence of increased levels of AMP 
deaminase. This method relied on the overproduction of AMP 
deaminase due to the presence of multiple copies of the gene.
The strategy involved the production of a specially 
constructed strain where in theory only the AMP deaminase 
reaction could supply the cell with the necessary IMP and 
guanylic derivatives thereof. Suitable strains were produced 
but at no stage could any sensitivity to the AMP deaminase 
inhibitor be shown in these intact cells. Attempts were made 
to promote uptake of the drug dCF, but these were 
unsuccessful. Attempts using spheroplasting treatments were 
unlikely to succeed since the cell membrane is the more 
likely barrier to dCF. Other methods of finding sensitivity 
were considered. These methods included using certain 
permeabilising treatments such as toluene or toluene and heat 
treatments (Weitsman and Hewson, 1973; Murakami et al.. 1980) 
but no way of incorporating such intrinsically damaging 
treatments into a screening system could be conceived.
Another alternative which was considered was to screen for 
mutants which are sensitive to dCF in liquid culture, by 
selecting for non growing cells by one of the so called 
suicide methods (Snow, 1966; Littlewood, 1972; Littlewood and 
Davies, 1973; Ferenczy et al.. 1975; Henry and Horowitz,
1975; Henry et al.f 1975; Young et al.. 1976). This strategy 
however required that the uptake of dCF and the inhibition of 
AMP deaminase within the cell merely prevented the cell from 
actively growing, but was not lethal; there is no evidence to 
this effect. Such strategies were however discarded because 
of the scarcity of dCF. In fact at all stages of the study 
involving dCF the availability of the drug proved to be a 
critical factor, because sufficient quantities of dCF or CF, 
for detailed studies could not be obtained. Therefore the
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plan to use dCF as a means of selecting for the AMP deaminase 
gene was abandoned.
r
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CHAPTER 4
MODIFICATION OF HISTOENZYMATIC STAINS AS A SELECTION SYSTEM 
FOR THE ISOLATION OF THE YEAST AMP DEAMINASE GENE
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4.1 INTRODUCTION
Since the approach described in chapter 3 to isolate the 
yeast AMP deaminase gene had failed, it was hoped that some 
quick and convenient biochemical method of screening a large 
number of transformants could be found. Using our chosen 
genomic library which has an average insert size of lOkb 
(Carlson and Botstein, 1982), the number of transformants 
that would have to be screened to give a 99% probability of 
selecting a single copy gene has been calculated to be 
approximately six and a half thousand (see section 3.1).
Therefore screening the library by carrying out assays on 
extract produced from this number of transformants, to detect 
individual transformants with increased AMP deaminase 
activity, was deemed too time-consuming and it was hoped that 
a more efficient method might be found. For example, small 
liquid cultures could be grown in microtitre wells, the cells 
lysed by the addition of wall degrading enzymes and 
detergents, and then a sensitive assay for AMP deaminase 
employed to detect over-production of the enzyme.
Two histochemical for stains for AMP deaminase in muscle 
sections have been reported. Both rely for their specificity 
on aspects of the AMP deaminase reaction.
The first stain makes use of the fact that spontaneous 
reduction of nitro blue tetrazolium by a thiol to produce a 
coloured formazan will occur when the pH in a weakly buffered 
solution is raised from 6.1 to 6.4 (Fishbein, 1977b). This 
increase in pH occurs by the production from NH3 from the AMP 
deaminase reaction (see figure 4.1.1).
The second method makes use of an AMP analogue, 6- 
chloropurine ribonucleotide, in which the NH3 group at 
position 6 of AMP is replaced by a Chlorine atom. This 
analogue can be used as a substrate by AMP deaminase at 
approximately 9% the efficiency of AMP (Nakatsu, 1975). The 
Cl” ions produced are trapped by Ag+ ions to produce AgCl 
which precipitates from the solution and which is visible in 
the form of black deposits by visible light.
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FIGURE 4.1.1 PRINCIPLE OF THE NITROBLUE TETRAZOLIUM 
HISTOENYMATIC STAIN FOR AMP DEAMINASE
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FIGURE 4.1.2 PRINCIPLE OF THE 6-CHLOROPURINE RIBONUCLEOTIDE 
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The structure of the analogue and the principal of the stain 
is shown in figure 4.1.2.
It was hoped that one of these stains could be modified to 
screen a yeast genomic library for transformants with excess 
AMP deaminase, produced by multiple copies of the AMP
deaminase gene.
\
4.2 RESULTS
Attempts were made to modify both stains for use as a 
microtitre assay. Although both methods gave reasonable 
results when used with varying amounts of NH^-containing 
standard solutions, the assaying of either cell free extract 
or lysed cells as described above proved more difficult.
The tetrazolium stain requires a pH change from 6.1 to 6.4, 
however the pH optimum of yeast AMP deaminase has been shown 
to be pH 7.1 (Yoshino et al.. 1979b). It became even more 
difficult when attempting to lyse cells using either 
glucoronidase or novozyme in conjunction with detergents, 
since both the enzyme preparations contained extremely high 
levels of NH3 which interfered greatly with the stain. Since 
the specific activity of AMP deaminase is extremely low in 
unpurified cell-free extracts the significant signals could 
not be obtained above background levels even in concentrated 
extracts (see chapter 2 ).
The 6-chloropurine ribonucleotide stain also had its 
problems, but for quite different reasons. For this method 
to be successful, it was vital that there should be 
insignificant levels of chloride ions in buffers and 
solutions, since they interfere with the staining reaction. 
The removal of chloride ions proved extremely difficult. In 
addition, many other anions such as acetate, will associate 
with Ag+ ions and generate precipitates of silver metal with 
light, and this also caused problems. Even when such 
problems were overcome by pHing buffers with nitric acid, it 
was still not possible to detect AMP deaminase activity from 
cells lysed in microtitre-scale assays. All cell wall 
degrading enzyme preparations commercially available are
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fairly crude and resulted in immediate precipitation of 
silver salts on mixing with the stain. This in conjunction 
with the low specific' activity of the cellular AMP deaminase 
made assaying in this manner impossible.
r
A final colorimetric assay was tested for its usefulness in 
this type of screening system. This was the ammonia assay 
using a-* phenol and hypochlorite mixture, communicated by John 
Hinton, of I.e.I. (Bergmeyer and Beutler, 1982). This assay 
again gave reasonable results both with gradients of NH4Cl 
and also with cell-free extracts, but no activity could be 
detected in cells lysed in microtitre wells. This was again 
attributed to the high NH3 concentrations in cell wall 
degrading enzyme preparations and to the low AMP deaminase 
specific activity.
Having attempted to modify these published AMP deaminase 
assays, further attempts at finding a microtite-scale visible 
assay were abandoned.
The phenol/hypochlorite method of NH3 -determination however 
proved much more rapid and convenient than the glutamate 
dehydrogenase method previously used and hence it was 
subsequently adopted as the assay of choice (see Chapter 2)
4.3 DISCUSSION
As previously stated the initial aim in this study was to 
clone the yeast AMP deaminase gene. In this chapter possible 
screening strategies based upon biochemical assays for AMP 
deaminase are described.
Attempts to modify the two histoenzymatic stains described, 
to microtitre scale screens were unsuccessful.
All attempts to find a suitable screening system making use 
of the putative overproduction of the AMP deaminase protein 
in cells carrying multiple copies of a vector with a cloned 
genomic fragment carrying the AMP deaminase gene proved 
unsuccessful (see also chapter 3).
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As previously mentioned no cloned genes or purified protein 
were available to allow gene selection by heterologous 
probing or antibody production and screening. Unfortunately 
at this time, there were no known null mutants for AMP 
deaminase in any Suitable organism to allow cloning by 
complementation. Attempting to mutagenise and screen for AMP 
deaminase mutants would have proved extremely laborious. 
Therefore, the decision was made to purify AMP deaminase from 
S .cerevisiae and to obtain N-terminal amino acid sequence 
data to allow oligonucleotide production for use as 
hybridisation probes (see chapter 5).
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CHAPTER 5
PURIFICATION AND N-TERMINAL SEQUENCING OF AMP DEAMINASE
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TABLE 5.1.1 SUMMARY OF AMP DEAMINASE PURIFICATION FROM 
S.cerevisiae (Yoshino et al. 1979b)
Crude extract 
Column I 
Column II 
Column III
The steps 
by Yoshino
Specific activity Total Protein 
fyumoles NH3/min/mg protein) (mgs)
Purification factor %Recovery
0.08
2.0
16.1
343.0
26 700 
600 
48 
0.3
1
25
201
4290
100
56.1
36.2 
4.8
in the purification method of AMP deaminase adopted 
et al.. 1979b are discussed in section 5.1.
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5.1 INTRODUCTION
AMP deaminase from S.cerevisiae has been previously purified 
by Yoshino et al. (1979b). Their purification procedure 
uses phosphocellul'ose adsorption chromatography and affinity 
elution of AMP deaminase with ATP. The method they used is 
outlined below.
Phosohocellulose column I
The crude extract, made in 50mM potassium phosphate,pH7.5 was 
loaded on to a phosphocellulose column equilibrated with the 
same buffer. The enzyme-containing fraction was then eluted 
with 0.2M potassium phosphate buffer.
Phosphocellulose column II
The enzyme-containing fraction from the first column was 
diluted two-fold and loaded on to a second phosphocellulose 
column equilibrated with 0.1M potassium phosphate, pH7.5.
The active fraction is then eluted with 5mM ATP.
Phosphocellulose column III
The active fraction from column II is diluted two-fold and 
loaded on to a third phosphocellulose column equilibrated 
with 50mM potassium phosphate,pH7.5. The column was then 
washed with 0.1M potassium phosphate, 0.15M NaCl. The column 
was then subjected to a linear ATP gradient from 0 - 0.6mM 
and the active fraction was then collected. This fraction 
was electrophoretically homogeneous. The degree of 
purification at each stage is shown in table 5.1.1.
As can be seen from this table this purification resulted in 
a purification of over 4000-fold. This was an extremely large 
scale purification with starting material of over 27g of 
protein. However the entire purification only yielded 300 ug 
of protein, and only 4.8% of the original activity.
It was hoped that a rapid, efficient and smaller scale 
purification of AMP deaminase from S .cerevisiae could be 
developed which would yield material of sufficient purity to 
allow the N-terminal amino acid sequence of AMP deaminase to 
be determined. With this information an oligonucleotide 
would be designed to allow cloning of the AMP deaminase gene.
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FIGPRE S.2.1.1 THE STABILITY AT ROOM TEMPERATURE OF AMP
DEAMINASE IN CRUDE YEAST EXTRACT
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Aliquots of a single preparation of crude extracc were 
incubated at room temperature for various times as indicated 
prior to assaying for AMP deaminase activity in the standard 
manner. All reactions were carried out in triplicate.
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5.2 STUDIES TO FACILITATE AMP DEAMINASE PURIFICATION
5.2.1 The Stability of AMP deaminase
Most stages of an 'enzyme purification should be carried out 
at low temperatures, assuming the enzyme of interest is not 
coi'd-labile. This reduces the activity of contaminating 
proteases, and is less likely to lead to chemical 
denaturation. However, it is not always practicable for all 
stages to be carried out in a cold room, so prior to the 
purification it is desirable to know something of the 
enzyme's stability at room temperature.
When yeast cell-free extract was made it was stored at -20°C 
and rapidly thawed prior to use when required. An experiment 
was carried out whereby extract was assayed for AMP deaminase 
activity at various times after this thawing process. The 
results of this experiment are shown in Figure 5.2.1.1. It 
is clear that under these conditions the enzyme is reasonably 
stable at room temperature for one to two hours.
As in Chapter 3, AMP deaminase activities quoted in this 
chapter are the average of three reactions (unless otherwise 
stated) with a single substrate blank to account for 
endogenous NH3 in reagents and extracts. For all 
determinations quoted from now on the phenol-hypochlorite 
ammonia assay was employed (see Chapter 2). Errors for this 
assay are in the range of +/- 4%.
It is also of interest to know under what buffering and ionic 
conditions the enzyme remains active. Clearly the buffer 
should also not interfere with the AMP deaminase assay. To 
this end a range of buffers were tested for their effect on 
the assay system. It was found that several buffers, 
including Tris, are unsuitable for use with this assay system 
and thus they were not used during purification procedures. 
Suitable buffers included cacodylate (the buffer used in AMP 
deaminase determinations), phosphate buffers and TEA, all of 
which had little effect on the assay system.
It was also desirable to know what extremes of pH the enzyme 
would withstand while maintaining activity. To this end an
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FIGURE 5.2.1.2 THE EFFECT OF pH ON YEAST AMP DEAMINASE
ACTIVITY
>-
5.5 60 70 7.5
pH of extract
Specific AMP deaminase activities were measured when soluble 
proteins were extracted in 50mM potassium phosphate buffer at 
various pHs, prior to assaying in the standard manner 
(section 2.11). All reactions were carried out in 
triplicate.
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experiment was set up extracting total yeast proteins into 
50mM phosphate buffer at a range of pHs. The actual pH of 
these extracts was then measured. These extracts were stored 
at -20°C/ overnight and then assayed in the standard reaction 
mix. Therefore this experiment does not test the optimum pH 
for AMP deaminase activity (which has been shown to be 7.1 by 
Yos'hino et al, 1979b), but the optimum pH for storage and 
maintenance of activity. The results of this experiment are 
shown in figure 5.2.1.2. Clearly, under these conditions the 
pH optimum for maintenance of AMP deaminase is between pH 7.0 
and 7.5 and activity is greatly reduced wher the extract’s pH 
drops below pH6 or rises above pH8 suggesting that extremes 
beyond these limits should be avoided. It has been shown 
previously that yeast AMP deaminase's pH optimum is 7.1 and 
that cacodylic acid is the most suitable assay buffer. 
Therefore samples are assayed in 20mM cacodylic acid, pH7.1 
(see Chapter 2 for full assay details) and any purification 
steps were carried out using 20mM cacodylic acid or TEA, 
pH7.1 - 7.5 unless otherwise stated.
The cytoplasm contains a number of compounds which help 
maintain a high reducing potential. Many enzymes lose 
activity rapidly during extraction due to covalent 
modifications which occur spontaneously under oxidising 
conditions. This can often be alleviated by maintaining the 
reducing conditions by the addition of such compounds as DTT, 
or B-mercaptoethanol to all buffers. Both these compounds 
were tested for their effect on AMP deaminase activity. DTT 
or B-mercaptoethanol at a concentration of only ImM reduce 
the AMP deaminase activity (results not shown) as well as 
affecting the efficiency of the AMP deaminase assay, 
therefore the use of these compounds was not investigated 
further.
Many proteins are also very sensitive to the effects of 
contaminating heavy metal ions in buffers, and to prevent 
this happening a chelating agent such as EDTA is frequently 
used. To check the affect of this chelating agent on AMP 
deaminase activity a series of reactions were set up with 
varying concentrations of EDTA in the standard AMP deaminase 
reaction mix. The results of this experiment are shown in 
table 5.2.1.1. As can be seen from these results low
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TABLE 5.2.1.1 THE EFFECT OF EDTA ON AMP DEAMINASE ACTIVITY
CONCENTRATION OF EDTA IN
REACTION MIX AMP DEAMINASE ACTIVITY
(mM) (nmoles NHg/ml/min)
0 420
1 397
5 396
10 380
50 52
EDTA was added at various concentrations to standard assay 
mixes containing the same amount of identical extract. All 
the reactions were carried out in triplicate with a single 
substrate blank reaction. Specific activities were not 
examined in this case.
TABLE 5.2.1.2 THE EFFECT OF EDTA ON YEAST AMP DEAMINASE 
ACTIVITY AFTER OVERNIGHT STORAGE AND THE 
EFFECT OF STORAGE TEMPERATURE
AMP DEAMINASE ACTIVITY 
(nmoles N^/ml/min)
EDTA IN EXTRACT (mM) STORAGE AT 4°C STORAGE AT -20°C
0 181 393
1 52 207
10 69 206
EDTA was added at various concentrations to identical 
aliquots of crude extract which was then store overnight at 
the stated temperatures. These extracts were then assayed 
for AMP deaminase activity in the standard manner. All the 
reactions were carried out in triplicate with a single 
substrate blank reaction. Specific activities were not 
examined in this case.
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concentrations of EDTA have apparently little effect on the 
enzymes activity, although 50mM virtually abolishes activity.
To further test the effects of EDTA, and also to discover the 
best method of storage, enzyme extracts were stored overnight 
at either 4°C or -20°C with various concentrations of EDTA. 
The' results of this experiment are shown in Table 5.2.1.2.
It is diear from these results firstly that -20°C is the more 
suitable temperature of storage of the enzyme at least in its 
crude form, and secondly that the addition of even ImM EDTA 
greatly reduces the activity of AMP deaminase when it is used 
in a buffer for storage. The nature of this delayed effect 
of inhibition is unclear and was not studied further. EDTA 
was not adopted in any future analyses.
Since a number of purification steps rely on elution in 
differential salt concentrations an experiment was carried 
out to see what effect varying concentrations of NaCl has on 
the activity of AMP deaminase. Cell free extracts were 
prepared into buffer containing varying concentrations of 
NaCl, up to 5M and the AMP deaminase activity was assayed 
under normal conditions by diluting enzyme ten-fold with 
reaction mix, see Chapter 2). These results are shown in 
Table 5.2.1.3. It is clear that NaCl does not reduce AMP 
deaminase activity, but appears to increase it. Therefore 
NaCl could be used in ion exchange chromatography as the 
chosen eluant.
5.2.2. The effect of ammonia on AMP deaminase activity
Many enzymes are inhibited allosterically by one or more of 
the products of their reaction. It was not inconceivable 
that AMP deaminase fell into this category, although ammonia 
has not been reported as an allosteric effector of the 
enzyme. Since ammonium sulphate precipitations were one of 
the methods of purification to be tested it was necessary to 
know whether the presence of small amounts of NH3 remaining 
after dialysis would affect the activity of AMP deaminase.
It is of course essential to always account for small 
contaminating amounts of NH3 left over after precipitation 
since the AMP deaminase activity is assayed by the production
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TABLE 5.2.1.3 THE EFFECT OF NaCl ON AMP DEAMINASE ACTIVITY
IN YEAST EXTRACT 
Concentration of Final Concentration
NaCl in extract NaCl in mix Specific Activity
(M). (mM) (nmoles Nl^/mg/min)
0 0 30.3
1 100 51.1
5 500 64.1
The effect of extracting yeast proteins into standard 50mM 
potassium phosphate, pH7.5 buffer in the presence of absence 
of various concentrations of NaCl. All reactions carried out 
in triplicate with a single parallel substrate blank 
reaction.
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of NH3 . This possible contamination is accounted for by 
carrying out substrate blank reactions, along with every 
actual assay reaction'. To measure the effect of NH3 on AMP 
deaminase activity, reactions were set up containing various 
concentrations of iTH^Cl in parallel with substrate blank 
reactions. The results of this experiment are shown in 
Tab’le 5.2.2.1. It is clear from these results that small 
concentrations of NH3 in reaction mixes have no effect on AMP 
deaminase activity.
5.3 PURIFICATION BY DIFFERENTIAL PRECIPITATION: AMMONIUM 
SULPHATE PRECIPITATIONS
5.3.1 Introduction
There are a number of methods of protein purification which 
rely on the differential solubility of proteins under 
different salt or ionic conditions. This process is often 
known as salting out. A protein solution is taken stepwise 
from low ionic strength to high, by the addition of a salt or 
in some cases an organic solvent (the effect of the latter 
class is somewhat different and is discussed in section 
5.4.1).
Salting out largely depends on the hydrophobicity of the 
protein in question. Typically a protein in solution has 
hydrophobic regions on its surface (normally due to the side 
chains of Phenylalanine, Tyrosine, Tryptophan, Leucine, 
Isoleucine, Methionine and Valine). Forcing these patches 
into contact with the aqueous solvent causes an ordering of 
water molecules, effectively "freezing" them around the side 
chains. This ordering is thermodynamically unstable since it 
represents a large decrease in entropy compared with the 
unsolvated proteins and free water molecules. As salt is 
added and the salt ions become solvated, there is a greater 
tendency for the ordered water structures around the 
hydrophobic regions to be disrupted thus allowing these 
patches to interact with one another leading to precipitation 
of the proteins.
82
TABLE 5.2.2.1 THE EFFECT OF NH^Cl ON AMP DEAMINASE ACTIVITY
Concentration of NH4Cl Activity
(nmoles NH3/ml/min)
0 37.7
O.OljuM 36.4
0.1/iM 35.5
Ip M 39.6
IOjuM 34.3
100JUM 32.5
ImM 37.4
Each assay (carried out in triplicate) was accompanied by an 
appropriate substrate blank (i.e. contained the same 
concentration of NH4C1).
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In a crude mixture coaggregation is great and a proportion of 
many proteins, which in isolation would precipitate at a much 
higher salt concentration, will be aggregated with very 
hydrophobic fractions, at relatively low salt concentrations. 
However, the major portion of most proteins will precipitate 
in a sufficiently narrow range of salt concentration to make 
ammonium sulphate precipitations an effective method of 
enrichment. Other factors are involved in this salting out 
process, including pH and temperature.
Many different salts can be used for this method of 
purification the most commonly used is ammonium sulphate 
There are a number of factors in favour of its use. Sulphate 
is the most effective anion for salting out purposes because 
of its multiple charge, and NH^+ is a good choice of cation 
because it is monovalent. In practice the choice of anion is 
the more important. Another factor to be considered is the 
density of a concentrated solution of the chosen salt, since 
centrifuging a precipitate depends on the difference in 
density between the aggregate and the solvent. A saturated 
solution of ammonium sulphate has a sufficiently low density 
at 1.235g/cm3 (Skopes, 1987). Also the solubility of 
ammonium sulphate varies little between 0 and 30°C. It is 
also available in a sufficiently pure state to be used 
economically in large quantities. One major advantage of 
ammonium sulphate is that it stabilises most proteins, 
allowing them to be stored in the form of a precipitate, 
while the high salt also inhibits proteolysis and bacterial 
action. For the above reasons ammonium sulphate has been the 
traditional salt of choice for most salting out procedures.
5.3.2 Results
Various experiments were carried out using small amounts of 
crude cell-free extract (10 - 30 mis). Briefly, following 
the addition of (NH^^SC^ to either crude extract or the 
remaining supernatant after a precipitation step, the mixture 
is stirred slowly for 15 - 30 minutes at 4°C. The mixture is 
then centrifuged at 10000 x g for 15 minutes. The 
supernatant is then treated appropriately. The pellet after 
each precipitation step is resuspended in the smallest
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FIGURE 5.3.2.1 THE PATTERN OF PRECIPITATION OF AMP DEAMINASE
WITH AMMONIUM SULPHATE
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suitable volume, and then dialysed, in a 1000-fold excess of 
buffer, 20mM TEA, with a single change of buffer. Each 
fraction was assayed for protein concentration and AMP 
deaminase activity. By varying the percentages of the cuts it 
was found that mos't of the AMP deaminase activity was 
recovered in the fraction precipitated between 35-45% 
ammonium sulphate. One such experiment demonstrating this is 
summarised in figure 5.3.2.1. In this experiment only 12.4% 
of the original activity was recovered. In all experiments 
the recovery was in this range, the average recovery being 
14.7%. The maximum purification in any experiment was only
2.1 fold.
5.3.3. Discussion
As stated above, both the recovery and purification of AMP 
deaminase using ammonium sulphate precipitation were low.
Many proteins are very stable in ammonium sulphate and can be 
stored in the precipitated form for some time. However, it 
is obviously essential when assaying for an ammonia producing 
enzyme activity such as AMP deaminase to remove the salt in 
some way. It is possible that the low recoveries were due to 
loss of activity during dialysis. This commonly occurs due 
to the loss of an essential low molecular weight co-factor. 
Dialysis in the presence of ImM MgCl, lOmM NaCl or lOOmM KCl 
(all known activators of AMP deaminase) had no effect on the 
amount of activity recovered. Another possibility is that 
AMP deaminase is extremely sensitive to some of the 
denaturing effects of raising the concentration of ammonium 
sulphate (see section 5.3.1.). The recoveries and low level 
of purification made ammonium sulphate precipitations an 
unsuitable step in a purification strategy, and further 
analysis was abandoned.
5.4 PURIFICATION BY DIFFERENTIAL PRECIPITATION: ACETONE 
PRECIPITATIONS
5.4.1 Introduction
Addition of a solvent such as ethanol or acetone to an
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aqueous extract containing proteins has a variety of effects 
which lead to protein precipitation. The principles causing 
precipitation are different to those in salt precipitations, 
and precipitation with organic solvents can be an additional 
rather than an alternative step in purification. The 
principal effect of the addition of an organic solvent is the 
reduction of water activity. The solvating power of water 
for a charged hydrophobic enzyme is decreased as the 
concentration of the solvent increases. Hydrophobic 
attractions are less involved in the formation of aggregates 
because of the solubilizing influence of the solvent in these 
areas. Aggregation tends to occur rather by interactions 
between oppositely charged areas on the protein surface. 
Another feature affecting organic solvent precipitation is 
the size of the molecule. All else being equal, the larger 
the molecule the lower the concentration of solvent required 
to precipitate it. Thus, if one could compare a range of 
proteins with different molecular weights but similar 
hydrophobicity and isoelectric points the precipitation order 
would be the reverse of the order of size.
There are a number of factors involved in the choice of 
solvent. It must be completely water miscible, unreactive 
with proteins, and have good precipitating properties. The 
most commonly used solvents are ethanol and acetone. Other 
possible solvents are methanol, n-propanol, i-propanol and 
various other exotic alcohols, ethers and ketones.
One advantage of organic solvent fractionation is that it can 
be carried out at sub-zero temperatures since the aqueous- 
solvent mixtures freeze well below 0°C. This is advantageous 
since at about 10°C denaturation effects become significant. 
At low temperatures a lack of conformational flexibility 
means that organic solvent molecules are unlikely to 
penetrate the internal structure and cause destabilisation. 
Long chain alcohols are more denaturing than short ones. 
Although ethanol is standardly used for plasma protein 
fractionations (Curling, 1980), acetone has a lesser tendency 
to cause denaturation than ethanol partly because lower 
concentrations are needed to cause comparable amounts of 
precipitation at low temperatures.
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FIGURE 5.4.2.1 THE PATTERN OF PRECIPITATION OF AMP DEAMINASE
WITH ACETONE
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i Acetone of cut Activity 
(nmoles NHj/ml/min)
Protein
(mg/ml)
Specific activity 
(nmoles NHg/mg/min)
% of original
Crude extract 499.8 8.5 58.6 (100)
0 - 1 0 206.7 11.4 18.1 1.1
10 - 15 266.7 11.7 22.7 1.4
15 - 20 300.0 18.0 16.7 2.2
20 - 25 901.8 21.2 42.5 7.2
25 - 30 1483.3 11.3 131.3 22.5
30 - 35 1492.5 7.8 191.3 21.5
35 - 40 99.9 8.8 11.4 1.8
40 - 50 16.7 14.6 1.1 0.3
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Ideally acetone precipitations should be carried out on a 
solution with low salt concentrations, otherwise 
electrostatic aggregation is impaired and higher levels of 
organic solvent are needed and denaturation is more likely. 
Addition of solvent to water causes heat evolution, 
consequently slow addition with efficient cooling is 
desirable.
5.4.2 Results
All steps were carried out as close to 0°C as possible. The
method used is detailed in chapter 2.
A number of pilot experiments were set up, typically
precipitating lOmls of cell-free extract (at approximately 
5mg/ml protein). Recovery values were reasonable, averaging 
50 - 60% of original activity. The best purifications were 
3.3-fold. Most of the AMP deaminase activity was found to 
precipitate with between 25 and 40% acetone. It was found 
that the most efficient way of obtaining reasonable amounts 
of sufficiently purified material was to take the sample in 
multiple steps to the correct concentration of acetone. If a
single 0 - 25 % acetone cut was carried out, a significant 
proportion of the AMP deaminase activity was precipitated in 
this crude first step, presumably due to coaggregation 
effects (data not shown). A typical acetone precipitation is 
detailed in figure 5.4.2.1. In this experiment a total of 
58% of the original activity was recovered and of this 44% is 
located in the 25-30 and 30-35% cuts. The 30-35% cut 
material represents a 3 .3-fold purification.
5.4.3 Discussion
Acetone precipitation appeared to represent a reasonable 
first crude purification step. It removed a large proportion 
of the cell protein, and allowed a small level of 
purification while maintaining a large proportion of the AMP 
deaminase activity. The precipitated material was simply 
resuspended in a small volume of 20mM TEA, pH 7.1 buffer. 
Attempts to remove the acetone by lyophilisation resulted in
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large losses of activity. However, when this material was 
filtered or loaded on to a PD-10 buffer exchange column, for 
use in further purification, more than 90% of the activity 
was lost. This appeared to be due to the incomplete 
resolubilisation of the protein after acetone precipitation. 
The protein mixture cannot be redissolved effectively but 
remains particulate. The AMP deaminase activity is still 
assayabie, however. Attempts to completely dissolve this 
particulate material were unsuccessful either in a larger 
buffer volume or by changing the buffer conditions. At all • 
stages the AMP deaminase activity remained associated with 
this particulate material thoughout all attempts to clear the 
protein solution. For this reason the use of acetone 
precipitation as a purification step was abandoned.
5.5 AFFINITY CHROMATOGRAPHY WITH CIBACRON BLUE SEPHAROSE
5.5.1 Introduction
A standard method of enzyme purification is affinity 
adsorption chromatography. Here, the protein of interest is 
adsorbed to a medium by a mechanism normally related to the 
ligand binding properties of the protein. There are two 
basic classes of affinity adsorbents. Firstly, there are the 
true affinity adsorbents which specifically bind proteins 
that have binding sites for the immobilised ligand. The 
second class contains the more general adsorbents, sometimes 
called pseudo-affinity adsorbents which include the dye 
adsorbents.
Many ready-made adsorbents are available commercially.
Because of the low capacity of these adsorbents the method is 
most useful for purifying proteins that make up a small 
proportion of the total protein present, in which case it can 
be used as the first step in the purification as was hoped in 
this case.
Falling into the class of true affinity adsorbents are 
adsorbents with AMP as the protein binding ligand. AMP 
agarose media are commercially available and would seem the 
ideal choice in the purification of AMP deaminase. However,
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the commercially available chromatbgraphic media have their 
AMP ligand bound to the media matrix by the N-6 group of AMP. 
Since the N-6 group is that which undergoes catalysis during 
the AMP deaminase reaction it was judged that this media 
would be unsuitable for the purification of AMP deaminase 
(Ohlsson et al.. 1972).
The second class of more general affinity adsorbents include 
the dye adsorbents. Often the dye used as a protein binding 
ligand bears little obvious resemblance to the true ligand, 
hence the term pseudo affinity adsorbents. One such dye is 
Cibacron blue F3GA, which behaves as an analogue of ADP- 
ribose and has been shown to bind to most enzymes that bind a 
purine nucleotide including AMP, ATP, IMP, NAD, NADP and GTP 
(Biellmann et al.. 1979). This type of media has been used 
successfully in the purification of yeast pyruvate kinase 
(Haeckel et al.. 1968). Fortuitously, these media have a 
good protein binding capacity of 20-30mg/cm^. Hence a media 
with Cibacron Blue as its ligand such as cibacron blue 
sepharose seemed like an extremely good choice of adsorbent 
in the purification of AMP deaminase.
5.5.2 Results and Discussion
Small scale columns were set up with a bed volume of 
approximately 1.0 ml. These columns were equilibrated with 
20mM cacodylic acid, pH7.1. Varying amounts of yeast cell 
free extract were then loaded and the column washed with 
several volumes of the above buffer. When a small amount of 
cell free extract (less than 5mg total protein) was applied 
to this column the AMP deaminase activity appeared to be 
retained on the column. However, if the column was loaded 
with a greater amount of protein a proportion of the AMP 
deaminase activity was eluted immediately from the column. 
This unbound material showed no purification in terms of 
specific activity and protein concentration.
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Step gradients were run on the columns described above with 
the following eluants;
1) 5, 10, 20, 50 and lOOmM AMP in Start buffer
2) 0.1, 1, 10/50 and lOOmM ATP in Start buffer
3) 0.1, 1, 2, and 3M NaCl in Start buffer
4) v 10, 20 and lOOmM MgS04 in Start buffer
5) 10, 20, 50 and lOOmM AMP in Start buffer + 0.1
NaCl
6) 20mM ATP and 20mM AMP in Start buffer
In each of the cases described above no AMP deaminase 
activity was detected in the eluted fractions.
It seems likely that yeast AMP deaminase is bound by the 
Cibacron blue dye ligand rather than somehow becoming 
inactivated during the course of the chromatography. This 
view is supported by the fact that when a column is 
overloaded the unbound AMP deaminase maintains its activity. 
It has also been reported that Cibacron blue binding is very 
often tighter than the true substrate with a K^ in the uMolar 
range (Skopes, 1987). It is possible that since the enzyme 
is tetrameric it can become complexed with more than one 
ligand molecule thus being more stably bound than an enzyme 
with only one ligand binding site per molecule. It is 
possible that the conditions for elution described above are 
not strong enough to overcome this binding, or alternatively, 
the inherent structure of the enzyme itself may have been 
disrupted during adsorption and/or elution. Another 
possibility is that although adsorption generally weakens 
with increasing ionic strength, the adsorption of a given 
protein may be due to hydrophobic attraction of regions of 
the protein rather than to ionic attractions. Therefore, 
increasing the ionic strength can, under certain 
circumstances, strengthen adsorption. This was not examined 
further and Cibacron blue sepharose medium was abandoned as a 
method of purification.
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5.6. ION EXCHANGE CHROMATOGRAPHY USING FPLC MONO 0 MEDIA
5.6.1. Introduction '
Proteins bind to ion exchangers mainly by electrostatic 
forces between its surface charges and the dense clusters of 
charged groups on the exchangers. The substitution level of 
a typical DEAE-cellulose or CM-cellulose may be as much as 
0.5mmol/cm^, ie 0.5M of charged groups. The charges are 
balanced by counter-ions such as metal, chloride or buffer 
ions. A protein must displace the counter-ions and become 
attached.
Protein molecules in solution are neutralised by counter-ions 
to become effectively neutral, i.e. a protein with a net 
negative charge is pre-equilibrated with say Tris.Cl buffer 
and therefore the counter-ion associated with the protein is 
H+Tris. An anion exchange column is equilibrated with Cl- 
counter-ions. The protein then displaces the Cl” , and 
Tris.Cl is discharged. This Tris.Cl is the acid salt of Tris 
and if displacement is rapid it could lead to a lowering of 
the effective pH in the column ahead of the band of adsorbed 
protein. Also the pulse of Tris.Cl represents an increase in 
the ionic strength of the buffer flowing through the column. 
Typically for every lmg/ml protein that is adsorbed, it is 
replaced by approximately ImM of extra buffer salts. The pH 
of non-adsorbed fractions can be shown to be lower than the 
preceding buffer wash (or higher in cation exchangers) if the 
protein concentration of the applied sample is too high. To 
avoid pH and ionic aberrations, the applied protein 
concentration should not be too high, especially if a large 
proportion of it is expected to bind. In addition, 
inadequate buffering could allow extremes of pH to develop 
causing denaturation. Generally lOmM of a buffer within 0.3 
of its pKa is sufficient. Protein being adsorbed should be 
no more than 5mg/ml (non-adsorbing proteins are less 
important but should not be more than lOmg/ml) (Skopes,
1987). Capacity of an ion exchanger is protein size 
dependent. Large molecules can only bind to the surface of 
the ion exchange particles and therefore capacity for these 
is low. Overloading of columns may result in the emergence 
of the larger molecular weight protein first, although there
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FIGURE 5.6.2.1 ELUTION OF AMP DEAMINASE FROM A MONO Q 5/5
COLUMN LOADED WITH CRUDE EXTRACT
Column volume: 1ml
Flow rate: lml/min
Fraction size: 1ml
Buffer: 20mM potassium phosphate, pH 7.5
Sample: 1.5ml crude extract (see below)
20
MO
WO
0 2550 5
FRACTIONS collected
Fraction Activity Protein Specific Activity
(nmoles NHg/ml/min) (mg/ml) (nmoles NHg/mg/min)
extract 941.0 10.3 90.9
2 26.7 2.8 9.5
3 16.7 0.52 31.8
4 11.6 0.3 38.8
18 36.6 0.82 44.8
19 4 3.4 0.68 6 3.8
2 0 5 6.6 0.3 9 145. 0
21 5 8.3 0.3 0 191.0
2 2 15.0 0.26 57.7
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may be sufficient capacity to adsorb all the smaller 
molecules.
All chromatographic studies and purification steps discussed 
from now on were cfarried out using a Pharmacia FPLC system. 
Most of this work was carried out at the Biological products 
division of ICI in Billingham. All ion exchange was carried 
out using pre-packed Mono Q columns. Mono Q is a strong 
anion exchanger based on a beaded hydrophilic resin with one 
of the narrowest particle size distributions available. The 
beads have a particle size of lOum. Since there are no small 
particles with these beads the packed columns have void 
volumes of 40% and therefore a very low back pressure. The 
charged group on the gel is -CH2-N-(CH3 )3 . The ionic 
capacity of the gel is 0.27-0.37 mmoles/ml and the exclusion 
limit of the beads is 107 daltons.
Note: all subsequent analyses of AMP deaminase in this
chapter consisted of only a single reaction mix and a 
parallel substrate blank. Reactions were no longer carried 
out in triplicate, to reduce losses of purified material and 
to aid the speed of analysis. As previously stated, errors 
using this assay are in the range of +/- 4%.
5.6.2. Pilot experiments with FPLC Mono 0 media
Using a 1ml Mono Q 5/5 column, pilot experiments were carried 
out using yeast cell-free extract made in 20mM TEA, pH7.5.
The protein was found to bind under these conditions and was 
eluted when a 0 - 1M NaCl linear gradient was applied, the 
AMP deaminase activity peaking at around 0.32M NaCl.
Recovery was in the range of 20-37%, and the purification was 
on average 3.4-fold under these conditions. A typical small 
scale Mono Q run is detailed in Figure 5.6 .2.1. Fraction 21 
represents a 2.1-fold purification and 22.3% of the activity 
which was loaded on the column was recovered in fractions 18 
to 22. The run detailed here gave a particularly low 
purification factor, but this value never exceeded 5 or 6- 
fold.
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As can be seen a small but significant proportion of the 
activity does not bind to the column but appears to be eluted 
immediately. Data sh'eets regarding capacity of Mono Q beads 
state it as 25mg/ml. As can be seen in the case of this run 
only 15.5mg of pro'tein was loaded, and therefore, it would 
appear that this is not simply a case of protein overloading. 
This problem is discussed further in section 5.6.3. More 
worrying than the loss of this material, is the low recovery 
of activity, and the low purification factor.
The situation improved somewhat when the same conditions were 
scaled up for use on large columns. On Mono Q 16/10 columns 
(20ml bed volume) the recovery of activity was lower, 
averaging 15% of that loaded. But the level of purification 
increased to 9.6-fold on average, and on occasion was 
considerably higher. However, the low recoveries were 
unacceptable and the steps taken to improve these results are 
discussed in section 5.6.3.
j
5.6.3. Improving the performance of Mono 0 anion exchange
Data provided with FPLC suggest that recoveries for 
chromatography of most proteins should approach 100%. This 
clearly was not the case for AMP deaminase under the 
conditions discussed in the previous section.
All chromatography was carried out at room temperature. 
However, no analysis would require samples to be at room 
temperature for more than two hours. Results shown in figure
5.2.1.1 show that AMP deaminase activity might be expected to 
fall at most 20%, therefore losses of up to 85% can not be 
explained by mere heat inactivation.
Many proteins require the presence of reducing conditions as 
provided by DTT or B-mercaptoethanol for their activity to be 
maintained. However, this is not the case for AMP deaminase 
as shown in section 5.2. Nor does the addition of EDTA help 
maintain AMP deaminase activity as it does for many enzymes.
Many proteins lose stability when diluted. Enzymes exist in 
a very concentrated solution within the cell, but when
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TABLE 5.6.3.1 FRACTIONS CONTAINING AMP DEAMINASE ACTIVITY
FROM MONO Q 16/10 WHEN CRUDE EXTRACT IS 
APPLIED AT HIGH CONCENTRATIONS
Fraction Activity Protein
(nmoles NHg/ml/min) (mg/ml)
Specific Activity 
nmoles NHg/mg/min)
extract
5
6
7
8 
9
10
11
12
13
14
15
156.6
49.6
72.9
250.0
335.0
305.0
302.0
308.0
318.0
315.0
270.0 
20.3
12.0
1.3
7.9
7.1
13.0
39.0 
13.8
41.0 
108.0
54.5
38.3
43.4 
38.7
42.0
50.1
13.5
30
31
32
33
10.3 
21.0
14.3 
7.3
0.54
0.72
0.99
1.09
19.1
29.2 
14.5
6.7
Elution of AMP deaminase activity from a Mono Q 16/10 column 
run under standard conditions with the exception that the 
sample of 48mls crude extract is applied at a concentration 
of 12mg/ml (see figure 5.9.2.1).
Fractions 5-15 represent AMP deaminase activity which does 
not adsorb to the Mono Q media (i.e. is eluting prior to the 
application of the NaCl gradient).
Fractions 30-33 represent adsorbed AMP deaminase activity 
which is eluted at around 0.3M NaCl on application of the 
NaCl gradient.
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released from the cell the environment radically changes.
AMP deaminase appears to be reasonably stable in the form of 
a crude cell extract,' especially when stored at -20°C. It is 
possible that dilution during purification was causing 
destabilisation. 'Alternatively, purification may lead to the 
loss of an unidentified but essential co-factor.
The first of these problems is sometimes overcome by adding a 
known protein such as BSA to storage solutions. (This is why 
BSA is included in the AMP deaminase reaction mix). This 
seemed an undesirable step and was not considered at this 
stage since protein concentrations were still reasonably 
high. Nothing could be done to overcome the loss of a co­
factor without first identifying the putative co-factor and 
including it in all chromatography buffers.
In fact this low recovery or instability problem was 
drastically improved by carrying out all purification steps 
in potassium phosphate buffer, pH7.5. Many enzymes are 
stabilised by this buffer, but the reason for this is 
somewhat obscure. This one change, from 20mM TEA to 20mM 
potassium phosphate for Mono Q 5/5 columns, vastly improved 
average recoveries from 30% to 114% with a new average 
purification factor of 10.7-fold. In the case of the 
preparative scale columns (8 or 20ml volumes) the recovery 
rose from 15% to 114%, with an average purification of 13- 
fold.
Unfortunately, the second problem regarding the proportion of 
AMP deaminase activity not adsorbed to the column was not 
improved by the use of phosphate buffer. An extreme example 
of this unbound activity is detailed here in table 5.6 .3.1. 
97.9% of the recovered activity is found in fractions 5 to 
15, with only 2.1% being adsorbed to the column and then 
eluted as normal at around 0.32M. This phenomenon is not 
simply due to overloading the column. Here, 480mg of protein 
was loaded, the column has a stated capacity of 500mg. Also 
as can be seen from the specific activities of fractions 7 to 
15, there appears to be a low level of purification. It 
would appear that some cellular proteins are being bound 
preferentially over AMP deaminase hence the increase in 
specific activity of these non-adsorbed fractions.
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The capacity of an ion exchanger is protein size dependent. 
Large molecules can only bind to the surface of the ion 
exchange particles and therefore capacity for them is low. 
Overloading of columns may result in the emergence of the 
larger molecular v/eight proteins first, although there may be 
sufficient capacity to adsorb all the smaller molecules. AMP 
deaminase, at a reported molecular weight of 320 kDa (it is a 
tetramer) (Murakami, 1979), could easily be included in the 
former category.
There can also be an effect by loading a protein mixture at 
too high a concentration, as discussed in section 5.6.1. If 
too high a concentration is applied to the column, and a high 
proportion of this is adsorbed, a pulse of buffer, at a more 
acid pH (in the case of anion exchange) and higher ionic 
strength may be released.
To check whether this concentration effect may be a 
contributing factor, two parallel experiments were set up, 
using identical conditions with the exception that one column 
was loaded with 0.5ml cell free extract at a protein 
concentration of 9.30mg/ml and the other with 2mls of the 
same extract diluted 4-fold at a protein concentration of 
2.35mg/ml. In the case of the first column only 40.6% of the 
activity recovered was bound, the remaining 59.4% running 
straight through. In the case of the column loaded with 
dilute extract 85.7% of recovered activity was bound and then 
eluted with 0.3M NaCl. This clearly shows that the 
concentration of extract loaded on to the column is of 
importance as well as the actual amount. In subsequent 
experiments extracts were diluted to a final concentration of
1.5-3mg/ml prior to loading, and the stated capacity of 
25mg/ml was not adhered to, the amount loaded never exceeded 
16mg/ml. In this way all further Mono Q columns were found 
to adsorb a high percentage of the AMP deaminase activity 
loaded.
Therefore, ion exchange chromatography for the actual 
purification was carried out with the following modifications 
to that detailed in section 5.6.2.
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Low protein concentration: 1.5-3.Omg/ml
Low protein loading: less than 70% of the
manufacturer's stated capacity 
Buffer conditions: changed from 20mM TEA to 20mM
r potassium phosphate
Another point to note is that in some cases the activity 
recovered exceeds that which was loaded. There are a number 
of possible reasons for this. The activity of some proteins 
is actually increased by an increase in temperature during 
chromatography. AMP deaminase does not fall into this 
category of thermo-activation, as shown in section 5.2.
Another possibility is that during purification the enzyme 
may have been separated from some inhibitory component. 
Alternatively the increase in ionic strength of the eluted 
fraction may in some way be stabilising or activating AMP 
deaminase. This was not studied further.
5.7. HYDROPHOBIC INTERACTION CHROMATOGRAPHY WITH FPLC PHENYL- 
SUPEROSE MEDIA
5.7.1. Introduction
During the development of affinity chromatographic support 
mediums a number of control experiments were carried out 
looking at the behaviour of matrices containing spacer arms 
but no ligand. In a few cases, enzymes were found to bind 
strongly to hexamethylene arms even without charged ends (Er- 
el et al.r 1972). These findings were used in the 
development of hydrophobic interaction chromatography, so 
called because it involves the interaction between the 
aliphatic chains on the adsorbent and hydrophobic regions on 
the surface of the proteins (Hofstee and Otillio, 1978;
Ochoa, 1978).
Relatively few proteins bind to short immobilised aliphatic 
chains at low ionic concentrations, but hydrophobic 
interaction chromatography can be extended to cover all 
proteins since the hydrophobic interactions increase with 
increasing salt concentration. The reasons for hydrophobic
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interactions are similar to those involved in the 
precipitation of proteins with ammonium sulphate as discussed 
in section 5.3.1. Consequently at high salt concentrations 
most proteins can be adsorbed to hydrophobic groups attached 
to inert matrices ,r Typical hydrophobic adsorbents include 
C4, C6, C8 and CIO linear aliphatic chains, and the same 
chains containing a terminal amino group. Phenyl-based 
matrices are also available (Gopalakrishna and Anderson, 
1982), such as the one used here, Phenyl Superose produced by 
Pharmacia in the form of pre-packed columns to be compatible 
with their FPLC systems. Phenyl Superose is a derivative of 
the rigid, cross-linked agarose-based Superose 12 and 
contains covalently bonded phenyl groups. The degree of 
substitution is approximately 50umoles/ml of gel bed. The 
average particle size is lOum. Phenyl Superose has a 
negligible amount of charged groups meaning that true 
hydrophobic interaction chromatography is possible.
Hydrophobic interaction adsorbents provide a complementary 
purification medium to ion exchange. In practice, 
hydrophobic interaction chromatography does not usually 
achieve very high resolution. This is because binding 
behaviour changes only slowly with altering conditions and 
therefore there can be a relatively large degree of overlap 
between components. However, the protein capacity of this 
type of medium is very high (10-100mg/cm3). It also does not 
require any buffer exchange, since samples are loaded in high 
salt buffer and salt can simply be added to the sample to 
achieve this.
For the above reasons, hydrophobic interaction chromatography 
was considered a suitable second step in the purification of 
AMP deaminase. This is a suitable point to consider it in 
this purification strategy for a number of reasons. Firstly, 
precipitation methods, based upon protein hydrophobicity had 
not been previously used, and secondly a method with a 
reasonably high protein capacity is required at this stage 
since fairly large amounts of protein are still to be dealt 
with. Therefore experiments using the FPLC phenyl-superose 
pre-packed column were carried out.
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FIGURE 5.7.2.1 ELUTION OF AMP DEAMINASE FROM A PHENYL-
SUPEROSE 5/5 COLUMN LOADED WITH CRUDE EXTRACT
Column volume: 1ml
Flow rate: 0.5ml/min
Fraction size: 1ml
Buffer: 20mM potassium phosphate, pH 7.5
Sample: 2.0ml crude extract (see below)
2-00-5
1600
1400 ~
0-4
1000 c:
000 2
0-5
400
200
FRACTIONS collected
Fraction Activity Protein Specific Activity
(nmoles NHg/ml/min) (mg/mi) (nmoles NHg/mg/min)
extract 399.0 4.05 98.8
17 3.32 0.12 2 7.7
18 83.3 0.13 641.0
19 173.0 0.115 1510.0
20 200.0 0.16 1250.0
21 12 3.0 0.175 704.0
2 2 5 6.7 0.0 9 6 3 7.0
2 3 3 3.3 0.07 477.0
facing page 97
5.7.2. Pilot experiments with FPLC phenyl-suoerose media: 
Results and Discussion
Pilot experiments were carried out using crude extract loaded 
onto a Phenyl Supe'rose 5/5 column (1ml bed volume). Using 
cell-free and partially purified material from an ion 
exchange column were not expected to give comparable results 
since the differing components in each mixture would compete 
differently in binding. However, experiments with cell-free 
extract give an indication of the suitability of this method 
of purification.
NaCl was chosen as the salt to be used in these analyses 
since its effect on AMP deaminase at high concentrations had 
already been studied (Section 5.2.2). Initially the 
material was loaded in 4M NaCl but since AMP deaminase was 
found to elute at a low salt concentration when subjected to 
a linear gradient from high to low salt, the material was 
subsequently loaded in 2M NaCl, to reduce the competitive 
binding of less hydrophobic components. These pilot 
experiments were encouraging, giving high returns of activity 
in the range of 70-85% of the material loaded. The level of 
purification, as expected, was not particularly high ranging 
from 5 to 15-fold. One such experiment is shown in figure
5.7.2.1. AMP deaminase activity peaks at approximately 0.24M 
NaCl, and fraction 19 represents a 15.3- fold purification. 
84% of the loaded activity was recovered. Therefore, Phenyl 
Superose chromatography appears to represent a reasonable 
second step in the purification of AMP deaminase. Hence, 
similar experiments were carried out using fractions purified 
from an ion exchange column.
Those fractions with the highest AMP deaminase specific 
activity after Mono Q chromatography were pooled, salt was 
then added to make the sample up to 2M NaCl. The column was 
then run as described above. In general, the recoveries from 
such columns loaded with partially purified material were 
much lower than those from columns loaded with crude extract. 
The average recovery was only 20.8% ranging from as low as 
4.9% to 44.4%. Related to this was the poor level of 
purification, averaging only a 2.9-fold increase. It was 
also found that the AMP deaminase from this partially
97
purified material was generally eluted at a higher salt 
concentration than that when using crude extract. The 
activity normally peaked at around 0.7M NaCl, as opposed to 
0.2M NaCl using crude material. These differences are 
discussed below. 'The Phenyl Superose chromatographic step in 
the final purification is detailed in section 5.9.
This reduced recovery is not too surprising when coupled with 
the fact that Mono Q semi-purified fractions lost AMP 
deaminase activity rapidly when stored. It was found that 
activity could decrease dramatically overnight, and all 
activity could be lost when the fractions are stored at -20°C 
for 2 to 3 days (data not shown). Storage at 4°C did not 
improve matters. As nothing was known about the nature of 
this activity decay, the final purification procedures were 
carried out rapidly without storing fractions for longer than 
necessary. This was accomplished by carrying out the entire 
fractionation in one day. In this way at least some AMP 
deaminase activity was maintained and assayable.
The reason for the different elution patterns seen with crude 
and partly-purified material is somewhat obscure. It may be 
that partially purified AMP deaminase is competing for 
binding with a population of relatively more hydrophobic 
proteins than that encountered in the crude extract.
5.8 GEL FILTRATION WITH FPLC SUPEROSE 6
5.8.1 Introduction
The previous methods of purification have involved phase 
changes, i.e. the proteins pass from a liquid phase (when in 
solution) to a solid phase (when adsorbed or precipitated) 
and back again. Not all proteins can withstand these 
stresses, and as has been discussed previously, AMP deaminase 
appears to lose a high proportion of its activity during all 
attempts to purify it.
Gel filtration is a relatively gentle technique, where the 
proteins remain in solution at all times. It was hoped that 
this technique coupled with the two adsorptions processes
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TABLE 5.8.1.1 PROPERTIES OF PHARMACIA SUPEROSE GEL 
FILTRATION MEDIA
PROPERTIES SUPEROSE 6 SUPEROSE 12
Exclusion limit for 
globular proteins (MW)
Optimal separation 
range (MW)
Average particle 
size (jum)
Yields and activity 
recovered (%)
approx 4 x 10
5000 - 5 x 10'
13 +/- 2
80 - 100
approx 2 x 1 0  
1000 - 3 x 10! 
10 +/- 2 
80 - 100
Information quoted from data sheets regarding Superose 6 and 
12 supplied with prepacked columns from Pharmacia.
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described in sections 5 .6 and 5.7, would allow enough AMP 
deaminase activity to be maintained to sufficiently purify 
the enzyme for N-terminal amino acid sequencing.
The basic principles of gel filtration are simple. The gel 
matrix consists of an open cross-linked 3-dimensional 
molecular network, cast in bead form. The pores within the 
beads are of such sizes that they are not accessible to the 
largest molecules, and the smallest molecules can penetrate 
all pores. Within these two extremes are molecules which can 
penetrate many or few of the pores depending on the size of 
the molecules. In this way large molecules are excluded from 
most of the pores, and therefore, move more rapidly through 
the column. They are eluted ahead of smaller molecules which 
are impeded in their passage by having to pass through pores 
in the beads. In this way gel filtration medium can separate 
molecules largely on the basis of size.
Again all purifications were carried out using the Pharmacia 
FPLC system. There are two gel filtration media available 
with this system, Superose 6 and Superose 12.
Superose is a cross-linked agarose based medium which 
exhibits negligible ionic interactions at ionic strengths of 
0.05M and above. However, some hydrophobic interactions have 
been shown, and therefore some proteins may be eluted 
somewhat later than predicted. The properties of the two 
media are shown in table 5.8 .1.1. Since the molecular weight 
of AMP deaminase from S. cerevisiae is reported to be 320 
kDa, Superose 6 was chosen for use in the purification of 
this enzyme because of its greater exclusion limit. The 
column has a bed volume of 20mls.
Gel filtration requires that a sample be applied in a small 
volume (commonly not greater than 1-2% of the column volume) 
because of its ability to seperate molecules on the basis of 
their size. Therefore, since the column used has a volume of 
20mls, no more than*40Op 1 of a protein solution could be 
loaded. The actual amount of protein is of less importance, 
but obviously a protein solution which is too concentrated 
results in precipitation of proteins. This curtails the 
actual capacity of the column, and although pilot experiments
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FIGURE 5.8.2,1 ELUTION OF AMP DEAMINASE FROM A SUPEROSE 6
COLUMN LOADED WITH CRUDE EXTRACT
Column volume: 
Flow rate: 
Fraction size: 
Buffer:
20ml 
lml/min 
0.5ml
50mM potassium phosphate, pH 7.5
Sample: 200jjl crude extract (see below)
2-0
300 2
250 -
200
150 «
100
FRACTIONS collected
Fraction Act ivity 
(nmoles NFU/ml/min)
O
Prote in 
(mg/ml)
Specific A 
(ninoles NHg
extrac t 4 0 3.0 14.2 28.4
2 3 3 1.7 0.044 2 6 5.0
24 26.7 0.112 2 3 8.0
2 5 33.3 0 . 1 3 3 3. 0
26 3 0 . 0 0.195 15 4. 0
27 25.0 0.405 61.7
28 13.3 0. 68 19.7
21 58.3 0.30 191.0
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were carried out using semi-pure fractions from ion exchange 
it soon became apparent that another purification procedure 
would be advisable prior to gel filtration. Hence the use of 
hydrophobic interaction chromatography, which although not 
giving a great ove'rall purification does considerably reduce 
the amount of protein to be dealt with.
Gel fiTtration requires no buffer exchange of the sample, but 
does normally require a concentration step, to reduce the 
volume. Protein concentration was carried out using Amicon 
filter concentrators, which remove water from a solution by 
blotting it through a membrane (see chapter 2). This was 
found to be a satisfactory method of concentration, which 
could be carried out rapidly and at low temperatures.
5.8.2 Pilot experiments with FPLC Superose 6 media: Results 
and Discussion
Pilot experiments were carried out using crude extract to 
determine the elution characteristics of AMP deaminase from 
Superose 6 . AMP deaminase was routinely eluted between 12 
and 14mls after loading. Recovery of this activity was 
normally high, approaching 100%. A typical Superose 6 run is 
detailed in figure 5.8 .2.1. In this case, the activity peaks 
at 12.5mls, and fraction 25 represents a 11.7-fold 
purification. 87% of the loaded activity was recovered. 
However, as previously discussed, partially purified AMP 
deaminase rapidly loses activity, and purification by 
Superose 6 chromatography using partially purified material 
was less efficient (see section 5.9.2).
As at every stage, all attempts to stabilise the enzyme had 
failed. Also the AMP deaminase assay was the only method of 
monitoring the enzyme during the purification. Hence, it was 
felt that the entire purification procedure would have to be 
carried out as quickly as possible, preferably in a single 
day.
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FIGURE 5.9.2.1 ELUTION OF AMP DEAMINASE FROM A MONO Q 16/10
COLUMN LOADED WITH CRUDE EXTRACT
Column volume: 
Flow rate: 
Fraction size: 
Buffer:
20ml 
8ml/min 
8ml
20mM potassium phosphate, pH 7.5
Sample: 100ml crude extract (see below)
600
0-75 500
0-S.
300
o
025
100
FRACTIONS collected
Fract ion Activity 
(nmoles NHg/ml/min)
Protein 
(mg/ml)
Specific Activity 
(nmoles NHg/mg/min)
extract 128.0 3.1 41.3
28 23.3 0.67 34 .8
29 39.9 0.89 44.8
30 61.6 1.10 55 . 7
31 12 5.0 0 . 98 127.5
3 2 192.0 1 .07 17 9.0
3 3 2 3 9.0 1.05 22 7 . 0
34 356.0 0.92 38 7.0
3 5 476.0 0. 96 4 96 . 3
36 512.0 0.88 581 . 2
37 290.0 0.75 387.0
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5.9 THE PURIFICATION OF YEAST AMP DEAMINASE
5.9.1 Introduction
What follows is a 'detailed description of the purification of 
AMP deaminase from crude extract to the point where activity 
recovered in a fraction correlates with the major band on an 
SDS polyacrylamide gel. This material was used for N- 
terminal sequencing.
The entire procedure was carried out without long term 
storage (i.e. overnight) of semi-purified material. Although 
all chromatography was carried out at room temperature, 
wherever possible fractions were collected and immediately 
stored on ice, prior to assaying for AMP deaminase activity. 
Small samples were taken at each stage for AMP deaminase 
assays, protein determination, and for analysis by SDS 
polyacrylamide electrophoresis.
The phenol-hypochlorite method for ammonia determination as 
described in chapter 2 was used in all AMP deaminase assays 
throughout the purification. However, the assay was 
increased in its sensitivity by determining the ammonia 
produced by a lOOul reaction mix by the addition of 0.33ml 
reagent 1, followed by the addition of 0.5ml of both reagent 
2 and 3 (as opposed to the normal additions of 1ml, 1.5ml and 
1 .5ml respectively). This increased the lower limit of 
detection of the assay to 5nmoles of NH3 . For every AMP 
deaminase assay, a substrate blank reaction was set up to 
account for endogenous ammonia in the protein sample and 
reagents. A set of NH^Cl standards was included in every 
batch of ammonia determinations carried out.
5.9.2 Results
The first step of the purification was carried out using 
crude extract at a protein concentration of 3.1mg/ml, with an 
AMP deaminase specific activity of 41.3nmoles/min/mg. lOOmls 
of this extract in 20mM potassium phosphate buffer, pH7.5 was 
loaded on to the Mono Q 16/10 (20ml) column equilibrated with 
the same buffer. The column was then washed with the
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FIGURE 5.9.2.2 ELUTION OF AMP DEAMINASE FROM A PHENYL-
SUPEROSE 5/5 COLUMN WHEN LOADED WITH 
PARTIALLY PURIFIED MONO Q 16/10 FRACTIONS
Column volume: 
Flow rate: 
Fraction size: 
Buffer:
lml
0.5ml/min 
lml
20mM potassium phosphate, pH 7.5
Sample: 10.5ml of pooled Mono Q fractions 35 and 36 (see
figure 5.9.2.1) in 2M NaCl (see below)
20
1200=*
1000 <
oR «oo 2-
a
0-50-5
200
42 8 10 12 14 16 16 20 22 24 26 28 BO 32 3 46
FRACTIONS collected
Fraction Activity Protein Specific Activity
(nmoles NHg/ml/min) (mg/ml) (nmoles NHg/mg/min)
sample 323.0 0.87 372.0
20 18.7 0.072 260.0
21 4 6.3 0.09 5 487.4
22 67.5 0.05 13 50.0
2 3 13 0.0 0.158 823.0
2 4 13 2.0 0.172 770.3
2 5 108.0 0.170 6 3 7.0
26 60.0 0.162 370.0
27 26.3 0.075 351.0
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starting buffer until there was no further protein elution as 
determined by absorbance at 280nm. A linear gradient of 0- 
0.5M NaCl in 20mM potassium phosphate was then applied to the 
column. 8ml fractions were collected and assayed for AMP 
deaminase activity'.
A trace of the elution of proteins from this column is shown 
in figure 5.9.2.1. Activity was found in fractions 28 
through to 37, the activity peaking at around 0.34M NaCl. 
144.6% of the activity loaded was recovered in these 
fractions, and fraction 36 represents a 14-fold purification.
Fractions 35 and 36 were pooled and made up to 2M NaCl. This 
pooled material had a protein concentration of 0.87mg/ml and 
an AMP deaminase specific activity of 371.5 nmoles/min/mg. 
10.5mls of this material was then loaded on to a Phenyl- 
superose 5/5 (lml) column, equilibrated with 2M NaCl in 20mM 
potassium phosphate, pH 7.5. The column was then washed with 
this buffer until no more protein was seen to elute. A 
linear gradient of 2M-0M NaCl in 20mM potassium phosphate, 
pH7.5 was then applied to the column and lml fractions were 
collected. These fractions were then assayed for AMP 
deaminase activity. The elution pattern is shown in figure
5.9.2.2. Fractions 20 through to 27 showed AMP deaminase 
activity. However only 15.8% of the loaded activity was 
recovered in these fractions, with fraction 22 representing a
3.6-fold purification. The elution of AMP deaminase peaked 
at around 1M NaCl. Fractions 21 through to 26 were pooled 
and concentrated in an Amicon concentrator.
The material was concentrated approximately 10-fold, and 
200jil of this material was loaded on a Superose 6 column 
equilibrated with 50mM potassium phosphate, pH 7.5. This 
loaded material has an AMP deaminase specific activity of 432 
nmoles/min/mg and a protein concentration of 3.5 mg/ml. All 
protein was then eluted with this buffer and 0.67ml fractions 
were collected and assayed for AMP deaminase activity. A 
trace of absorbance at 280nm is shown for this run in figure
5.9.2.3.
Activity was found in fractions 17, 18 and 19. Of the loaded 
activity 102% was recovered in these three fractions and
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FIGURE 5 . 9 . 2 . 3 ELUTION OF AMP DEAMINASE FROM A SUPEROSE 6
Column volume: 
Flow rate: 
Fraction size: 
Buffer:
COLUMN WHEN LOADED WITH PARTIALLY PURIFIED 
PHENYL SUPEROSE FRACTIONS
20ml
0.333ml/min
0.67ml
20mM potassium phosphate, pH 7.5
Sample: 200ul of concentrated Phenyl superose fractions 21
26 A see figure 5. 9.2.2 and below)
|03
1600 g
1200
600
400
6 8 10 12 14 16 18 20 22 24 26 2ft 30 32
FRACTIONS collected
Fraction Activity
(nmoles NH^/ml/min
sample
17
18
19
1510.0
117.0
226.0 
12 0.0
Protein Specific Activity
(mg/ml) (nmoles NHg/mg/min
3.52 429.0
0.3 389.0
0.1 2260.0
0.1 1200.0
i
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fraction 18 represents a 5.2-fold purification. Samples from 
each stage of the purification were subjected to SDS/PAGE and 
this gel is shown in Figure 5.9.2.4. All protein 
electrophoresis was carried out using the Pharmacia Phast Gel 
system (Chapter 2)r.
5.9.3 Ehiscussion
The entire purification is detailed in table 5.9.3.1. If 
these results are compared with those in table 5.1.1 the 
purification of yeast AMP deaminase by Yoshino et al.
(1979b), it can be seen that this purification results in a 
sample of much lower specific activity, i.e. the purified 
material described here has a specific activity of 
2.26jumoles/min/mg in comparison with that described by 
Yoshino et al. : 343 .3)umoles/min/mg. Both purifications 
started with extracts of similar specific activity i.e. 0.041 
(here) and 0 . 08jamoles/min/mg (Yoshino et al. . 1979b). This 
low specific activity is also accompanied with a low level of 
recovery after the three rounds of purification and with a 
low level of purification (only 54.7-fold purification in the 
method described here as opposed to 4291-fold purification in 
the Yoshino method).
It is not clear why the figures from this purification should 
be so low. It has been seen at each stage of the 
purification that activity is lost. The reasons for these 
losses are unknown. It seems unlikely to be due to protease 
contamination for a number of reasons. Firstly, there was no 
apparent differences in the activities recovered during 
purifications which included the protease inhibitor, PMSF and 
those that did not (data not shown). PMSF was routinely 
added at all steps of the purification at ImM.
Alternatively, the enzyme may be undergoing some form of 
denaturation or inactivation of the catalytic site. 
Denaturation is normally brought about by extremes of either 
pH or temperature or by the presence of denaturants. All of 
these conditions have been avoided as far as possible.
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FIGURE 5.9.2.4 AN ELECTROPHORETIC SUMMARY OF THE
PURIFICATION OF AMP DEAMINASE
M W
(kDa)
1 2  3 4 5 6 7 8
94-0 —
1
• H ■
67-0—  mm
43-0—  | ■* **»■■* •i^1” ***
30 0 — d
20*0— I _ _
14*4— **
LANE
1 Protein molecular weight standards
2 Crude extract
3 Mono Q fractions 36 (see figure 5. 9.2.1)
4 Phenyl-superose fraction 22 (see figure 5.9.2.2)
5 Phenyl-superose fraction 23 (see figure 5.9.2.2)
6 Pooled and concentrated Phenyl-superose sample (see
figure 5.9.2.3)
7 Superose 6 fraction 18 (see figure 5. 9. 2.3)
8 Protein molecular weight standards
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Catalytic site inactivation is more complex. It may be 
brought about by the loss of an essential co-factor, as 
suggested initially in section 5.3.3 when dialysis appeared 
to greatly reduce AMP deaminase activity. The loss of this 
putative co-factor' may contribute to a destabilisation of the 
enzyme, possibly allowing breakdown of its tertiary structure 
(i.‘e. the tetrameric enzyme may be breaking down into its 
monomebic form which is either completely inactive, unstable 
or is lost at some stage of the purification). This type of 
inactivation could be prevented if the co-factor was known, 
which is not the case here.
Another form of active site inactivation is when there is a 
covalent modification of active site. Cysteine residues at 
the active site are most susceptible to modification. The 
sulphydryl group may be in the ionised form and therefore 
very prone to oxidation. Sulphydryls can undergo a number of 
modifications, including disulphide bond formation and either 
partial oxidation to sulphinic acid or irreversible oxidation 
to sulphonic acid. These modifications are normally avoided 
by the addition in buffers of a chelating agent, such as EDTA 
to remove trace divalent cations which activate oxygen 
molecules and complex with sulphydryls and the addition of a 
sulphydryl containing compound such as DTT or B- 
mercaptoethanol to maintain reducing conditions. As 
discussed in section 5.2.1 all of these precautions are 
deleterious both to the assay system employed and to the AMP 
deaminase activity itself.
Another possibility is that AMP deaminase is a fragile enzyme 
and that during the phase change methods of chromatography 
the enzyme cannot maintain its structural integrity. AMP 
deaminase is a large multimeric protein (a tetramer of 
apparently four identical subunits (Yoshino et al.. 1979b) 
and it is possible that the methods of purification which 
involve adsorption to a matrix from solution and back again 
are too stressful to allow the protein to be maintained 
efficiently in its active form. The final gel filtration, 
which does not involve a phase change, allows 102.% of loaded 
activity to be maintained suggesting that this more gentle 
type of purification is more suited to AMP deaminase.
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TABLE 5.9.3.1 SUMMARY OF AMP DEAMINASE PURIFICATION FROM 
S .cerevisiae AS PRESENTED IN THIS CHAPTER
(nmoleB NH3/min/mg protein) (mgs)
Crude extract 41.3 310>0 x 100
Applied to P-sup 372.0 9 14 g 0 26 5
Applied to Sup 6 199.0 0.70 10.5 2.36
Sup 6-Fraction 18 2260.0 0 07 54 7 x 17
Finally, it is known that very dilute enzyme solutions lose 
activity quickly. This is often prevented by the addition of 
another protein such 'as BSA. Extreme dilution of a protein 
may lead to dissociation of subunits which whether active or 
not may be unstabie and denature quickly. The addition of 
BSA was not considered appropriate in this purification 
although with hindsight some trial experiments with it might 
have proved advantageous. Other stabilising compounds might 
have been added such as glycerol. The non aqueous components 
of a cell equal 10-15%, most of which is protein. This high’ 
non aqueous component reduces the water activity. Glycerol 
and some sugars like sucrose or glucose appear to mimic this 
by forming strong hydrogen bonds with water, slowing down the 
motion of water molecules and therefore reducing water 
activity (Gekko and Timasheff, 1981; Smith, et al.. 1978). 
20-30% glycerol has apparently little effect on ion exchange 
(Skopes, 1987) although salting out methods and hydrophobic 
interaction chromatography may well be affected.
Regardless of the reasons for the loss of activity, enough 
activity was maintained up until this point in the 
purification to allow the correlation of the activity with a 
major band on an SDS polyacrylamide gel (data not shown). The 
size of the AMP deaminase subunit has been reported to be 
approximately 83kDa (Murakami, 1979). This single major band 
in fraction 18 (see figure 5.9.2.4), representing 
approximately 80% of the total protein in this sample, has an 
apparent molecular weight of approximately 83kDa.
Fraction 18 was freeze dried and sent to ICI Pharmaceutical 
Division for N terminal amino acid determination.
5.10 N-TERMINAL SEQUENCE OF THE PURIFIED PROTEIN
5.10.1 Introduction
The analyses described in this section were carried out by 
John Fitton, of ICI Pharmaceutical Division. The protein in 
fraction 18 was run on a 15% SDS polyacrylamide gel, and the 
gel was then electroblotted* Protein on
the membrane was then detected by Coomassie blue staining and
105
FIGURE 5.10.1 N-TERMINAL AMINO ACID SEQUENCE OF THE MAJOR
POLYPEPTIDE BAND IN FRACTION 18
RESIDUE:
AMP deaminase1 ? ALANINE/GLUTAMINE/
LYSINE
hsp902 METHIONINE ALANINE
RESIDUE:
AMP deaminase GLUTAMIC ACID
hsp90 GLUTAMIC ACID THREONINE
RESIDUE: 8
AMP deaminase GLUTAMIC ACID PHENYLALANINE
hsp90 GLUTAMIC ACID PHENYLALANINE
RESIDUE: 10
AMP deaminase ALANINE
hsp90 ALANINE
1 This study
2 Farrelly and Finkelstein, 1984
3
SERINE/GLYCINE
SERINE
6
PHENYLALANINE
PHENYLALANINE
9
GLUTAMIC ACID 
GLUTAMIC ACID
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the portion of the membrane corresponding to the 83kDa 
protein was cut out. This material was then applied directly 
to an Applied Biosystems Gas Phase Sequencer.
r
5.10.2 Results
The first ten amino acids of the N terminal of this pure 
protein were determined, with the assumption that the first 
residue was methionine since this residue was lost either 
during purification or the sequencing process. Some of the 
remaining residues showed ambiguity and the fifth residue 
could not be determined. The sequence is shown in Figure
5.10.2.1.
This sequence data was compared with those in the protein 
database and homology was found to the S .cerevisiae heat 
shock protein 90 (hsp90)(Farrelly and Finkelstein, 1984).
The first ten amino acids of this protein are also shown in 
Figure 5.10.2.1. All the residues which could be determined 
from the pure protein in fraction 18 match with the reported 
sequence of hsp90 (Farrelly and Finkelstein, 1984). At 
residue 5 in the hsp90 sequence corresponds to a threonine. 
This residue could not be determined in the putative AMP 
deaminase sequence, but threonine is especially susceptible 
to degradation in this sequencing process (John Fitton, 
personal communication).
5.10.3 Discussion
The protein was purified on the basis of AMP deaminase 
activity and was found to have a subunit size which 
correlates exactly with that previously reported for AMP 
deaminase. The N-terminal sequence of this protein is 
homologous to yeast hsp90. Clearly this raises some 
interesting questions.
Is it possible that this homology has simply occurred by 
chance? The chances of two proteins having this level of 
similarity in the N terminal region is (1/20)^ x 2/20 x 3/20 
which equals 2.34 x 10“10. It therefore seems very unlikely
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that the sequence homology is a chance occurrence, suggesting 
that the 80kDa band on SDS gels does correspond to hsp90. 
Hence, it would appear that AMP deaminase and hsp90 may be 
one and the same protein. This matter is addressed in the 
next chapter. r
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CHAPTER 6
THE RELATIONSHIP BETWEEN AMP DEAMINASE AND HSP90
108
6.1 INTRODUCTION
The Heat Shock Response
r
In 1962 Ritossa noted that a sudden increase in temperature 
resulted in the production of novel chromosome puffs in 
DrosophiTa cells. Chromosome puffs were known to indicate 
sites of active transcription. This was accompanied by the 
concomitant subsidence of previously active puffs (Ritossa, 
1962). This finding received little attention until other 
workers noted that this treatment also resulted in the 
production of a new subset of proteins (Tissieres et al.. 
1974). This phenomenon is known as the heat shock response 
and the particular set of proteins synthesised during heat 
shock are known as heat shock proteins (hsps).
It is now clear that this phenomenon is not unique to 
Drosophila but is common to all organisms so far studied. It 
represents one of the most highly conserved genetic 
regulatory systems known. Subsequently it became apparent 
that this reponse was not a function of temperature but can 
be brought about by a number of stimuli, including amino acid 
analogues and ethanol (for review of stimuli, see Ashburner 
and Bonner, 1979). The cellular trigger for this response is 
unknown but it seems likely that the heat shock proteins 
function to repair damage caused by different types of stress 
(for reviews of response see Ashburner and Bonner, 1979; 
Pelham, 1985; Lindquist, 1986).
Of the heat shock proteins produced, there is great 
conservation between different organisms. All organisms 
produce an hsp of between 80 and 90 kDa, one or more of 
approximately 70 kDa and one or more of between 15 and 30 
kDa. The proteins in each class are highly conserved in 
different organisms suggesting that they have similar 
functions in the different cell types.
It is worth noting, at this point, that the hsps have been 
named by their apparent sizes on SDS polyacrylamide gels. 
Fortunately, in most organisms, hsp70 does appear to be very 
close to this molecular weight. The case is not as simple
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for hsp90. As its name suggests yeast hsp90 had an apparent 
molecular weight of 90 kDa on the gel systems used in the 
first reports of this 'protein (Finkelstein et al.. 1982). 
Subsequent work has shown that the derived molecular weight 
of this protein from DNA sequence data is approximately 82- 
83kDa (Farrely and Finkelstein, 1984). It is now frequently 
known as yeast hsp83, and the homologous proteins in 
different organisms can be called, variously, hsp82, hsp83 
and hsp89. For the purposes of this report I have elected to 
maintain the original name of hsp90 for the yeast protein, 
and where the homologous protein from other organisms is 
named otherwise, it will be accompanied by hsp90 in brackets.
There are differences in the response depending on the 
organism and the degree/type of stress. In some organisms 
the response to a temperature rise is transient when the 
shift is to a temperature at which normal growth can occur.
In some organisms heat shock is not transient and this 
pattern of protein synthesis maintained while the high 
temperature is maintained. When the temperature is 
decreased, normal transcription and translation resumes 
(Lindquist, 1986). Where heat shock is to a non-growth 
permissive temperature or induced by a lethal stimulus the 
cell maintains the production of hsps and the response 
continues until cell death occurs. Even under circumstances 
where the response is transient there is some evidence that 
even after normal synthesis is resumed the accumulated hsps 
are maintained at higher levels than prior to the heat shock 
for some time (Neidhardt et al.. 1984). The response is also 
modulated by the metabolic state of the cell. Fermenting 
yeast cells when heat shocked to 36°C show a transient heat 
shock response, whereas at 40°C the response is maintained. 
Respiring yeast cells in contrast show the transient response 
at 34°C but maintain it at 36°C (Lindquist, 1986).
Different organisms and cell types have different mechanisms 
to facilitate expression of hsps. In almost all cases, 
immediately upon heat shock, transcription of normal cellular 
mRNAs ceases, polysomes are seen to disappear for several 
minutes (Ashburner, 1982) and then polysomes representing 
heat shock specific mRNAs appear. In Drosophila. the 
organism in which heat shock was first widely studied, there
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appears to be a specific translational control mechanism in 
addition to transcriptional specificity. Pre-existing mRNAs 
remain in the cytoplasm but are no longer translated while 
heat shock lasts. Instead, heat shock messages are 
specifically translated, and since these messages are induced 
up to 1000-fold the major hsps rapidly become highly 
abundant. In Drosophila after prolonged heat shock, hsp70 is 
more abundant than actin (Pelham, 1985). Once heat shock is 
over and the cell starts to revert to its normal pattern of 
gene expression, pre-existing messages are at this stage 
again translated, indicating that these normal mRNAs are not 
modified or inactivated in any way, but that upon heat shock 
the cells translational machinery must be able to 
specifically recognise and translate heat shock messages 
(Storti et al.. 1980). Therefore, there must be selective 
alterations in the translation components of heat shocked 
cells causing selective translation of heat shock mRNAs, and 
hence there must be information in the heat shock mRNAs to 
allow their specific translation.
Although this is the classic example of the heat shock 
response, other organisms respond differently. In yeast, for 
example, again polysomes break down and normal mRNAs cease to 
be transcribed as the heat shock mRNAs become actively 
transcribed to a fairly high level. There appears, however, 
to be no translational specificity. All cellular messages 
are translated, including pre-existing ones (Lindquist,1984). 
Therefore the gradual reduction in the normal translational 
products are due simply to the depletion of normal cellular 
mRNAs. This depletion appears to be a function of the 
specific messages inherent stability. Even so, the hsps soon 
become major products of protein synthesis. HsplOO in 
S .cerevisiae represents 2.5% of total soluble protein 60 
minutes after heat shock (McAlister et al.. 1979). These 
differences between Drosophila and yeast account for the more 
dramatic changes seen on gels of labelled proteins for 
Drosophila in comparison to yeast (Lindquist, 1984).
It is thought that these differences in the evolution of 
mechanisms are at least partly due to the inherent 
differences in mRNA stability in the different organisms. 
Drosophila mRNAs have average half lives in the region of 8
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hours and therefore to allow the remaining cellular mRNAs to 
compete for the translational machinery of the cell would 
mean a long delay in the accumulation of the required hsps. 
Yeast on the other hand, has mRNAs with stabilities in thet '
region of 5 to lOO^mins (Santiago et al.. 1986). Therefore 
most cellular messages are quickly degraded allowing the hsp- 
specific mRNA to quickly become the major substrate of 
translation (McAlister and Finkelstein, 1980b). In support 
of this theory is the differences in the mechanism of heat 
shock response seen in Xenopus somatic cells and oocytes. 
Xenopus somatic cells react to heat shock in a way very 
similar to Drosophila with regulation at both the 
transcriptional and translational level. Oocytes, conversely 
show no transcriptional effects on heat shock. It appears 
that hsp mRNAs are in existence at high levels within the 
oocyte, prior to heat shock and upon heat shock they become 
the sole substrates for translation, hence the hsps rapidly 
accumulate (Lindquist, 1984). It is thought that the reason 
for this novel response to heat shock is due to the unusually 
large size of the oocyte. If the accumulation of hsps 
required depended on newly transcribed messages from a single 
genome, it is estimated that for the hsps to reach the 
necessary concentration within this large cell would take 
several days.
Hsps are generally defined as those whose synthesis is 
sharply and dramatically induced at high temperatures. It is 
presumed that these proteins are required for the homeostatic 
regulation of the cell to a rapid but physiological 
environmental change. However there are a number of reports 
of minor proteins which are also induced by heat. These 
analyses normally involve the use of very large 2-dimensional 
protein gels. Some estimates for the number of these minor 
induced proteins are as high as 70 (Anderson et al.. 1982; 
Reiter and Penman, 1983; Maytin et al.. 1985).
As well as the induction of a specific subset of proteins, 
other physiological effects of heat shock have been reported. 
In particular it has been shown in yeast that a heat shock to 
a moderate temperature or treatment with ethanol can save the 
cells from thermal killing at a non physiological temperature 
as well as effects of some mutagens, including ionising
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radiation (Plesset et al.. 1982; Mitchel and Morrison, 1983 
and 1986). There appears to be a good correlation under 
these conditions between the levels of hsps and the level of 
protection, but subsequent work has shown that protein 
synthesis is not required to induce this thermotolerance 
(Hall, 1983; Watson et al.. 1984; Cavicchioli and Watson,
1986). It seems likely that thermotolerance is induced 
either by the activation of a pre-existing cellular component 
activated at the higher temperature or by the inactivation of 
a component at the increased temperature which in some way 
interferes with thermotolerance.
Heat shock has a number of other effects. It has been shown 
in two species of Tetrahvmena that within 3 minutes of heat 
shock, the cellular ATP content is reduced by 50% (Findley et 
al.. 1983). There is no accompanying increase in ADP or AMP, 
but there is an increase in Pi, suggesting that ATP is 
hydrolysed to the free nucleoside.
It has also been shown that heat shock or other stimuli 
induce a significant drop in internal pH (Weitzel et al..
1985 and 1987). Other effects reported are the accumulation 
of trehalose in yeast (Attfield, 1987; Hottinger et al..
1987) and an increast in the level of phosphotyrosine in 
proteins in most cultured cells (Maher and Pasquale, 1989).
Another interesting effect of heat shock is that cells appear 
to be transiently arrested in G1 phase (Shin et al.. 1987). 
Also it was shown that yeast cells which are in GO show 
qualitative differences to actively growing cells. They show 
different RNAase activity, poly A content and specifically 
synthesise about 20 proteins, 5 of which are hsps (Lindquist, 
1984; Boucherie, 1985). This finding has subsequently been 
found in chick embryo fibroblasts, mouse lymphocytes and 
Drosophila cells (Iida and Yahara, 1984a). Along with this 
is the finding that stationary cells are more resistant to 
thermal killing than exponentially growing cells.
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Hsps in development
As previously stated several hsps are also present in non 
heat shocked cells, suggesting that they fulfil necessary 
functions in the upstressed cell. Interestingly a specific 
subset of hsps are induced during normal development in a 
number of organisms. Hsps 28, 26 and 83 (hsp90) are 
abundantly transcribed during oogenesis in Drosophila ovarium 
nurse cells (Lindquist, 1984). They then pass into the 
oocyte at stages 10 - 11. Curiously, pre-blastoderm embryos 
fail to accumulate these hsps even if heat shocked (Zimmerman 
et al.. 1983; Kurtz, 1986). Hsp70 is not induced at this 
time. Similarily yeast hsp26 and 90 are strongly induced as 
the cells approach stationary phase and during spore 
formation (Kurtz and Lindquist, 1984; Lindquist, 1986). This 
differential accumulation indicates the existence of 
differential and possibly multiple controls of heat shock 
gene expression and belies the original view of the heat 
shock response as the classical example of coordinate 
regulation of a family of genes.
The expression of Heat Shock proteins
The question of the regulation of the hsps expression has 
attracted a great deal of attention. A number of workers 
have examined the chromatin structure of heat shock genes.
In Drosophila the 5 ’ ends of heat shock genes are 
hypersensitive to treatment with DNAse I, as though they are 
prepared for immediate transcription (Wu, 1980). Fine 
mapping of this region in 5 Drosophila heat shock genes shows 
that there are at least 2 hypersensitive regions, one 
representing the TATA box, the other is a region found 
approximately 115bp upstream of the transcriptional start 
site. This region has been widely studied and is now known 
as the heat shock element (HSE) (Holmgren'et al.. 1981; 
Costlow, 1984). There is evidence that this is a protein 
binding site (Sorger and Pelham, 1987). The element appears 
to be a hyphenated dyad, and the consensus in Drosophila is 
given thus
C GAA TTC G
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Although only a 5\8 match is sufficient for the 10-fold 
induction of one hsp (Craig, 1985), this element is highly 
conserved throughout Evolution, and the Drosophila HSE has 
been shown, when present in two or more copies, to bei
sufficient for heat shock specific induction of genes in 
yeast (Wei et al.. 1986; deBanzie et al.. 1986) and monkey 
COSvcells (Pelham, 1985), suggesting great conservation not 
only of'^the hsps themselves but also of the regulatory 
mechanisms associated with their expression.
Using these consensus sequences as substrates for affinity 
chromatography a heat shock binding or transcription factor 
(HSBF or HSTF) has been purified from both yeast and 
Drosophila (Wiederrecht et al.. 1987; Sorger and Pelham, 1987 
and 1988). Both are 70kDa polypeptides, and the Drosophila 
HSTF has been show to stimulate HSE-dependent transcription 
in yeast.
A recent report has suggested that the HSE is better 
described as a dimer of the following lObp consensus (Xiao 
and Lis, 1988)
NTTCNNGAAN
and this has led to the suggestion of the following yeast 
specific consensus (Tuite et al.. 1988)
nnTTCTAGAAnn
Of the heat shock genes studied very few have introns. In 
fact only the hsp83 (hsp90) of Drosophila. chick and human 
(Lindquist, 1986; Vourch et al.. 1989; Hickey et al., 1989) 
and a small hsp of nematodes (Lindquist, 1986) fall into this 
category. There may be a very good reason for this. In 
Drosophila. hsp83 (hsp90) shows a different pattern of 
expression to other hsps. It is produced at moderately high 
temperatures but not very high temperatures. There appears 
to be a block in the processing of the RNA at very high 
temperatures (Lindquist, 1986), hence it makes sense that few 
HSP genes contain introns. Interestingly, the first intron 
in all these hsp90 genes are all adjacent to the ATG 
translational start codon.
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Prior to heat shock hsp90 RNA is found solely in the poly 
(A)” fraction, but after heat shock it is dispersed between 
the poly (A)+ and (A)T fractions (Craig, 1985; Storti et al._,
1980). In the case of Hela cells at least, this distribution 
between both fractions is also seen for hsplOO, 70 and 37 
(Burdon and Cutmore, 1982).
\
The function of the hsps
Although a great deal is known about the expression of hsps 
and the physiological effects of stress, very little is known 
about the specific functions of hsps. Most progress has been 
made in this field where known gene products have been 
inadvertantly shown to be heat inducible. Included in this 
category are several yeast glycolytic genes including 
glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate 
kinase (Piper et al.. 1986). In addition, in yeast an isozyme of 
enolase has been shown to be hsp48 (Iida and Yahara, 1985) 
but this was not confirmed by another report YUemara et al._._, 
1986). One interesting addition to this category is 
ubiguitin (Finley et al.. 1984; Bond and Schlesinger, 1985;
Munro and Pelham, 1985). This small polypeptide has a role 
in directing the attack of proteinases (Finley et al.. 1984).
It has been suggested that ubiquitin-linked protein 
degradation has a key role in the regulation of the heat 
shock response. One of the physiological effects of heat 
shock is to cause the accumulation of denatured or aberrant 
proteins, which may require to be removed from the cell 
before the cell can recover (Pelham, 1986).
As yet, none of the major hsps have been assigned a proven 
function. To help elucidate their functions a lot of effort 
has been put into localising the proteins within the cell.
It is now apparent that hsp70, is a cytoplasmic protein which 
moves to the nucleus, and particularily the nucleolus on heat 
shock (Welch and Feramisco, 1985). Hsp90 appears to be an 
abundant cytoplasmic protein.' The low molecular weight hsps 
in mammals appears to form aggregates of unknown function 
both in the cytoplasm and the nucleus (Lindquist, 1986).
HsplOO in yeast and hspllO in mammals also appear to be 
associated with the nucleolus, whereas mammalian hsplOO seems
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to be a golgi protein. However in mouse, two proteins 
related to hsp70 and hsp90 have been found in the lumen of 
the endoplasmic reticulum (Pelham, 1986; Craig et al.. 1987). 
In most eukaryotes there are several members of the hsp70 
family, some of which are heat shock induced, some not. It 
is possible that each member is fulfilling similar functions 
but' in different cellular compartments both prior to and 
during heat shock.
There is an ever increasing number of fragments of 
information regarding the function of the hsps. Hsp26 in 
Drosophila has been shown to be an RNA-binding protein (Kurtz 
and Lindquist, 1984). Hsp70 as the most abundant and 
conserved hsp has attracted the greatest effort, and its 
function is becoming apparent. It was shown in 1985 to be an 
ATP binding protein (Welch and Feramisco, 1985; Lewis and 
Pelham, 1985) and Chirico et al. (1988) recently demonstrated 
that yeast cytoplasm contains two distinct activities that 
stimulate protein translocation. Both activities are 
constitutively expressed hsp70-related proteins. It is now 
clear that at least some of the hsp70 family are involved in 
post-translational import of precursor polypeptides into the 
mitochondria and endoplasmic reticulum lumen (Deshaies et 
al.. 1988^. This has led to the classification of hsp70 as a 
molecular chaperone or chaperonin (Ellis and Hemmingsen,
1989) along with such proteins as BiP which has been 
implicated in the assembly of the oligomeric enzyme 
ribulosebisphosphate carboxylase oxygenase in chloroplasts 
(Hemmingsen et al.f 1988). It is proposed that during heat 
shock, nuclear components are damaged and that binding to, 
being released from and rebinding to hsp70 can reassemble 
these denatured or aggregated proteins (Pelham, 1988).
Heat Shock Protein 90
Hsp90 has, as yet, been assigned no clear function. It is 
the second most highly conserved hsp; the Drosophila and 
E .coli proteins are 36% homologous, with some regions showing 
90% homology at the amino acid level (Lindquist,1986). All 
organisms so far studied contain an hsp in the region of 80 - 
90 kDa and the protein always has a fairly acidic pi at
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between 5.1 and 5.4. In eukaryotes it is a major 
cytoplasmic protein under non-stressed conditions, and in 
vertebrates it is methylated at lysine and arginine residues, 
and phosphorylated. It has also been shown to be glucose 
regulated. Under glucose starvation its synthesis is 
repressed (Kasambalides and Lanks, 1983).
It has also been shown in Hela cells, rabbit reticulocytes, 
Xenopus and Arbacia egg extracts that double stranded DNA 
induces the phosphorylation of several proteins including 
hsp90. This double stranded DNA-dependent phosphorylation is 
not seen in mouse cell extracts (Walker et al.. 1985). The 
implication of this form of regulation of hsp90 
phosphorylation is unclear.
Recently a tissue specific transplantation antigen has been 
purified to homogeneity from a methylcholanthrene-induced 
tumour in mice. The antigen consists of two similar 
polypeptides of 84 and 86 kDa both of which are highly 
homologous to Drosophila and yeast hsp90. The antigen is a 
highly abundant cytosolic protein but it is also present at 
the cell surface and is hence accessible to the host's immune 
system (Ullrich et al.. 1986).
Most cellular hsp90 is found in a monomeric form (Lindquist, 
1986) but it has also been reported that chick hsp89 (hsp90) 
can be isolated as an aggregate with the predominate form 
having a molecular weight of 560 kDa (Schlesinger et al..,-, 
1982). Very recently, Radanyi et al. (1989) presented 
evidence that in chick oviduct cells, hsp90 exists as a 
dimer.
There is a great deal of evidence to show that hsp90 is to be 
found associated with a wide number of cellular components, 
including viral transforming proteins and steroid hormone 
receptors.
In 1981, Brugge et al. used sera from rabbits bearing tumours 
induced by Rous Sarcoma virus to purify the transforming 
protein pp60src. The precipitated protein consisted not only 
of the pp60src but two other transformation specific 
phosphoproteins named pp50 and pp90. These proteins were not
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precipitated with sera from uninfected cells or 
transformation defective-virus infected cells (Brugge et al.,
1981). Sedimentation analysis revealed that pp60src is found 
within the cells in two forms. 95% are monomeric and the 
remaining 5% is associated with the other two proteins in a 
complex of approximately 200 kDa. pp50 is as yet 
unidentified and pp90 is now known to be hsp90. pp60src 
functions by phosphorylating IgG, but only the monomeric form 
is capable of this. pp60src in the monomeric form has both 
phophotyrosine and phosphoserine residues, in its complexed 
form it has been shown to contain much less phosphotyrosine.
Other work has shown that these associations occur in many 
vertebrate sources (Qpoermann et al.. 1981) and also in cells 
transformed by Fujinami and Yamaguchi Sarcoma viruses 
(Lipsich et al.. 1982). The complexed form is mostly 
cytosolic, the monomer is membrane associated (Yonemoto et 
al.f 1982), In 1983, Brugge et al. went on to show that only 
a discrete population of pp60src complexes with pp90 and pp50 
and that this population represents newly synthesised 
pp60src. The complex is short lived with a half life of 
approximately 15 minutes, and it has been found under a 
number of lysis conditions, even in the presence of 
detergents (Brugge et al.. 1983). The complex has not yet 
been reconstructed in vitro.
Shortly after the finding that hsp90 associates with the 
pp60src transforming protein, came a report that hsp90 is 
also found associated with immunoprecipitated chick oviduct 
progesterone receptor (Catelli et al.. 1983: Gasc et al.. 
1984). Later it was shown that this association was not 
confined to progesterone receptors, but was also apparent for 
at least four other steroid hormone receptors (Joab et al.. ,
1984). In fact the antibody raised for the 
immunoprecipitation of these receptors was directed against 
hsp90. However, it was also reported by Sanchez et al_.
(1985) that in the case of the glucocorticoid receptor, the 
association was only seen in the presence of molybdate and 
that if the complex was incubated at 25°C, dissociation of 
subunits occurs.
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Non-transformed hormone receptors found in the cytosol of 
target cells have a sedimentation coefficient of 
approximately 8S and a molecular weight of 250 - 300 kDa.
The receptor alone has a sedimentation coefficient of 4S, 
while the receptor-hsp90 complex has a sedimentation 
coefficient of 8S. The 8S complex is incapable of binding 
further hsp90 (Catelli et al.f 1985). There is evidence that 
two molbcules of hsp90 and one hormone receptor make up this 
8S complex (Radanyi et al.. 1989).
In 1985, Binart et al. reported that the amino acid sequence 
of chick hsp90 reveals a "DNA-like" structure which may be 
the potential site of interaction with steroid receptors 
(Binart et al.. 1985). They proposed that this region, in 
the absence of hormone, can interact with and "cap" the 
positively charged binding domain of steroid receptors. 
Recently the hormone receptor-hsp90 complex has been 
demonstrated in vitro (Denis and Gustafsson, 1989), 
suggesting that the complex is not merely an artefact of 
homogenisation.
There have been isolated reports of hsp90 associating with 
other cellular proteins including actin (Koyasu et al.,
1986), the halogenated aromatic hydrocarbon receptor (Ah 
receptor) (Perdew, 1988), tubulin (Sanchez et al.. 1988) and 
the heme-sensitive eukaryotic initiation factor-2 kinase 
(Rose et al.r 1989). It has been proposed that hsp90 
functions by binding to newly synthesised proteins and serves 
to move them about within the cell to the membrane or other 
cellular location, possibly holding them in an inactive form 
(Lindquist, 1986). However hsp90 is an abundant protein and 
at least in the chick oviduct cytoplasm only about 1% of it 
is associated in the 8S hormone receptor complex. This begs 
the question, is there a hundred-fold excess to ensure that 
all target proteins will be successfully complexed or does 
hsp90 have another function?
Yeast hsp90
In 1982, Finkelstein et al. showed that the pattern of poly 
(A)+ RNA dramatically changes on heat shock. Using in vitro
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translation of heat shock RNA they demonstrated that a 2.9kb 
RNA codes for hsp90. By differential plaque hybridisation 
using heat shock and Unshocked RNA, heat shock responsive 
genes (including the gene for hsp90) were isolated. The same 
group later went ofi to study the effect of an increased gene 
dosage of HSP90 as supplied on a multicopy plasmid. This 
apparently had no affect other than increasing the level of 
hsp90 oh heat shock (Finkelstein and Strausberg, 1983; 
Finkelstein, 1983).
In 1983 the same group (Farrely et al.. 1983) isolated the 
HSC90 gene (heat shock cognate), whose product is 90% 
homologous to HSP90. They showed that hsc90 is an abundant 
protein under non-stress conditions whose expression is only 
affected slightly by heat shock. Hsp90 from yeast has a 
predicted molecular weight of 81418 Daltons. It is an acidic 
protein, composed of 13.4% glutamate which contains no 
cysteines. It has a novel region of 21 charged amino acids 
with the structure (acid3 lys2 )3 acid4 lys2 . The most 
significant difference between hsp90 and its cognate is that 
hsc90 lacks one of the charged pentapeptide units (Farrely et 
al.. 1983).
In 1984 the entire DNA sequence of the HSP90 gene was 
published (Farrely and Finkelstein, 1984). All the sequences 
for the heat shock regulated expression reside no more than 
273 residues 5' of the transcription origin. By transcript 
mapping it was shown that the hsp90 mRNA carries a 59 
nucleotide 5' untranslated region, a coding sequence of 2130 
bases and a 3' untranslated region of 128 nucleotides. The 
5' end of this gene shows only limited homology with the 
Drosophila HSP83 (HSP90) gene, and the codon useage is not 
random, diagnostic in yeast of an efficiently expressed gene 
(Sharp et al.. 1988)
Is hsp90 actually AMP deaminase?
As stated at the end of the last chapter, when purified AMP 
deaminase-containing fractions were subjected to N terminal 
amino acid analysis, it was found that those of the first 10 
residues which could be determined were identical to the N
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terminal of yeast hsp90 (Farrely and Finkelstein, 1984).
This finding begs the question; are AMP deaminase and hsp90 
the same protein? There are several lines of evidence both 
for and against this hypothesis.
The major fact in favour of the above hypothesis is that AMP 
deaminase activity co-purifies with the hsp90 protein in 
samples apparently containing only a single protein species 
of the appropriate size. Is it likely that AMP deaminase 
would function during heat shock? AMP deaminase (as 
discussed in Chapter 1) has been strongly implicated in the 
stabilisation of the cell's adenylate energy charge. The 
cell must maintain the ratio of ATP to ADP to AMP at a high 
level to remain viable. It seems likely that during heat 
shock the maintenance of the energy charge would play a major 
role in the cells ability to recover, since most cellular 
metabolism must at the very least be perturbed by this form 
of induced stress. Pelham (1985) has suggested, that a major 
physiological effect of heat shock, and possibly the actual 
trigger for the response is the accumulation of denatured and 
aberrant protein. He also suggests that this protein 
aggregate is renatured and reassembled by the action of hsp70 
via the hydrolysis of ATP. If this is case the cellular 
requirement for ATP will be greatly increased. Along with 
this, goes the finding by Findley et al. (1983), that at 
least in two species of Tetrahvmena the cellular ATP 
concentration is reduced by 50% within the first 3 minutes of 
heat shock. It seems possible that the cell, in its attempt 
to recover from this stress, would evolve methods of 
maintaining a high energy charge, both by synthesising extra 
ATP and possibly by removing cellular AMP by the action of 
AMP deaminase as described in Chapter 1. There have been 
several reports of glycolytic genes which are induced during 
heat shock, at least in yeast (Piper et al.. 1986), 
presumably this induction is to allow continued ATP 
production via glycolysis during heat shock. Therefore, it 
is not unlikely that an enzyme which maintains a high energy 
charge might also be induced during heat shock. In addition, 
the AMP deaminase reaction may be useful to the cell in a 
different way during heat shock. There have been a number of 
reports that the pH of the cell is reduced significantly 
during heat shock (Weitzel et al.. 1985 and 1987). This
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major physiological alteration must be restored in some way 
and there is evidence in a number of tissue types that the 
AMP deaminase reaction is one of the major sources of 
cellular ammonia. This increase in the production of ammonia 
may also help the bell to restore its pH to normal.
Another feature which supports the hypothesis that AMP 
deaminase and hsp90 are the same protein is their respective 
molecular weights. Hsp90 from yeast has a calculated 
molecular weight of 81412 (Farrelly and Finkelstein, 1984), 
which is in very good agreement with the apparent molecular 
weight of yeast AMP deaminase at 82000 (Yoshino et al..
1979b). Conversely, this close agreement in size might 
explain why only a single band is resolved on SDS gels in the 
case that the two proteins have simply co-purified.
There is however some strong evidence against the proposed 
hypothesis. There is strong evidence to indicate that a 
homologue of eukaryotic hsp90 exists in E .coli. It seems 
likely that the E .coli heat inducible dnaK gene product is 
functionally homologous to hsp90 in eukaryotes. AMP 
deaminase activity has never been shown in any prokaryotic 
species, and it is widely held that the role AMP deaminase 
plays in the eukaryotic purine nucleotide cycle is played, at 
least in part, by the enzyme AMP nucleosidase (Leung and 
Schramm, 1980). DnaK and the Drosophila hsp83 (hsp90) are 
only 36% homologous, although some regions are up to90% 
homologous. Is it possible that both are AMP metabolising 
enzymes which do not fulfil the same function. This would 
account for regions of homology.
Stronger evidence against the hypothesis exists in the fact 
that hsp90 has been shown to be a glucose regulated protein 
in mammalian cells (Lanks and Kasambalides, 1979;
Kasambalides and Lanks, 1983; Welch et al.. 1983; Craig,
1985). Its synthesis is strongly repressed upon glucose 
starvation. This does not fit in with the theory that hsp90 
is AMP deaminase. During glucose starvation one would expect 
that the importance of a balanced energy charge, as aided by 
AMP deaminase activity, would be more essential than under 
good growth conditions.
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FIGURE 6.2.1 IN VIVO 35S LABELLED YEAST PROTEINS BEFORE AND 
AFTER HEAT SHOCK
0 IS 30 60
205- 1 |
Aliquots of a culture were labelled for 10 minutes with 
[35g]_methionine in GYNB and the proteins were extracted. 
Equal portions of radioactivity were loaded onto each lane of 
a standard 9% SDS polyacrylamide gel. The gel was dried and 
the resulting autoradiograph is shown. Note that the heat 
shock response is confirmed by the production of diagnostic 
heat shock proteins.
Lane designations - the times at which samples were taken for 
AMP deaminase assays following transfer from 23°C to 37°C.
Note: Sample denoted 15 was labelled from T10 to T2q, sample 
denoted 30 was labelled from T25 to T35 etc., as explained in 
section 6 .2 .
Numbers on the left of the gel are the sizes of molecular 
weight standards in kDaltons and the positions of hsps 70, 90 
and 100 are noted at the right of the diagram.
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The largest body of information about hsp90 is with respect 
to its apparent association in the cell with a large and 
diverse number of proteins and cellular components, notably 
with steroid hormone receptors and sarcoma virus transforming 
proteins in vertebrate cells. These associations have led to 
the proposal that hsp90 functions by associating with these 
proteins and shuttling them to different cellular 
compartments. Pelham has proposed that on heat shock the 
cells accumulate aggregates of denatured proteins both in the 
nucleus and elsewhere and that hsp90 is induced to aid the 
disassembly and transport of these complexes (Pelham, 19E5 
and 1986).
Intriguingly, there is some conflicting information about the 
form in which hsp90 normally exists within the cell. 
Apparently most exists as a monomer (Lindquist, 1986).
However two separate reports have indicated that in chick 
oviduct cells the major form has a molecular weight of 
approximately 560 kDa (Schlesinger et al.. 1982) and a very 
recent report puts the major form as a dimer of molecular 
weight of 180 kDa (Radanyi et al.. 1989). This conflicting 
information may give an indication of the nature of hsp90. A 
lot of the complexes studied have been shown to be short 
lived and few have been reconstructed in vitro. Could it be 
that at least some of the reports are simply of artefacts of 
the extraction processes used, and that in actual fact hsp90 
is simply a highly hydrophobic protein which during 
extraction may not maintain its normal physiological form but 
complex, preferentially with other hydrophobic proteins. AMP 
deaminase is apparently a tetramer protein (Murakami, 1979), 
and so presumably there are hydrophobic regions on the 
surface of each subunit, which might account for its possible 
association with other proteins.
6.2 THE EFFECT OF HEAT SHOCK ON AMP DEAMINASE ACTIVITY
Is hsp90 AMP deaminase? In an attempt to answer this 
question, the effect of heat shock on AMP deaminase activity 
in yeast was investigated. To this end mid log cultures of 
strain DBY 747 were heat shocked as described in Chapter 2 
and small portions of the culture were in vivo labelled with
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FIGURE 6.2.2 AMP DEAMINASE ACTIVITY BEFORE AND AFTER HEAT 
SHOCK (23°C - 37°cn
cn
>-h-
> 6A 
5  60
LJ
u. 56
o. 52
I Si
TIME (mins
HEAT SHOCK
TIME AFTER HEAT SHOCK SPECIFIC ACTIVITY
(mins) (nmoles N ^ /mg protein/min)
0 
15 
30 
60
59 +/-2.5 
71 +/-1.0 
74 +/-2.0 
66 + / - 1.0
AMP deaminase determinations were carried out in triplicate 
with a single substrate blank and the figures given are an 
average of these determinations
facing page 125
[35g]_methionine at different times during heat shock to 
confirm that heat shock had occurred. The [35S]-labelled 
protein samples taken'at times, T q , T15, T3q and T60 minutes 
were extracted, into SDS loading buffer (a detailed account 
of this method is given in section 6.5). Portions of these 
labelled samples were counted in a scintillation counter and 
equal amounts of radioactivity were applied to a 9% SDS 
polyacrylamide gel. An autoradiograph of this gel is shown 
in Figure 6.2.1. As indicated hsps 100, 90 and 70 are 
clearly induced in T15 and T3q samples, as well as a number 
of minor species. Most of these changes have reverted by the 
T60 time point as might be expected from a fairly mild heat 
shock to 37°C (Piper et al.. 1988). From this gel it is 
clear that the culture had been successfully heat shocked. 
Protein extracts were prepared from larger portions of the 
culture taken at the same time points and these extracts were 
assayed for AMP deaminase specific activity. The results of 
this experiment are shown in Figure 6.2.2.
As in chapter 3 all AMP deaminase determinations in this 
chapter are the average of three identical AMP deaminase 
assays with a single substrate blank. In this chapter ranges 
are shown and are in agreement with those previously quoted 
(+/- 4%).
As can be seen from these results there is a slight increase 
in the AMP deaminase specific activity for the first 30 
minutes which then recedes by 60 minutes. Hsp90 has been 
reported to be induced ten-fold in heat shocked cultures, 
which correlates well with the result shown in Figure 6.2.1. 
However these findings do not correlate the increase in the 
synthesis of hsp90 with an increase in AMP deaminase 
activity. However, the synthesis of most yeast proteins is 
greatly reduced during heat shock since their mRNAs are no 
longer being transcribed, and this does not seem to be the 
case for AMP deaminase, since its activity is at least 
maintained through heat shock. This discrepancy does not 
rule out the possibility that hsp90 is AMP deaminase. In 
most reported heat shock experiments only changes in protein 
synthesis are examined, not the actual abundances of a 
particular protein species. As discussed in Section 6.1 
yeast, as well as containing a gene for HSP90 which is highly
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FIGURE 6.3.1.1 THE DESIGN OF AN HSP90 GENE SPECIFIC
OLIGONUCLEOTIDE PROBE
-50
HSP90 5'TCATACCTGATAGAAAATAGAGTCCTATAAACAAAAGCACAAA
OLIGO 328 3 1CGTGTTT
1
HSP90 CAAACACGCAAAGAT ATG GCT AGT GAA ACT TTT GAA
OLIGO 328 GTTTGTGCGTTTCTA TAC CGA TCA C 5'
30
HSP90 TTT CAA GCT GAA ATT ACT CAG TTG ATG AGT TTG
60
HSP90 ATC ATC AAC ACC GTC TAT TCT AAC AAG GAA ATT 3 1
The nucleotide sequence presented is the sense strand of the 
HSP90 gene. The nucleotide marked +1 is the putative 
translation origin of hsp90. The nucleotide sequence of 
oligonucleotide 328, which is shown in bold, is complimentary 
to the plus strand, and therefore is also complimentary to 
the mRNA.
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inducible under heat shock, contains the heat shock 90 
cognate gene HSC90, which is only mildly affected by heat 
shock (Farrelly et al:. 1983). The two genes are 90% 
homologous and are therefore probably fulfilling similar 
functions. Together, hsp90 and hsc90 constitute a major 
cytoplasmic protein under,normal conditions. Therefore, 
although the rate of hsp90 synthesis may be induced ten-fold, 
this may not reflect the actual increase in abundance of the 
protein. This experiment was inconclusive in determining 
whether hsp90 and AMP deaminase are one and the same and 
hence the decision was made to study the effects of 
insertionally inactivating the HSP90 gene and studying the 
effect on AMP deaminase activity, before and during heat 
shock. The steps to facillitate this, and the results of 
this experiment are discussed in the rest of this chapter.
6.3 ISOLATING THE HSP90 GENE FROM A YEAST GENOMIC LIBRARY
6.3.1 Designing an oligonucleotide to facilitate HSP90 gene 
isolation
The first step in constructing a strain which is 
insertionally inactivated for HSP90 by the integration of a 
yeast integrating vector is the isolation of the HSP90 gene. 
As stated earlier, the HSP90 gene of S .cerevisiae has been 
cloned and sequenced by Farrelly, Finkelstein and coworkers 
(Finkelstein et al.. 1982; Finkelstein and Strausberg, 1983; 
Farrelly and Finkelstein, 1984). Although a request for this 
gene was made, it was not sent. Figure 6 .3.1.1. shows the 
nucleotide sequence of the HSP90 gene as determined by these 
workers from -60bp upstream of the coding region and 
including the first 30bp of the coding region. Not shown, are the 
transcriptional startand the heat shock consensus element 
(Tuite et al.. 1988) Jfae sequence of the oligonucleotide
synthesised for the purposes of this experiment is shown
in this, figure. The oligonucleotide is a 32mer spanning the 
beginning of the coding region and some of the 5 1 untranslated 
region of the mRNA. The two genes HSP90 and HSC90 are highly 
homologous (Farrelly and Finkelstein, 1984). The sequence of 
the HSC90 gene has not been published but it was assumed that 
because of the differences in expression of these two genes
FIGURE 6 .3.2.1 STRUCTURE OF THE YEp24 LIBRARY (Carlson and
Botstein. 1982)
P0R322
Inserted 
Yeost DNA 
Segments
9 BomHI 
t BomHl/SouZA 
? EcoRl 
T Mndm
Y S2./I 
9 Xbal  
9 Atol
Yeast genomic DNA was partially digested with Sau 3A and 
fragments of greater and equal to lOkb were selected and 
cloned in the the unique Bam HI site of vector YEp24.
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the 5 1 regions was likely to be different. Therefore, this 
part of the sequence was used for the construction of the 
oligonucleotide. It was thought that an oligo hybridising to 
this part of the HSP9Q gene would be less likely to select 
inadvertantly for the HSC90 gene. In addition if the HSC90 
gene were selected it could easily be distinguished from the 
HSP90 gene by sequence analysis of clones using this oligo as 
primer. The oligo was also synthesised to be complementary
to the RNA sequence as well as the DNA, to allow it to be
used in RNA analyses, as well as in the isolation of the 
HSP90 gene. Therefore the sequence of the synthesised
oligonucleotide, named oligo 328 is
5' CACTAGCCATATCTTTGCGTGTTTGTTTGTGC 3 ’
Oligo 328 was synthesised by Dr. V. Math of the Biochemistry 
Department, Glasgow University.
6.3.2 Screening the YEp24 libraries with Oligo 328
Available in this laboratory were aliquots of David Botsteins 
YEp24 yeast genomic library (Carlson and Botstein, 1982) 
transformed into E .coli. This library was made by cloning 
partial Sau3A yeast genomic fragments into the BamHI site of 
the yeast-E .coli shuttle vector YEp24, see Figure 6 .3.2.1.
The inserted fragments were size selected to lOkb and 
greater. The aliquots available represented two separate 
libraries made in parallel experiments (David Botstein, 
personal communication) and are named 378 and 380. Aliquots 
of these libraries were plated on to LB agar + ampicillin.
In total approximately 100,000 colonies were plated per 
library. These plates were grown overnight at 37°C. The 
cells were then scraped off into LB and this cell suspension 
was treated in the usual way to Birnboim-Doly plasmid DNA
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preparation followed by Caesium Chloride density gradient 
centrifugation (see Chapter 2).
Equal amounts of DNA from both libraries were subjected to
restriction endonuclease digestion with Hind III and run on a
/
0.8% agarose gel. Figure 6 .3.2.2.A shows this gel. In lane 
3 is X4003-5B genomic DNA also digested with Hind III, to
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FIGURE 6 . 3 . 2 . 2 SOUTHERN BLOT ANALYSIS OF PLASMID LIBRARIES
378 AND 280 AND X4003-5B GENOMIC DNA
A A/R/H 1 B
21.2 -
3.5-
2.0-  
190 —
158 —  
130 —
0.98- 
0.83 —
0.56 —
A LANE 1 library 378
2 library 380
3 X4C03-5B
B LANE 1 library 378
2 library 380
3 X4003-5B
A Agarose gel (stained with ethidium bromide) of DNA
prepared from YEp24 plasmid libraries 3 78 and 380 and 
X4003-5B genomic DNA, all digested with Hind III (see 
section 6.3.2)
B this represents an autoradiograph of the above gel
Southern blotted and probed with oligonucleotide 328 (See 
section 6.3.2.2 )
A/R/H here and in future figures refers to lambda DNA which 
has been digested  with Eco RI and Hind III to yield fragments 
of the sizes shown on the left of this di agram
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compare the representation of DNA sequences homologous to the 
oligo 328. This gel was subjected to Southern blot analysis 
(see Chapter 2). The radioactive probe used was oligo 328 
which was end labelled with [32P]-dATP with T4 DNA kinase 
(see Chapter 2). The result from this analysis is shown in 
Figure 6 .3.2.3.B . There are approximately equivalent amounts 
of DNA on this gel representing the two libraries, 378 and 
380. It is clear from the Southern analysis that the 378 
library has better representation of the sequences homologous 
to oligo 328. In lane 3 the Hind III digested yeast genomic 
DNA, although not equivalent in amount to the two libraries 
clearly shows that the two libraries have an efficient 
representation of oligo 328 homologous sequences. There is 
in fact 2 to 5-fold less yeast DNA in lane 3 than in lanes 1 
and 2, but it is clear that sequences homologous to oligo 328 
are better represented in lanes 1 and 2, even taking into 
account the lower loading. This lends merit to the use of 
these libraries for screening with oligo 328 to isolate the 
HSP90 gene.
Also worthy of note is the fact that the major bands in the 
Southern analysis for libraries 378 and 380 are not the same 
in the two libraries. In fact both of the two major bands in 
library 378 are substantially larger than the two major bands 
in library 380. The reason for this is unclear. There are a 
number of bands which show up on this autoradiographic 
exposure which are common to the two libraries. Presumably 
although the libraries were made in parallel experiments the 
Sau3A digestions have resulted in the preferential production 
of the strong bands indicated. It is possible that the two 
libraries were made from separate genomic DNA preparations 
which have led to this differential digestion.
For this reason, both libraries were screened. It was 
calculated that 6400 colonies would have to be screened to 
allow a 99% chance of selecting any one sequence, as 
discussed in Section 3.1. To this end plasmid DNAvprepared 
from both libraries as described previously was transformed 
into E .coli strain C1400, by the standard method and plated 
on to LB agar + ampicillin. Of these colonies approximately 
3200 from each library were picked randomly in arrays on to 
LB agar + ampicillin in 10cm square petri dishes. These
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FIGURE 6 .3.2.3 IDENTIFICATION OF PUTATIVE HSP90 CLONES BY
COLONY HYBRIDISATION
Legend: E .coli colonies transformed with library 378 plated
in an array. These colonies were then transferred 
to a nitrocellulose filter, the colonies were lysed 
(see Chapter 2) and the filter was probed using 
oligo 328. A positive clone, is clearly visible.
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arrays were grown overnight and the colonies were lifted on 
to nitrocellulose filters. These filters were transferred 
colony side up to chloramphenicol plates and were incubated 
at 37°C for 8 hours. The filters were then removed and the 
colonies lysed and the DNA fixed as described in Chapter 2. 
After fixing, the filters were wet in 2 x SSC and gently 
rubbed with a gloved hand to remove most of the remaining 
cell debris. The filters were then prehybridised in 20% 
formamide at 37°C, as described in Chapter 2 and end labelled 
oligo 328 was added and allowed to hybridise for 
approximately 24 hours at 37°C. The filters were then washed
and autoradiographed. A typical autoradiograph of one of
these filters is shown in Figure 6 .3.2.3. Colonies giving a
positive reaction with the oligo 328 probe were picked and
stabbed on to a second array, along with several negative 
colonies, including non-insert containing YEp24 
transformants. These colonies were screened in exactly the 
same way as the first screening and 21 positive colonies were 
retained for further analysis. 15 of these clones originated 
from library 378 and 6 from 380. Of the 21 clones, eight had 
given much stronger signals in both rounds of the screening. 
These 21 colonies were grown in small liquid cultures which 
were then subjected to STET plasmid DNA preparation. These 
DNA samples were then subjected to 0.6% agarose gel 
electrophoresis alongside a YEp24 standard. All but one of 
the 20 selected plasmids were of a greater molecular weight 
than YEp 24 and this exception, YEp373.2.3, was discarded 
from further analyses.
6.3.3. Confirmation that selected plasmids contain HSP90 
sequences
To further confirm that the twenty remaining selected clones 
do in fact react positively with the oligo 328, the STET 
prepared DNA was digested to completion with X]ba I and 
subjected to 1% agarose gel electrophoresis. This'vgel is 
shown in Figure 6 .3.3.1.A. Xba I was chosen to digest the 
clones since there is an Xba I fragment of approximately 
700bp that spans the region of the HSP90 gene, to which the 
oligo 328 corresponds, as shown in the map in Figure 6 .3.4.1. 
Note that this 700bp Xba I fragment is frequently used as a
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FIGURE 6.3.3.1 SOUTHERN BLOT ANALYSIS OF PLASMIDS SELECTED
DURING SCREENING OF LIBRARIES 378 AND 380
LANE SAMPLE
1 a/R/h
2 YEp24
3 378.2.1
4 378.2.2
5 378.2.4
6 378.3.1
7 378.3.3
8 378.3.4
9 378.4.1
10 378.4.2
11 378.5.1
12 378.5.2
13 378 .5.3 g  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 1 6 1 7 1 8 19 20 21 22
14 378.5.5
15 378.7.3
16 378.8.1
17 380.1.5
18 380.2.5
19 380.3.1
20 380.4.3
21 380.4.4
22 A/R/H
A Agarose gel of mini-preps of plasmids selected during 
screening of libraries 378 and 380, digested with Xba I
B The gel shown in A, subjected to Southern blotting and 
probed with oligonucleotide 328, the autoradiograph of this 
blot is shown here
Note: A/R/H are molecular weight standards comprising lambda
DNA digested with EcoRI and Hind III Sizes of standards fi 
top to bottom of gel (in kbs) are 21.2, 5.0 (doublet), 4.2. 
3.5, 2.0, 1.9, 1.58, 1.3, 0,98, 0.83 and 0.56,
*
$
22 21 20 19 18 17 16 15 1 4 13 12 11 10 9 6 7 6 5 4 3 2
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probe in other analyses described in this chapter. Therefore 
clones containing this region should produce a 700bp band on 
this gel to which the oligo 328 will hybridise. This gel was 
blotted on to nitrocellulose and probed with oligo 328 as 
previously described. The autoradiograph of this Southern 
blot is shown in Figure 6.3.3.I.B. It is clear from this 
autoradiograph that there are several different families of 
clones within the twenty selected plasmids. These families 
are shown below
Family A : yields a strong, approx 700bp band on this
Southern analysis. Members are 378.2.1; 378.3.4 
and 378.7.3
Family B : yields a strong approx 3.5kb band on this Southern 
analysis. Members are 378.2.1; 378.4.1; 378.5.5 
and 380.3.1
Family C : yields a strong, approx 1.2kb band on this
Southern analysis. Members are 378.5.1; 380.4.4 
and 380.7.1
Family D : yields a weak, high molecular weight band on this 
Southern analysis. Members are378.3.3 and 378.5.3
Family E : yields a weak, approx 3kb band on this Southern 
analysis. Members are 378.2.4; 378.4.2 and 
378.5.2
The remaining five plasmids were discarded because they 
produced little or no signal when hybridised with oligo 328 
on this Southern analysis. Several of the family members 
appeared to be identical, in this and future analyses, for 
instance 378.2.2 and 378.4.1. In fact only nine different 
plasmids remained at this stage. They are listed below in 
their family groups. \
A - 378.2.1 and 378.3.4
B - 378.2.2 and 380.3.1
C - 378.5.1
D - 378.3.3 and 378.5.3
E - 378.2.4 and 378.5.2
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FIGURE 6 .3.4.1 PARTIAL RESTRICTION MAP OF THE 5.5kb Hind III
FRAGMENT ON WHICH THE HSP90 GENE RESIDES
Hh
H y X Be 8 X E
IU U--f
\  / %  eh
* 500 bp1
B - Bgl II 
Be - Bel I 
E - Eco RI 
H - Hind III
Hh - Hha I 
Hp - Hpa II 
X - Xba I
The open bar indicates the location of the HSP90 coding 
region. The filled bars denote sequence encoding the 5' and 
3* untranslated region of the mature HSP90 mRNA. Data taken 
from Farrelly and Finkelstein, (1984)
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It still remained to be confirmed that oligo 328 in this 
diagnostic blot and in the library screening, was actually 
hybridising to the predicted sequence within the HSP90 gene, 
as shown in Figure 6 .3.1.1. Clearly family A, which produce 
a 700bp band to which oligo 328 hybridises on digestion with 
Xba I would appear to be the correct species from the 
previously published sequence (Farrelly and Finkelstein, 
1984). However, the decision was made to obtain some DNA 
sequence data from a member of each family to confirm that 
oligo 328 is hybridising to the expected sequence and which 
if any of the selected clones contain HSP90 specific 
sequence. To this end, a member of each family was subjected 
to dideoxy plasmid sequencing using T7 polymerase (see 
Chapter 2), using oligo 328 as the sequencing primer. The 
plasmids to be sequenced were large, averaging 15kb, and the 
oligo used as primer, at 32 residues was considerably longer 
than 17 residues which has been shown to be optimal for use 
as a sequencing primer (Hattari and Sakaki, 1986). It became 
apparent that the quality and purity of the plasmid DNA was 
of prime importance to allow any sequence to be determined. 
The method of plasmid purification used is described in 
Chapter 2.
From these analyses it was clear that those families to which 
oligo 328 hybridised most strongly, namely A,B and C 
contained sequence identical to the published sequence of 
HSP90 (data not shown). No sequence of members of family D 
could be determined using oligo 328 as primer, despite 
repeated attempts and this analysis yielded unrelated 
sequences from family E. Therefore members of families D and 
E were discarded, leaving only five, HSP90 plasmids for future 
analyses.
6.3.4 Partial mapping of HSP90 clones
\
Since the object of selecting the HSP90 gene was to construct 
a plasmid vector capable of integrating at the HSP90 
chromosomal locus, and thereby disrupting the HSP90 gene, it 
was essential that at least a large portion of the HSP90 gene 
was available for use in the vector construction. Since the 
sequence of the entire HSP90 coding and 5 1 and 3 1 coding
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FIGURE 6.3.4.2 PARTIAL RESTRICTION MAP OF PLASMID YEP378.3.4
3
H - Hind III 
E - Eco RI
The figure shows a partial restriction map of YEp378.3.4.
This plasmid is approximately 16kb, about 8 .3kb of which 
represents yeast genomic DNA (shown as boxed region). Within 
this, the entire HSP90 coding and flanking regulatory 
sequences are located (between asterixed Hind III sites 
(Farrelly and Finkelstein, 1984))
a - according to the map of Finkelstein and Strausberg (1983) 
there are three Hind III sites closely situated in this 
region
b - according to the map of Finkelstein and Strausberg (1983) 
there are two Hind III sites closely situated in this 
region
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regions was known, a restriction map could be produced.
Figure 6 .3.4.1 shows some of the restriction sites within the 
HSP90 gene (Farrelly and Finkelstein, 1984).
To test whether any of the remaining clones contained a 
sizeable part of this sequence, including the entire coding 
region, the plasmids were digested with Hha I and Mlu I.
This should yield a fragment of 2488bp if the entire region 
is present, to which the oligo 328 will hybridise. These 
digested samples were therefore subjected to Southern blot 
analysis as previously described. In this analysis, only 
plasmid YEp378.3.4 yielded a band of approximately the 
correct size (data not shown). To confirm that this fragment 
was the expected one, plasmid 378.3.4 was digested, again 
with MluI and Hhal followed by digestion with several 
enzymes. These digests were subjected to 1% agarose gel 
electrophoresis. The gel was then blotted and probed as 
before. The sizes of fragments, to which oligo 328 
hybridised agreed in each case with what is expected, 
confirming that this 2.5kb Hha I/Mlu I fragment is the 
expected one (data not shown). Clearly plasmid YEp378.3.4. 
does indeed contain at least this region of the HSP90 .gene, 
including the entire coding region. The estimated size of 
this plasmid is approximately 16kb of which approximately 
8.3kb is yeast genomic DNA (YEp 24 is approximately 7.7kb). 
Therefore as well as containing the 2.5kb fragment described 
plasmid 378.3.4 also contains a further 5.8kb of yeast 
genomic DNA. A partial map o£ YEp378.3.4 is shown in figure 
6 . 3 . 4 . 2 .
6.4 CONSTRUCTION OF A YEAST INTEGRATING VECTOR TARGETED AT 
HSP90
6.4.1 Introduction
\
Since the demonstration by Hinnen et al. (1978) th a t  
S .cerevisiae can be transformed with DNA via homologous 
recombination between the transforming DNA and the yeast 
chromosome, this method has been used in a number of 
analyses. In most cases these integrations occur only at the 
chromosomal position represented in the integrating vectors.
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FIGURE 6 .4.2.1 STEPS IN THE PRODUCTION OF A Yip VECTOR TO
INSERTIONALLY INACTIVATE THE HSP90 GENE
digested with ^uytf^ieu i ii i_________
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digest with Hind 111 
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digested pUC8
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PHSP90-37
digest with Xba
Klenow-fill
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pHSPUR 22
Not to scale 
Be - Bel I 
Hp - Hpa II
digest with Bgl I 
and Hind II! 
tor transformation
YEAST TRANSFORMATION
H - Hind III 
X - Xba I
B - Bgl II
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. Exceptions to this, where the vector integrates at a low 
frequency at other chromosomal locations can be explained by 
the presence of repeated sequences on the plasmid used 
(Kingsman et al.. 1979).
The frequency of integration at a particular site is at least 
somewhat proportional to the length of the homologous 
sequence so that manipulation of sequence lengths can give 
some direction to the integration process. Increased 
direction of integration can also be achieved by cleavage of 
the vector in the sequence homologous to the target site.
The free ends that are generated are increased in their 
recombinogenic potential (Orr-Weaver et al.. 1981).
6.4.2 Subclonina the HSP90 gene into pUC 8
To facilitate the production of a Yip vector the sequence 
which is desired to target the integration must be isolated. 
To allow the construction of the intended integrating vector, 
the first step was to subclone HSP9Q sequence into a suitable 
vector. The E .coli multicopy cloning vector pUC8 was chosen 
for this purpose. The vector allows colorimetric selection 
for recombinant plasmids (via Lac__Z) and rapid plasmid 
amplification and purification.
The cloning strategy used, was designed to use two different 
restriction sites at opposite ends of the HSP90 insert which 
could be cloned into complementary sites in pUC 8 . The sites 
chosen, within the HSP90 gene were Bel I at position 385 and 
Hpa II which cuts twice, at positions 2293 and 2415.
Therefore the subcloned HSP90 fragment would span 385 to 2293 
which was cloned into the Bam HI and Acc I sites in pUC8 , as 
shown in Figure 6 .4.2.1.
The enzyme Bel I is sensitive to dam methylation, that is 
where adenosine residues are methylated by the E .coli enzyme 
dam methylase. DNA, purified from E .coli strains which have 
an active dam methylase, containingythe target sequence for 
the Bel I enzyme cannot be digested by the enzyme. Therefore 
to allow digestion of 378.3.4 with this enzyme, the plasmid 
had first to be transformed into and reisolated from an
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E.coli strain which is mutant for the dam gene. YEp378.3.4 
was transformed into the dam" strain, CB51 (see Chapter 2). 
Transformation efficiencies were extremely low for this 
plasmid into this strain. The reason for this is not clear. 
The plasmid was re-isolated by standard Birnboim-Doly plasmid 
preparation.
The pUC 8 vector was prepared by digestion with Acc I and Bam 
HI, followed by gel purification by the gene clean method 
(see Chapter 2). This was done primarily to remove the small 
fragment cleaved from the polylinker by digestion with these 
two enzymes, to prevent its reinsertion during ligation. The 
HSP90 insert was prepared by firstly digesting plasmid
378.3.4 with Bel I and Hpa II. This digested DNA was applied 
to agarose gel electrophoresis, and the 1.9kb band was cut 
out of the gel and also purified by gene cleaning (see 
Chapter 2). Digestion of 378.3.4 with Bel I and Hpa II 
results in the production of at least 6 fragments of varying 
sizes, the largest of which is approximately 1.9kb and the 
next largest between 1.5 and 1.6k b .
This purified material was mixed with prepared pUC 8 vector 
and ligated in the standard manner at 16°C overnight (See 
Chapter2). This material was then transformed into E .coli 
strain, DS902. Forty white transformants were subjected to 
STET DNA preparation to allow identification of plasmids 
containing the correct insert by means of several diagnostic 
restriction digestions. In this way a plas^dd was isolated 
which contained the correct HSP90 sequences. This plasmid 
was named pHSP90.37.
6.4.3 Inserting the URA3 gene into the coding region of the 
HSP90 aene
Yeast insertional vectors target the insertion^of the vector 
at a chromosomal region homologous to that within the vector, 
as discussed in Section 6.4.1. In this case, the vector 
under construction was to be targeted to the yeast HSP90 
gene. For two reasons this vector, which was intended to 
inser.tionally inactivate the chromosomal locus of HSP90, must 
also contain a yeast auxotrophic marker. Firstly the marker
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can allow for selection of transformants over untransformed 
yeast cells by growth on selective medium, following the 
transformation process. Secondly, since the intention of 
these experiments is to produce a yeast strain with an 
inactive HSP90 gene brought about by the insertion of the 
vector at the targeted chromosomal locus by homologous 
recombination between the vector and the targeted chromosomal 
locus, the vector must contain a homologous gene which has 
been made functionally inactive. The most simple way of 
constructing such a vector is to insert a fragment of DNA 
into the coding region of the gene used for targeting. It is 
therefore convenient that this piece of DNA used to mutate 
the gene of interest should also contain the required 
autosomal marker.
It was intended that the yeast strain to be used in these 
analyses should be the same one from which the AMP deaminase 
enzyme was purified, X4003-5B. This strain has a number of 
auxotrophic mutations, which allowed a choice of marker 
genes. The gene chosen was URA3 . URA3 can be isolated on a 
l.lkb Hindlll fragment from a number of plasmids available in 
this laboratory (Rose et al.. 1984). This fragment was to be 
subcloned within the coding region of the HSP90 gene located 
in plasmid pHSP90.37. Unfortunately there is no suitable 
restriction site within the HSP90 coding sequence to allow a 
forced cloning of the Hind III fragment. Instead, the URA3_ 
bearing fragment was blunt ended and cloned into a unique 
site in pHSP90.37. This strategy is shown in Figure 6 .4.2.1.
To this end, the plasmid pHSP90.37 was digested with Xba I. 
Since a small piece of the polylinker of pUC 8 , carrying the 
Xba I site was lost during the production of pHSP90.37, Xba I 
no longer cuts within the vector sequences of pHSP90.37. It 
does however cut within the coding region of HSP90 at 
position 799 and this is the only Xba I site.in pHSP90.37.
The ends of the Xba I digested pHSP90.37 were ^:hen filled 
with Klenow and phosphatased using Calf Intestinal’ 
Phosphatase (See Chapter 2).
V
r
The URA3 gene to be inserted was isolated f r o m U R 2 , see 
Figure 6 .4.2.1. pSv UR2 was digested with Hind III and then 
Klenow filled to yield blunt ended molecules and the -l.lkb
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FIGURE 6.4.5.1 FRAGMENTS EXPECTED IN GENOMIC SOUTHERN BLOT
ANALYSES OF X4003-5B AND X4003-22 GENOMIC DNA
HSP90 CHROMOSOMAL 
LOCUS IN STRAIN 
X4003-5B
I
H E  H
I 1___________L
HSP90
5-6  kb
3-Bkb
H H 1
HSP90 CHROMOSOMAL 
LOCUS IN STRAIN 
X4003-22
H
1
H
HSP90 URA3 HSP90
4-4 kb
H
6-7 kb
Fragments that will be yielded in genomic Southern blot 
analysis using an HSP90-specific probe, if insertion of Yip 
vector has occurred as predicted.
E = Eco RI 
H = Hind III
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fragment was gel purified. This DNA was then ligated in 
the standard reaction with the end-filled and phosphatased 
pHSP90.37 at room temperature for five hours. The ligation 
mix was then transformed into E .coli strain C1400. Since the 
pUC8 LacZ gene was already inactivated by the insertion of 
the HSP90 sequences, a blue/white selection on Xgal medium 
was not possible. Forty transformants were subjected to STET 
DNA preparation followed by restriction analysis, and in this 
way a plasmid with the URA3 gene correctly inserted was 
isolated. This plasmid was named pHSPUR22. It was not known 
in which orientation the URA3 Hind III fragment had inserted, 
but this was not examined since the l.lkb Hind III fragment 
used to provide the URA3 gene contains all flanking sequences 
required for expression of the gene, and therefore 
orientation of the fragment should not affect its expression.
6.4.4 Transformation of yeast strain. X4Q03-5B with 
integrating vector pHSPUR22
Integrative transformation into yeast is much less efficient 
than transformation with an episomal vector. Whereas one 
might expect to get in the region of 103 transformants/ug DNA 
with an episomal vector, this figure is reduced to about 1 - 
10 transformants/ug DNA with an integrating vector.
Therefore, a 50ul aliquot of X4003-5B spheroplasts produced 
in the standard method of yeast transformation (see Chapter 
2) was mixed with lOug of pHSPUR22 digested to completion 
with Bgl II and Hind III (Figure 6.4.2.I.). These mixture 
was then treated and plated in the normal manner on to soft 
agar medium containing the necessary amino acid supplements 
(in this case adenine, leucine, histidine, methionine and 
tryptophan each at a concentration of lOOug/ml).
The selectable marker for pHSPUR22 is URA3, hence anything 
growing on these selective plates should be transformants.
The transformation plates were incubated at 30°C for 4 days. 
At the end of this time, a number of transformants were 
streaked on to YPG plates to obtain/single colonies. A 
single colony was then patched on to selective plates to 
confirm that the correct genotype had been maintained. The 
transformation efficiency was in the region of those
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FIGURE 6.4.5.2 AGAROSE GELS OF GENOMIC DNA OF STRAINS
X4003-5B AND X4Q03-22 DIGESTED WITH Eco RJ 
OR Hind III
B
1 2 3
LANE
1 A/R/H
2 X4003-5B/Hind III
3 X4003-22/Hind III
B LANE
1
2
X4003-5B/Eco RI 
X4003-22/Eco RI
A/R/H molecular weight sizes are as shown in Figure 6 .3.2.2
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expected. A single transformant with the correct genotype 
was retained for future use and this strain was named X4003- 
22.
6.4.5 Confirmation of the integration of PHSPUR22
It was necessary at this stage to confirm that insertion of 
the integrating vector had occurred as predicted. The 
classical way to confirm that an introduced, auxotrophic 
marker such as URA3 has integrated at a novel and predicted 
position in the yeast genome is to study its behaviour in 
genetic crosses with respect to other marker genes. That is, 
the auxotrophic marker should now be linked to genes which 
are linked under normal conditions with the site of 
integration. This would have been difficult to do in this 
instance since the chromosomal location of HSP90 is not 
known. To confirm the position of integration it was decided 
to use Southern blot analysis of the genomic DNA from the 
control strain and X4003-22. The strategy behind this 
analysis is shown in Figure 6 .4.5.1.
A restriction enzyme which cuts outwith the gene of interest 
will produce a single band of a specific size on an 
autoradiograph of a Southern blot analysis of genomic DNA 
digested with the enzyme in question, when a probe specific 
the the gene in question is used. If an integration event 
has occurred within this gene (in this case, the URA3 gene 
borne on pHSPUR22), the same restriction enzyme will produce 
in the same Southern blot analysis, a band which is bigger 
than that seen for the control strain (assuming the enzyme in 
question does not cut within the auxotrophic marker gene).
The increase in size in this case will be l.lkb (the size of 
the URA3 gene-bearing fragment).
Thus, to confirm the integration of pHSPUR22 at' the correct 
chromosomal position, genomic DNA was prepared from X4003-5B 
and X4003-22. This DNA was then digested both with Eco RI 
and Hind III in separate digestions^and then subjected to 
0.8% agarose gel electrophoresis. ’ The gels of these digests 
are shown in Figure 6 .4.5.2. These gels were blotted on to 
nylon membranes and fixed and prehybridised in 20% formamide
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FIGURE 6 . 4 . 5 . 3 SOUTHERN BLOT ANALYSIS OF GENOMIC DNA FROM
STRAINS X4003-5B AND X4003-22
A 2 3 B
6-7 kb 
5-6 kb -4-4 kb “ 3-3 kb
Lane 1 A/R/H B Lane 1 X4003-5B/Eco RI
Lane 2 X4003-5B/Hind III Lane 2 X4003-22/Eco RI
Lane 3 X4004-22/Hind III
The calculated sizes of the major band in each lane is given 
to the right of each picture.
A Southern blot of gel shown in figure 6 .4.5.2A probed with 
a 700bp Xba I fragment from the HSP90 gene
B Southern blot of gel shown in figure 6.4.5.2B probed as 
above
In the two Southern blot analyses shown the major band 
detected, using a HSP90 -specific probe was approximately 
l.lkb larger in strain X4003-22 than X4003-5B as was expected 
if the integration of pHSPUR22 had occurred as predicted (see 
figure 6.4.5.1). The probe used was a random primed 700bp 
Xba I fragment from the HSP90 gene (see figure 6.3.4.1).
Other bands were also detected in these analyses, using this 
probe, but in most cases these bands were common to both 
strains and their nature was not investigated further
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at 37°C. The probe used was a gel purified 700bp Xba I 
fragment derived from YEp378.3.4, which was random primed to 
a specific activity of approximately 10^cpm/ug DNA (see 
Chapter 2). Probing with end labelled oligo 328 failed to 
give clear results, since there was a high degree of non­
specific binding (data not shown).
Eco RI cuts the HSP90 gene at position 1543 and at -1820bp 
upstream of the AUG (Szent-Gyorgi et al.. 1987). Therefore 
when genomic DNA is digested with Eco RI, a probe specific to 
the 5 1 end of the HSP90 gene (such as the Xba I fragment, 
described above) should hybridise to a fragment of 3363bp.
Eco RI does not cleave within the l.lkb URA3 fragment, 
therefore if insertion has occurred as expected DNA from 
strain X4003-22 treated in the same way, should yield a 
fragment of 4463bp.
Similarly, Hind III cuts outwith the entire HSP90 gene 
(Farrelly and Finkelstein, 1984). Using this enzyme the 
entire gene and its necessary flanking regions can be 
isolated on a 5.6kb fragment. Neither does this enzyme cut 
within the URA3 fragment, therefore an HSP90 specific probe 
should hybridise to a 5.6kb and 6 .7kb band on Southern blot 
analysis of strains X4003-5B and X4003-22 respectively using 
the restriction enzyme, Hind III.
These Southern blots are shown in Figure 6 .4.5.3. Clearly, 
these results are in complete agreement with the predictions 
in the case of integration of pHSPUR22 at the HSP90 locus.
To further confirm that the insertional inactivation of HSP9Q 
has occurred, RNA was prepared from mid-log cultures of 
X4003-5B and X4003-22 as described in Chapter 2. To allow 
analysis of the overproduction of hsp90 on AMP deaminase 
activity, the control strain, X4003-5B was transformed with 
pYEp378.3.4. This is a multi-copy vector bearing the entire 
HSP90 gene (see section 6.3). Therefore, RNA was a’lso made 
from this strain named X4003-3.4. The RNA was purified by 
spinning through a caesium chloride^cushion, and the
resulting pellet was resuspended in water. The absorbance at
/
260nm was measured, and equivalent amounts of RNA were 
applied to a formaldehyde/MOPS agarose gel (Chapter 2). This
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FIGURE 6.4 . 5.4 NORTHERN BLOT ANALYSIS OF RNA FROM STRAINS
X4003-5B, X4003-22 AND X4003-3.4
2 -
3-
Equal amounts of RNA were applied to each lane of a 
denaturing formaldehyde gel and blotted onto a nylon membrane 
which was then probed with a random primed 700bp Xba I 
fragment from the HSP90 gene (see figure 6.3.4.1).
From this analysis it was apparent that strain X4003-22 was 
not producing a mRNA corresponding to HSP90. It would also 
appear that strain X4003-3.4 has a higher amount of this same 
mRNA, confirming X4003-22 as a strain lacking a functional 
HSP9Q gene and X4003-3.4 as a strain containing an increased 
number of copies of the HSP90 gene.
Other bands are apparent in this Northern blot analysis. 
Attempts at more stringent washing of the filter failed to 
remove them. It was thought likely that the bands indicated 
on the left of the picture as 1 and 2 represent the 25S and 
18S ribosomal RNAs, respectively. These two bands are common 
to all three strains in this analysis. It is possible that 
the band indicated as 3 may represent a truncated mRNA 
produced by the HSP90/URA3 integrated gene visible only in 
the lane representing X4003-22 RNA. This was not 
investigated further.
5B 22 3.4
IBM
• •5 -hsp90
-
i
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gel was blotted on to nylon membrane and probed with random 
primed Xba I fragment of p378.3.4., as described elsewhere. 
The resulting autoradiograph of this Northern blot is shown 
in Figure 6 .4.5.4. Clearly, there is a high degree of non­
specific binding in this analysis which could not be removed 
by prolonged washing. The nature of this hybridisation was 
not examined. It is however clear from this analysis, that 
X4003-22 no longer produces a functional hsp90 mRNA and that 
X4003-3.4 appears to produce a higher basal level of hsp90 
mRNA. From this evidence it was clear that X4003-22 and 
X4003-3.4 represent strains with no functional hsp90 and an 
increased level of hsp90, respectively.
6.5 THE EFFECT OF LOSS AND OVERPRODUCTION OF HSP90 ON AMP 
DEAMINASE ACTIVITY
If hsp90 and AMP deaminase are the same protein then by 
inactivating the HSP90 gene, one would expect to see a 
reduction in AMP deaminase activity. This statement is 
complicated by the fact that in yeast there is also the heat 
shock cognate 90, HSC90 gene, which is highly homologous to 
HSP90. and that presumably their proteins are fulfilling 
similar functions. Hsc90 is abundantly expressed in normal 
cells, and little affected by heat shock (Farrelly et al., 
1983). Hsp90 on the other hand is strongly induced by heat 
shock. The two genes are fulfilling an essential function in 
the cell, since strains with mutations in both genes are not 
viable. Mutations in one or other gene have no apparent 
effect on the viability of the cell (Lindquist, 1986). We 
have shown in the previous section that yeast strain, X4003- 
22 has been insertionally inactivated at the HSP90 locus, but 
it is known, because of the lethal nature of the double 
mutation, that the HSC90 gene must be intact and normal. If 
we assume that hsp90 and AMP deaminase are the. same, then 
hsc90 should also produce AMP deaminase activity. Presumably 
at normal temperatures hsc90 accounts for the largest 
proportion of the activity, with hsp90 accounting for only a 
small proportion. If this is the case, a strain which is 
mutated in the HSP90 gene would be expected to have similar 
AMP deaminase specific activities at the normal temperature, 
but upon heat shock, the mutated.strain cannot induce hsp90
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synthesis, and therefore will have less AMP deaminase 
activity than the control strain. Similarly, a strain 
overproducing hsp90 (due to multiple copies of the gene), 
should have a slightly greater basal level of AMP deaminase 
activity, which will become much greater than the control 
strain upon heat shock.
To test whether this hypothesis is correct, strains X4003-22 
and X4003-3.4 have been constructed and an experiment was 
set up to measure the AMP deaminase specific activity of 
these strains, along with the control strain X4003-5B,before 
and after heat shock.
To this end, cultures of X4003-5B, X4003-22 and X4003-3.4 
grown in GYNB with the necessary growth supplements were set 
up and grown at 23°C to mid-log and an absorbance at 600nm of 
0.5-0.55. To confirm that heat shock has occurred in each 
case, small samples of each culture were in vivo labelled 
with 35S-methionine to allow the production of the 
diagnostic heat shock gels. These denaturing protein gels 
are autoradiographed and the labelled bands which are exposed 
represent newly synthesised proteins. If heat shock has been 
successful, samples taken after heat shock should show the 
synthesis of novel proteins, the hsps, relative to the 
control sample. Yeast heat shock gels are far less dramatic 
than those obtained from Drosophila cells, since normal 
cellular proteins are still being synthesised as explained in 
Section 6.1. The experiment was carried out thus. A 100ml 
portion of the culture was removed, and lOOmls of GYNB and 
the necessary growth supplements at 23°C were added. This 
dilution step was carried out because the rapid heat shock to 
37°C was achieved by the addition to the culture of an equal 
volume of GYNB and the necessary growth supplements at 51°C. 
Therefore the control sample must be treated in the same way 
with the exception that the added media was at 23°C. 1.0ml
of this dilution was removed to a plastic microfuge, it was 
then spun briefly in a microfuge at room temperature, the 
supernatant was removed and the cell pellet resuspended in 
lml of GYNB and the necessary growth supplements (without 
methionine). In this lml of media was 25jaCi of 33S 
methionine. This mixture was then incubated for 10 minutes 
at 23°C. At the end of this incubation, lOO^il of methionine
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FIGURE 6 . 5 . 1 .A IN VIVO 35S LABELLED PROTEINS FROM STRAINS
X4003-5B. X4003-22 AND X4003-3.4 BEFORE AND
AFTER HEAT SHOCK
X 4 0 0 3 - 5 B  X4003 -22 X 4 0 0 3 -3 .4
0 15 30 60 0 15 30 60 0 15 30 60
Aliquots of a culture were labelled for 10 minutes with 
[ S ]-methionine in GYNB and the proteins were extracted. 
Equal portions of radioactivity were loaded onto each lane of 
a standard 9% SDS polyacrylamide gel. The gel was dried and 
the resulting autoradiograph is shown. Note that the heat 
shock response is confirmed by the production of diagnostic 
heat shock proteins.
Note: Samples denoted 15 were labelled from T-^ q to T£q» 
samples denoted 30 were labelled from T 25 to Tgg etc., as 
explained in section 6 .5.
Lane designations - the times at which samples were taken for 
AMP deaminase assays following transfer from 23°C to 37°C.
Numbers on the left of the gel are the sizes of molecular 
weight standards in kDaltons and the positions of several 
heat shock proteins, including hsp90 are noted at the right 
of the diagram.
Note: hsp90 is induced upon heat shock of X4003-5B, and over­
induced (with respect to other cellular proteins) in X4003- 
3.4. However, hsp90 does not appear upon heat shock of 
X4003-22.
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(lOmg/ml) was added and the mixture was placed on ice prior 
to extraction. This treatment of spinning and resuspending 
the cells in media lacking methionine was necessary to allow 
the incorporation of 35S methionine into newly synthesised 
proteins. All three strains used in this experiment are 
methionine auxotrophs, and therefore require media 
supplemented with methionine for growth. Under these 
conditions 35S methionine labelling is extremely inefficient 
(data not shown) and to increase the efficiency, the 
methionine-containing media has to be removed and replaced 
with media containing no added methionine as described here. 
The harvesting of yeast cells by centrifugation and 
resuspension has been shown, in this and other laboratories, 
not to induce the production of stress proteins (data not 
shown; Sorger et al.. 1987b). The remainder of the 200ml 
sample was centrifuged at 10000 x g for 5 minutes and then 
the supernatant was removed. The cell pellet was then 
chilled on liquid nitrogen and stored at -20°C till required.
The rest of the culture had an equal volume of GYNB and the 
necessary growth supplements (pre-equilibrated at 51°C) added 
rapidly and from then the culture was incubated at 37°C. The 
temperature of the culture was thus changed to 37°C 
immediately on addition of the hot media. At 15, 30 and 60 
minutes after this heat shock 200ml samples were taken for 
protein extraction. The samples were harvested and frozen as 
described for the T q sample. lml samples of the heat shocked 
culture were removed and labelled as described before with 
the exceptions that the 33S methionine containing media had 
been pre-equilibrated at 37°C and the ten minute incubations 
were carried out at 37°C. These samples were taken and 
incubated at times, T10_2o/ T25-35 and T55-65 respectively.
The labelled protein extracts were then treated thus. The 
samples were spun for 2 minutes in a microfuge, the cell 
pellet was washed once with distilled water anct' resuspended 
in 200pl SDS sample buffer. Glass beads were added till no 
fluid remained, and the samples were vortexed for 30 seconds, 
three times, resting on ice between/each vortex. 200jul SDS 
sample buffer was added, the mix was briefly vortexed and the 
supernatant was removed. This material was spun in a 
microfuge for two minutes to remove cell debris, and the
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FIGURE 6.5.1.B
X 4 0 03 -3 .4  
0 15 30 60
- h s p 9 0
This photograph represents a longer exposure of the same gel 
detailed in figure 6 .5.1.A. All the details pertaining to 
this figure have been previously indicated.
Note: there is clearly a massive over-production of hsp90
(relative to other cellular proteins) in strain X4003-3.4.
X4003-5B X4003-22
200-
92-5-
69-
0 15 30 60 0 15 30 60
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supernatant was removed to a fresh tube. Aliquots of these 
samples were counted for radioactivity in a scintillation 
counter, and then the samples were heated to 100°C for 5 
minutes, and then spun for 2 minutes. Equal counts for each 
sample were then applied to a standard 7.5% SDS 
polyacrylamide gel along with *^C protein standards. The gel 
was dried and autoradiographed. This autoradiograph is shown 
in Figure 6 .5.1.A. Clearly for each of the three strains 
heat shock has occurred. Time points T15 and T30 clearly 
show the synthesis of new proteins. Most of these changes 
have reverted to normal by T60. This is in line with the 
finding of Sorcrer et al.. (1987), who showed that a transient 
heat shock in yeast lasts no longer than one hour.
In this gel, the band corresponding to hsp90 is clearly 
recognisable. In Figure 6.5.l.B this region of the gel is 
shown in greater detail. Hsp90 is quite clearly induced in 
the control strain, X4003-5B across the time of the heat 
shock. In stark contrast is the protein profile for X4003-22 
where the band corresponding to hsp90 is apparently 
completely absent, again confirming successful inactivation 
of the hsp90 gene. X4003-3.4 shows clear induction of hsp90 
to a greater level than with the control strain. This is to 
be expected in a strain carrying multiple copies of the gene.
Clearly, heat shock has occurred in all three strains. The 
protein extract pellets were therefore extracted thus. The 
frozen pellets were thawed into ice cold 50mM potassium 
phosphate buffer, pH7.5, the cells were re-harvested and 
resuspended in lml extraction buffer. Glass beads were added 
to this cell suspension till no fluid remained. This mix was 
then vortexed three times, for 30 seconds each time, with 
incubation of ice between each vortex. Another lml of 
extraction buffer was added and the mix vortexed briefly and 
the supernatant removed. The supernatant was. then spun in a 
microfuge for 5 minutes to remove cell debris and the 
supernatant was removed to a fresh tube. lOOul of'this 
extract was then added to standard 200ul AMP deaminase 
reaction mixes and incubation at 37^C was carried out for 30 
minutes. At the end of this time a lOOul sample was removed 
from this reaction mix and assayed for ammonia production in 
the standard way (addition of 0.33ml reagent 1, followed by
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FIGURE 6.5.2 AMP DEAMINASE ACTIVITIES IN STRAINS X4003-5B.
X4003-22 AND X4003-3.4 BEFORE AND AFTER HEAT 
SHOCK
e40
C71
>24,
-Ht-—
<16
3015 60
TIME (minsHEAT SHOCK
5B •--------------• 22     34
AMP deaminase determinations were carried out in triplicate 
and the figures given are an average of these determinations. 
Also shown in this figure are the errors produced by the 
assay system.
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0.5ml each of reagents 2 and 3). Each sample was assayed in
triplicate in this way. Included with each set of assays was
a substrate blank reaction. The same protein extracts were 
also subjected to standard Bradford protein assays and the 
AMP deaminase specific activity was calculated. The results 
of this experiment is shown in figure 6.5.2.
From these results it is clear that a similar pattern of AMP 
deaminase activity is seen in strain X4003-5B here, as was 
seen in Figure 6.2.2. However the pattern of AMP deaminase 
activity in strains X4003-22 and X4003-3.4 during heat shock 
do ndfagree with those predicted above if hsp90 and AMP 
deaminase are the same. It was hypothesised that if AMP
deaminase and hsp90 are the same, the mutation of the HSP90
gene would result in little difference in AMP deaminase 
activity prior to heat shock, but that the inactivated strain 
would have greatly reduced AMP deaminase activity after being 
heat shocked. Clearly strain X4003-22 does have a slightly 
lower basal level of AMP deaminase specific activity than 
X4003-5B but after heat shock the pattern of AMP deaminase 
activity is very similar (i.e. there is no dropping off of 
AMP deaminase activity in X4003-22 as predicted if AMP 
deaminase is hsp90). Similarly, one would predict that, if 
AMP deaminase is hsp90 a strain bearing multiple copies of 
the HSP90 gene would have a slightly elevated AMP deaminase 
activity prior to heat shock and considerably more AMP 
deaminase activity after heat shock. Clearly this is not the 
case in this experiment. The strain bearing multiple copies 
of the HSP90 strain has been shown to synthesise elevated 
levels of hsp90 protein during heat shock (Figure 6.5.1) but 
there is not a concomitant increase in AMP deaminase 
activity. Small differences in specific activities can be 
explained by slightly different growth conditions in the 
three different cultures used. However, the overall changes 
in the pattern of AMP deaminase activity predicted in these 
strains during heat shock are clearly not seenN It therefore 
seems clear that hsp90 and AMP deaminase are not the same 
protein.
143
FIGURE 6.6.1 SOUTHERN BLOT ANALYSIS OF PLASMIDS SELECTED
FROM COLONY SCREENING WITH OLIGONUCLEOTIDE 328 
PROBED WITH A RAT AMP DEAMINASE cDNA
LANE
1
2
3
SAMPLE
A/R/H
pBSAMPD A
4
5
YEp24 1 
378.2 . 2 l
6 378. 2.4C
7 3 78.3. ij
8 378.3.3*
9 3 78.3. 4H
10 378.4. l B
11 3 78.4.2 B
12 378.5.l B
13 A/R/E B
14 378.5.2 B
15 378. 5. 3 K
16 378.5.5 C
17 378. 7. 3 E
18 3 78.8. l B
19 380.1. 5 H
20 380.2.5 H
21 380.3.l B
22 380.4.3*
23 380.4.4*
24 380.7.l B     1
13 1415 16 171819 20 21 22 23 24
A agarose gel of pBSAMPD and plasmids which had been
selected by colony hybridisation as described in section 
6.3 (i.e during screening for HSP90-containing plasmids). 
All are digested with Eco RI (see section 6.6)
Note: only approximately 20ng of plasmid pBSAMPD digested
with Eco RI was loaded in lane 2, not visible on 
photograph
B Southern blot analysis of gel shown in A probed with a
2.5kb Eco RI fragment comprising a rat skeletal muscle AMP 
deaminase cDNA (from pBSAMPD). This fragment was gel 
purified twice and [ P]-labelled by random priming.
Note: Hybridisation was carried out at low stringency
(37°C with hybridisation solution containing 20% 
formamide).
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6.6 PROBING OF HSP90 SELECTED PLASMID WITH A RAT AMP
DEAMINASE cDNA CLONE
Towards the end of 1987, there was a report of the cloning of 
a rat myoadenylate deaminase cDNA (Sabina et al., 1987). Dr. 
Sabina kindly sent us this clone, to help in our analyses.
The clone was in plasmid bluescribe, and the AMP deaminase 
insert could be removed on a 2.5kb Eco RI fragment. This 
plasmid is called pBSAMPD. Sabina et al. had used this clone 
to probe genomic digests from a wide variety of sources 
including yeast. They had shown that at low stringencies a 
single Bam HI fragment of yeast genomic DNA, to which the rat 
cDNA probe hybridised to, was visible on a Southern blot.
This band disappeared at higher stringencies. When we 
recieved this clone, the selection of HSP90 clones was 
already in progress, and the decision was made to use this 
cDNA as a'probe against the selected YEp plasmids discussed 
in Section 6.3. To this end, the YEp clones were digested 
with Eco RI and run on a 1% agarose gel, along with Eco RI 
digested pBSAMPD. This gel is shown in Figure 6 .6.1.A. The 
gel was blotted and prehybridised with 20% formamide at 37°C. 
The probe used was the 2.5kb Eco RI cDNA fragment from 
pBSAMPD which had been random primed to a specific activity 
of approximately 109cpm/pg DNA. This insert had been twice 
gel purified to eliminate any contaminating plasmid based 
DNA. The blot was washed at very low stringency, 6 x SSPE, 
0.1% SDS at room temperature. The filter was then 
autoradiographed. This autoradiograph is shown in Figure 
6 .6 .I.B. Clearly the only thing which the probe hybridises 
to is itself. Even after prolonged exposure no other 
hybridisation was visible.
6.7 CONCLUSIONS
Described in this chapter is the work entailedNln answering 
the question asked at the end of the last chapter. ’' Are AMP 
deaminase and hsp90 the same protein?
yr
The first experiment carried out was the heat shocking of 
yeast and the assaying of the resulting AMP deaminase 
activity. As indicated in Section 6.2 the result of this
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experiment was inconclusive. AMP deaminase activity was 
maintained and in fact induced slightly for at least the 
first 30 minutes of heat shock (See Figure 6.2.2).
The decision was made to insertionally inactivate the HSP90 
gene by transforming a yeast strain with an integrating yeast 
vector targeted to the HSP90 chromosomal locus. The stages 
in the production of this vector are described and 
integration was achieved. This was confirmed by Southern and 
Northern blot analyses and later on by heat shock protein 
gels.
This constructed strain along with a control strain and the 
control strain transformed with a multicopy yeast plasmid 
carrying the HSP90 gene and all the sequences necessary for 
its heat shock-specific expression were heat shocked and 
their AMP deaminase activities were studied. The results 
show that inactivation or overproduction of hsp90 have little 
effect on AMP deaminase activity either prior to or during 
heat shock. This is conclusive evidence that hsp90 is not 
AMP deaminase.
This finding begs the question of why in AMP deaminase 
purified protein samples does there appear to be only one 
protein species of the appropriate size. Hsp90 and AMP 
deaminase from yeast are of very similar sizes (Farreily and 
Finkelstein, 1984; Murakami, 1979). If the two proteins have 
coincidentally co-purified, they may have run as a single 
band.
But why, if this is the case, was there no indication of two 
proteins during amino acid sequence analysis. The determined 
sequence was compatible with only one polypeptide being 
present (John Fitton, personal communication). One answer to 
this is that AMP deaminase is N terminally blocked in some 
way. This is the case with rat myoadenylate deaminase 
(Sabina et al.. 1987). This and other possible reasons for 
the lack of sequence from AMP deaminase is discussed in the 
following chapter. '
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CHAPTER 7 
CONCLUDING REMARKS
As. discussed in the individual chapters several different 
strategies have been adopted during the course of this study 
to facilitate the cloning of the AMP deaminase gene from
S .cerevisiae.
In Chapters 3 and 4 methods have been described which relied 
on the overproduction of AMP deaminase when the gene is 
introduced into yeast on a multicopy plasmid. During the 
course of these studies there was no evidence that such an 
increase in activity would be observed. It was felt that 
because of the role the enzyme plays in central energy 
metabolism and because of its exquisite control by allosteric 
effectors the cell might be extremely disadvantaged by 
increased amounts of the enzyme. Therefore, when the two 
different types of methods of screening described in Chapters 
3 and 4 failed, a time-consuming screen of the library (by 
simply assaying several thousand individual transformants) 
was not attempted. However, there is now some evidence that 
a strategy like this might have worked as will be discussed 
later.
The -decision was therefore made to attempt to purify AMP 
deaminase, generate N-terminal amino acid sequence data and 
hence design and make a suitable oligonucleotide for use as a 
probe to screen a genomic library. The decision was also 
made to design a new and more rapid purification method than 
that previously reported (Yoshino et al. . 1979b).
Attempts to use precipitation techniques as an initial 
purification step resulted in rather mixed success but were 
finally rejected (as discussed in Chapter 5). Similarly 
affinity chromatography was not used in the final 
purification as the types of affinity media studied were not 
appropriate for the purification of this enzyme. Finally, 
all purification steps were carried out using the Pharmacia 
FPLC system. At all stages of this purification problems 
were encountered in maintaining the enzyme's activity and all 
attempts to alleviate this situation proved fruitless. 
Finally, all the steps in the purification were carried out 
in a single day to maintain enough activity for the 
identification of an active fraction. Another problem was 
encountered in that AMP deaminase [at least from mammalian
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sources (Fishbein, personal communication) and apparently 
from yeast] does not enter non-denaturing polyacrylamide gels 
under normal running conditions and hence attempts to adapt a 
suitable activity gel were unsuccessful. Therefore, once 
purified material was produced it was subjected to SDS/PAGE 
and the presence of a single band of an apparent M.W. of 
approximately 83kDa (the reported size of yeast AMP deaminase 
(Yoshino and Murakami, 1979b) was observed. This was deemed 
to be evidence of sufficient purity to allow amino acid 
determination to be carried out. In fact there was some 
minor contamination of lower molecular weight material, but 
as the 83kDa band was further purified by.electroblotting 
this would not lead to contamination during sequencing.
Sequence analysis, as discussed in Chapter 5 led to the 
hypothesis that AMP deaminase was identical to heat shock 
protein 90. The only possible alternative to explain 
sequence results was that hsp90 had copurified with AMP 
deaminase.
An initial attempt to distinguish between these two 
possibilities was to heat shock a culture of yeast and 
extract the cells and assay for AMP deaminase activity before 
and after heat shock. The reasoning behind this was that if 
AMP deaminase activity decreases sharply on heat shock it 
would be extremely unlikely that it is a heat shock protein. 
This experiment proved inconclusive since: AMP deaminase 
activity appeared to be maintained, and possibly elevated 
slightly during heat shock. This could be due to a number of 
reasons (as will be discussed later) but did not rule out the 
possibility that hsp90 and AMP deaminase are the same 
protein.
Therefore, the chromosomal HSP90 gene was insertionally 
inactivated via the production of a Yip vector. The AMP 
deaminase activity upon heat shock was then compared in this 
hsp90 mutated strain and a control strain. The results 
indicated that AMP deaminase is not hsp90. This is strongly 
suggestive that hsp90 was copurified with AMP deaminase and 
that this contaminant yielded the amino acid data.
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In 1985, Meyer and Schramm reported that they had cloned the 
AMP deaminase from yeast. A lambda gtll library containing 
randomly sheared S .cerevisiae genomic DNA (to which Eco RI 
linkers were ligated) was screened using rabbit anti-yeast 
AMP deaminase antiserum. From this study the same 
recombinant phage was selected on three separate occasions 
using this antiserum. Western blot analysis revealed that 
the phage was producing a hybrid protein of 180kDa comprising 
114kDa of B-galactosidase and approximately 66kDa of the 
cloned gene product (Meyer and Schramm, 1985).
This clone was subjected to DNA sequence analysis and the 
sequence was compared to amino acid sequence data available 
from purified yeast AMP deaminase. This comparison revealed 
that the selected lambda clone did not contain even part, of 
the AMP deaminase gene (V.L. Schramm, personal 
communication). Therefore this screening system had been 
unsuccessful in selecting for the AMP deaminase gene, and had 
yielded only false positives.
As the work described in the body of this thesis was nearing 
completion, a personal communication from Professor V.L. 
Schramm indicated that the same group had succeeded in 
cloning and sequencing the yeast AMP deaminase gene. This 
work has now been published (Meyer et al.. 1989) and the 
method used by this group to clone the gene is summarised 
here.
Firstly, a yeast strain deficient in AMP deaminase was
isolated by direct enzymatic assay of colonies surviving1
treatment with nitrosoguanidine. Western blot analysis s
confirmed that the strain was deficient in AMP deaminase
(i.e. amd). Purified AMP deaminase was subjected to tryptic
digestion and small peptides were HPLC purified. The N-
terminal sequence of some of these peptides along with the
amino acid sequence of the intact protein were determined.
Amino acid data from one of these internal tryptic peptides
was used to design two synthetic oligonucleotides of 15 and
20 residues respectively. These oligonucleotides were used
to screen a lambda gtll yeast genomic library which allowed
selection of a clone containing part of the AMP deaminase
gene. A fragment from this clone was then used to screen a
\
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yeast genomic library in the yeast—E .coli shuttle vector 
YCp50. Selected plasmids were then transformed in to the amd 
strain and one clone'restored AMP deaminase activity to the 
deficient strain, and restored the band corresponding to AMP 
deaminase on Western blots.
Some of the findings of this group are pertinent to the study 
presented here. Firstly, they found that an amd~ strain 
(lacks AMP deaminase activity) is viable. They also found 
that when introduced into the cell on a multi-copy vector, 
multiple copies of the AMP deaminase gene resulted in a 15- 
fold increase in AMP deaminase specific activity, and this 
had little effect on the strain's growth (Meyer et al..
1989). These findings suggest that production of an AMP 
deaminase mutant would have been an alternative strategy to 
adopt. We had reasoned that, because of the enzymes central 
role in energy metabolism the AMP deaminase gene may be 
essential.
Western blot analysis performed by this same group revealed 
that extracts prepared from actively growing yeast indicates 
a major band at approximately 96kDaltons (which is in close 
agreement with their predicted molecular weight of 93,286 
Daltons). However, in such extracts several bands at lower 
molecular weight, including 83kDaltons are detected by the 
same antisera. This 83kDa polypeptide is the major form 
found in purifded preparations of AMP deaminase, as 
previously reported by Yoshino et al (1979b). It appears 
that during purification, and possibly to a certain extent 
within the cell, limited proteolysis occurs which results in 
a truncated, but active form of AMP deaminase. This is 
highly reminiscent of the findings discussed in Chapter 1 
where AMP deaminase of rabbit muscle, frog muscle, trout gill 
and muscle is subjected to limited proteolysis when stored 
(Raffin, 1986a and 1986b; Ranieri-Raggi et al.. 1985).
Raffin found that in the case of trout muscle AMP deaminase 
this situation could be mimicked trypsin treatment. These 
cases of limited proteolysis resulted in the enzyme having 
altered kinetics. This situation remains to be seen in the 
case of yeast AMP deaminase.
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This does not however answer the question, why did purified 
AMP deaminase material yield no amino acid sequence data, but 
instead hsp90 was successfully sequenced. There was no 
evidence during sequencing that more than one protein was 
present in the fraction purified on the basis of AMP 
deaminase activity. That is, the quality of the sequence was 
in agreement with there being only one protein present (John 
Fitton, personal communication). However, it is possible 
that AMP deaminase was present in the purified material in 
such low quantities as to yield- not even evidence of there 
being more than one polypeptide species present. As stated 
at the end of the previous chapter this seems unlikely. 
Unfortunately, the purification, procedure adopted in this 
study was inefficient in terms of recovery. It did not yield 
sufficient material to allow protease treatment to allow N- 
terminal sequencing of internal peptides to be carried out. 
Meyer and Schramm have found no' evidence that the 83kDa 
truncated protein was N-terminally blocked (V.L. Schramm, 
personal communication). However the question of what they 
term a "ragged" end (i.e. a number of protein species of 
various molecular weights can be detected) to AMP deaminase 
is intriguing. They found that in actively growing cultures 
the predominant species is the 96kDa one, and throughout 
purification, protease contamination lowers the yield of this 
high molecular weight form in favour of the lower molecular 
weight form. Might it be that in cells which are not 
actively growing (i.e. stationary cells, such as those that 
used to produce protein extracts) the proteolysed forms are 
predominant. It may even be that under certain conditions a 
further proteolysis to yield a 'slightly smaller polypeptide 
can occur and this intermediate may be blocked to Edman 
degradation of the N-terminal. : A range of protease 
inhibitors were tested, but with apparently no effect. Hence, 
only ImM PMSF was added to buffers in the final purification. 
Clearly, further study is required to answer these questions.
Using the sequence data produced by Meyer et al. (1989), the 
AMP deaminase gene has been selected and cloned in this 
laboratory, as descibed briefly here. Two oligonucleotides 
were designed and produced which are complementary to 51 and 
3* regions of the gene respectively. Using these 
oligonucleotides a lambda gtll genomic library was screened
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and lambda clones representing the 5 1 and 3’ sections of the 
gene were selected. The inserts of these lambda clones were 
subcloned into pUC18'and subjected to double-stranded 
sequence analysis to confirm that they are indeed AMP 
deaminase gene-specific sequences.
Work will continue to study some aspects of AMP deaminase 
expression. Interestingly, within the AMP deaminase gene 
promoter there is a 7 out of 8 match to the consensus 
described by Tuite et al. (1988), to best represent the heat 
shock responsive element in yeast. This consensus sequence 
and its positioning in the 5' regions of certain heat shock 
regulated genes is shown below.
Consensus nnTTCTAGAAnn
hsp26 -357 GGTTCTAGAAAG -346
hsp70 A -356 CATTCTAGAAAG -345
hsp70 B -203 TTTTCCAGAAAG -192
hsp90 -237 TTTTCTAGAACG -226
PGK1 -366 GGTTCTGGAAAG -355
AMPD -271 AGTTCTAGTAGC -263
As can be seen from this data, other genes known to be 
regulated by heat shock, namely HSP70B and PGK1 (the gene for 
phosphoglycerate kinase) have only a 7 out of 8 match to this 
consensus sequence. Therefore, one of the prime objectives 
is to study the effect of heat shock (and other related 
stresses) on the expression of AMP deaminase at the level of 
RNA. Clearly the results indicated in chapter 6 have 
strongly suggested that AMP deaminase activity is maintained 
during heat shock. This now awaits confirmation by Northern 
blot analysis.
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APPENDICES
APPENDIX 1:
Genotvoes of orocrenv of DBY868/W1--2D rho""C cross
1. A ade2+ f hptl+ his4+ 2. A ade2+ , hptl+ , his4+
B ade2+ f hptl- *his4+ B ade2- , hPtl+ . his4-
C ade2~ f hptl+ his4- C ade2- , hptl- , his4+
D ade2~ f hptl- :his4- D ade2+ , hptl- . his4-
3. A ade2- r hptl+ his4- 4. A ade2+ , hptl- , his4-
B ade2~ f h£tl+ his4+ B ade2+ . hptl- . his4+
C ade2+ r hptl- his4“ C ade2- , hptl+ , his4+
D ade2+ f hptl" his4+ D ade2- . hptl+ , his4-
5. A ade2+ , hptl- his4+ 6 . A ade2~, hEtl+ , his4+
B ade2- r hptl+ his4- B ade2~, hptl+ , his4-
C ade2~ r hptl- his4+ C ade2+ , hptl-, his4-
D ade2+ r hptl+ his4- D ade2+ . hptl- , his4+
7. A ade2- r hptl+ his4- 8 . A ade2+ , hptl.- , his4+
B ade2- . hptl+ -his4- B ade2- . hotl+ . his4-
C ade2+ r hptl- his4+ C ade2+ , hptl- , his4+
D ade2+ , hptl- his4+ D ade2- . hptl+, his4-
9. A ade2+ f hptl- his4+ 10. A ade2+ . hptl- , his4+
B ade2“ . hptl+ his4+ B ade2- . hptl+ . his4-
C ade2~. hptl+ his4- C ade2+ . hptl- . his4-
D ade2+ r hptl- his4- D ade2- , hptl+ , his4+
Genetic Analvs is of Cross 1
The recombination frequencies presented here have been 
calculated thus (Fincham, 1983)
R = Tetratypes + (2 x Non-parental ditypes)
2 x Total asci
Note: The status of the HPT1 locus could not be determined in 
ade2~ strains. However, probable HPT1 status has been 
assigned wherever possible, i.e. where two spores from the 
same tetrad are identical at the ADE2 and HIS4 loci, and one 
must be Hptl~ and one Hot . !
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APE2/HPT1 recombination analysis 
PDT 7 
NPDT 
TT 3
The recombination frequency between APE2 and HPT1 markers is
calculated as 15% within the limits of'this experiment. The
APE2 marker is known to reside on chromosome XV (Mortimer and
Schild, 1985). As yet HPT1 has not been assigned to a
chromosome. A recombination frequency between these markers
of 15% suggests that HPT1 may also reside^ on chromosome XV. 
Further evidence that these two loci are linked is the excess 
of parental ditype asci compared to non-parental ditype asci 
(i.e. 7 to 0).
APE2/HIS4 recombination analysis
PPT 3
NPPT 
TT 7
The recombination frequency between APE2 and HIS4 is 
calculated to be 35% in the limits of this experiment. This
is considered as not a significant deviation from the
expected frequency of 50%. This result is not surprising 
since as previously stated APE2 resides on chromosome XV and 
HIS4 has been reported as residing on chromosome III 
(Mortimer and Schild, 1985).
HPT1/HIS4 recombination analysis
PPT 2
NPPT 
TT 8
The recombination frequency between HPT1 and HIS4 is 
calculated as 48% within the limits of this experiment. This
is considered to be 50% which is as expected since as
previously stated HIS4 has been assigned to chromosome III, 
and we have hypothesised here that HPT1 resides on chromosome 
XV which would mean that these two genes are linked.
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APPENDIX 2:
Genotypes of the progeny of JMM1-1D/X4003-5B cross
1. ura3 met2 trp5 leu2 his4 ade- hptl
A
B - + - + +
C + - - - -  +
D + + + + - +
2. ura3 met2 trp5 leu2 his4 ade- hptl
A + + - + - -
B - + - - • +
C - + + - - -
D +
3. ura3 met2 trp5 leu2 his4 ade- hptl
A - - - - -  +
B - + - +
C + -  + + - -
D + + + + — ~
4. ura3 met2 trp5 leu2 his4 ade- hptl
A +
B + + + + - ~
C - - + - - -
D + + - + — ~
5. ura3 met2 trp5 leu2 his4 ade- hptl
A + -  + + - -
B  - - - - -  -  +
C + + + - -  +
D - + - + +
6. ura3 met2 trp5 leu2 his4 ade- hptl
A ■ - + - - - +
B + + + + - -
D + -  + + - -
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7. ura3 met2 trp5 leu2 his4 ade hptl
A - + + - - -  +
B +
C
D + + - + - +
8. ura3 met2* trp5 leu2 his4 ade- hptl
A - + + + - -  +
B
C + - - - -  +
D + + — - ~ —
9. ura3 met2 trp5 leu2 his4 ade- hptl
A - + - - -  +
B + — + + ~ -
C + + + + ~ -
10. ura3 met2 trp5 leu2 his4 ade- hptl
A + + + + - -
B - - - - - -  +
C - + - + + - +
D + - - - - -
11. ura3 met2 trp5 leu2 his4 ade- hptl
A + - -  + - +
B - - + - - - +
C - + + - -  - -
D + + - + - -
12. ura3 met2 trp5 leu2 his4 ade- hptl
A - + + + - -  +
B + - - - - +
C + + — + — —
D - -  + - -  - +
13. ura3 met2 trp5 leu2 his4 ade- hptl
A _ + +
B
C +
D + + + + — —
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14.
15.
16.
17.
18.
1 .
ura3 met2 trp5 leu2 his4 ade- hptl
A + - + + - -
B - + - - - - -
C + - + + - -
D - + - - - - +
ura3 met2 trp5 Ieu2 his4 ade- hptl
A - + - - - - +
B + - + + - +
D + + + + - -
ura3 met 2 trp5 leu2 his4 ade- hptl
A + - + - + -
B - - + + - +
C - + - + - - -
D + + - - + +
ura3 met2 trp5 Ieu2 his4 ade- hptl
A + + + + - -
B - - - - - +
C - + - - - - -
D + - + + - -
ura3 met2 trp5 leu2 his4 ade- hptl
A + - + + - -
B - + - - - +
C + - + + - -
D +
Dtvpes of the procreny of JMM1--5C/X4003-5B cross
ura3 met2 trp5 leu2 his4 ade- hptl
A + - - + + -
B + + + + - -
C - + - - - - +
D — — + — + - +
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2. ura3 met2 trp5 leu2 his4 ade- hptl
A - + -
B - - - - -  - +
C + 4- + + +
D + - + + -
3. ura3 met2 trp5 leu2 his4 ade- hptl
A + - + - + +
B - + - + +
C - + - + + +
D + -  + - - -
4. ura3 met2 trp5 leu2 his4 ade- hptl
A + + + +
B - - - - -  +
C - - -  + + - +
D + + + - + -
5. ura3 met2 trp5 leu2 his4 ade- hptl
A + -  + + + -
B - + - - -  +
C + + + + + -
D _ _ _ _ _ _  +
6. ura3 met2 trp5 leu2 his4 ade- hptl
A - +
B + + - + + -
C + - -  + - +
D - + + - - -
7. ura3 met2 trp5 leu2 his4 ade- hptl
A - +
B - — - + + - +
C + + + - - -
D + + - - -  +
8 . ura3 met2 trp5 leu2 his4 ade- hptl
A - + - + + +
B + + — + + —
C
D + — + — — +
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9. ura3 met2 trp5 leu2 his4 ade" hptl
A - - + + + +
B + - - +
C +  + -  -  -  -
D - + + + - -
10. ura3 met2 trp5 leu2 his4 ade- hptl
A - + + + + +
B + - + - -
C -  + - -  + -  +
D + — — + — —
Genetic Analysis of Crosses 2 and 3
The recombination frequencies presented here have been 
calculated thus (Fincham, 1983)
R = Tetratypes + (2 x Non-parental ditvoes)
2 x Total asci
Note: In all instances with the exception of HIS4. data from 
both crosses can be analysed together. Because both parents 
of cross 3 are his4~ . no assortment can be seen in this cross 
for this marker therefore data relating to HIS4. is taken 
only from cross 2.
All reference to chromosomal location is from Mortimer and 
Schild, 1985.
URA3/MET2 recombination analysis 
PDT 3
NPDT 4
TT 21
The recombination frequency between URA3 and MET2 is 
calculated as 52%. Therefore the two genes are unlinked.
Ura3 resides on chromosome V and MET2 on chromosome XIV.
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IJRA3 /TRP5 recombination analysis
PDT 12
NPDT 7
TT 9
The recombination frequency between URA3 and TRP5 is 
calculated as 41% which does not deviate significantly from 
50%. The URA3 gene has been assigned to chromosome V and is 
therefore not linked to TRP5 which has been assigned to 
chromosome VII.
URA3/LEU2 recombination analysis
PDT 16
NPDT 5
TT 7
The recombination frequency between URA3 and LEU2 is 
calculated as 28.2% which does not deviate significantly from 
50%. The URA3 gene has been assigned to chromosome V and is 
therefore not linked to LEU2 which has been assigned to 
chromosome III.
MET2/TRP5 recombination analysis
PDT 2
NPDT 5
TT 21
The recombination frequency between MET2 and TRP5 is 
calculated as 55% which does not deviate significantly from 
50%. The MET2 gene has been assigned to chromosome XIV and 
is therefore not linked to TRP5 which has been assigned to 
chromosome VII.
MET2/LEU2 recombination analysis
PDT 6
NPDT 3
TT 19
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The recombination frequency between MET2 and LEU2 is 
calculated as 44% which does not deviate significantly from 
50%. The MET2 gene has been assigned to chromosome XIV and 
is therefore not linked to LEU2 which has been assigned to 
chromosome III.
TRP5/LEU2 recombination analysis
PDT 12
NPDT 6
TT 10
The recombination frequency between TRP5 and Leu2 calculated
as 39% which does not deviate significantly from 50%. The
TRP5.gene has been assigned to chromosome VII and is ✓
therefore not linked to LEU2 which has been assigned to 
chromosome III.
HIS4/URA3 recombination analysis
PDT 2
NPDT 1
TT 7
The recombination frequency between HIS4 and URA3 calculated 
as 45% which does not deviate significantly from 50%. The 
HIS4: gene has been assigned to chromosome III and is 
therefore not linked to URA3 which has been assigned to 
chromosome V.
HIS4/MET2 recombination analysis
PDT 3
NPDT 3
TT 4
The recombination frequency between HIS4 and MET2 is 
calculated as 50%. The HIS4 gene has been assigned to 
chromosome III and is therefore not linked to MET2 which has 
been assigned to chromosome XIV.
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HIS4/TRP5 recombination analysis
PDT 1
NPDT 1
TT 8
The recombination frequency between HIS4 and TRP5 is 
calculated as 50%. The HIS4 gene has been assigned to 
chromosome III and is therefore not linked to TRP5 which has 
been assigned to chromosome VII.
HIS4/LEU2 recombination analysis
PDT 3
The recombination frequency between HIS4 and LEU2 is 
calculated as 35% which does not deviate significantly from 
50%. However both HI-S4 and LEU2 have been mapped to 
chromosome IIIL and the 35% recombination frequency may 
represent some level of linkage between these two loci.
NPDT
TT 7
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